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Background - Mobile health (mHealth) interventions to promote medication 
adherence have shown promise; among patients primarily diagnosed with Coronary 
Heart Disease (CHD), however, there is a lack of evidence for nurse-led mHealth 
interventions, in this particular group in Iran.  
Aim - To refine and evaluate a pre-developed nurse-led mHealth intervention to 
promote cardiovascular medication adherence in Iranian adult, male and female 
Cardiac Rehabilitation (CR) outpatients. 
Methods - A quantitative-dominant mixed methods study was conducted drawing 
upon the Medical Research Council’s (MRC) Framework on the development and 
evaluation of complex interventions. Phase 1 comprised of a self-completion CHD 
patients’ survey (n=123) and three focus groups with cardiac nurses (n=23) within 
three public university-affiliated hospitals in Tehran, which in turn informed Phase 2 
(the exploratory trial phase). The automated Short Message Service (SMS) 
medication reminder was designed based on the dimensions of adherence suggested 
by the World Health Organisation (WHO) and Bandura’ Self-efficacy Theory.  The 
intervention was refined according to the findings from Phase 1 and then piloted in 
an Iranian CR setting. Seventy eight CHD patients who were 18 years or older, and 
had mobile phone access were recruited and randomised to receive either daily SMS 
reminders (n=39) or usual care (n=39) for 12 weeks. The primary outcome was the 
effect on cardiovascular medication adherence as measured by the self-reported 
Morisky Medication Adherence Scale; secondary outcomes explored the feasibility 
of the mHealth intervention, intervention effect on medication adherence self-
efficacy, cardiac ejection fraction, cardiac functional capacity, hospital readmission/ 
death rate and health-related quality of life. Patient acceptability was assessed 
through completion of a post-intervention survey.  
Results - Feasibility was evidenced by high ownership of mobile phones in CHD 
patients, high application of SMS messaging, positive patients’ perception about the 
intervention, suboptimal cardiovascular medication adherence and patients’ high 
interest in receiving SMS reminders for their medications. Participants in the 
intervention group showed higher self-reporting of medication adherence compared 
to the usual care group χ
2 
(2) = 23.447; P<0.001. The Relative Risk (RR) was 
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indicated that it was 2.19 times more likely for the control group to be less adherent 
to their medications than the intervention group (RR = 2.19; 95% Confidence 
Interval (CI) 1.5 - 3.19). All secondary outcomes improved in the intervention group 
at the end of the study. Acceptability was evidenced by participants who received the 
intervention reporting that they perceived the SMS reminders useful.  
Conclusion - The SMS medication reminder intervention was well accepted and 
feasible with significantly higher reporting of medication adherence in Iranian CHD 






There are some patients who require support to take their medication after 
leaving the hospital. Using text message reminders sent by healthcare staffs to 
patients’ mobile phones may help them remember to take their medications after they 
have left the hospital. For patients in Iran who have heart disease, we do not know if 
nurses sending text message reminders to patients’ phones to improve their 
medication taking is possible and if it works.  In this study, we hoped to study these 
issues further.  
We asked 123 patients with heart conditions to answer a series of questions 
about their thoughts on using mobile phones to remind them to take their medication 
and whether it was possible and acceptable to them. For example, we asked whether 
they owned a mobile phone and sent/ received text messages to/ from others. We also 
asked them their thoughts on being sent text message reminders, when and how often 
they would prefer to receive reminders. We also spoke with a total of 23 nurses who 
were caring for patients with heart conditions about their thoughts on text message 
reminders. Nurses stated that text messages would be useful and could potentially act 
as a medication reminder, create a connection from hospital to home and avoid 
negative outcomes of medication mismanagement. We used all information from 
patients’ answers and nurses’ opinions to design automated text message reminders. 
We then went to a hospital in Tehran and recruited 78 patients who attended one 
outpatient clinic called “Cardiac Rehabilitation” (an exercise programme after 
patients have recovered from a heart attack). We divided them randomly into two 
groups (39 patients in each group). One group received daily text message reminders 
on their mobile phones for 12 weeks and the other group received the usual care with 
no text reminders (this type of study is called a “trial”). Before introducing the text 
message reminders to the groups, we visited all patients and asked questions about 
their age and background, any difficulties they had with taking their medications, 
general health, physical and mental wellbeing. After 12 weeks, we visited all the 
patients again and asked similar questions about their medications and health to 
make a comparison. We also asked them to answer questions about their experience 
of receiving reminders for their heart medications. 
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Our results showed that most of the patients, who took part in the initial survey, 
reported owning a mobile phone, used text messaging regularly and were happy to 
receive text reminders because they had difficulty in taking their heart pills. In the 
trial after 12 weeks, patients who received text reminders took their medications 
more accurately and their health was improved compared to patients who did not 
receive it. Patients also were satisfied with text messaging and felt that it helped them 
to remember to take their heart medications. 
Overall, nurse-led text message medication reminders were well accepted and 
helpful with greater results in medication taking in Iranian patients with heart 
disease. We also know that it is possible to use text message reminders in Iran. We 
now need to conduct a larger trial in future to understand more about the effect of 
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CHAPTER 1: INTRODUCTION 
This introduction chapter is presented in eight sections that review the 
background information relating to Cardiovascular Disease (CVD), Cardiac 
Rehabilitation (CR), medication adherence among patients suffering from Coronary 
Heart Disease (CHD) and Mobile Health (mHealth). The first section provides an 
overview of the nature and prevalence of CVD in different regions in the world and 
in Iran, where this study will be conducted. In the second section, the role of CR 
programmes and their importance in secondary prevention of CVD will be presented. 
This chapter also provides the background and sets the scene regarding non-
adherence among cardiovascular patients. mHealth as a new intervention to improve 
medication adherence will be introduced with a specific focus on CHD patients. 
Finally, the significance of the study and the structure of this thesis will be described. 
1.1 Cardiovascular Disease  
According to the World Health Organisation (WHO) (2016a), CVD is the main 
reason for mortality worldwide, accounting for more than 17 million deaths each 
year (46% of all deaths caused by non-communicable diseases) and this figure is 
projected to increase reaching 23.6 million by 2030. Over 80% of CVD deaths take 
place in low and middle-income countries )WHO, 2016a). CVD was the cause of an 
estimated 9.3 million deaths in the Asia/Pacific region and accounted for about one-
third of all deaths in 2012 (WHO, 2016a). CVD prevention in Asia is an important 
issue for world health, because half of the world’s population resides in Asia (United 
Nations Economic and Social Commission for Asia and the Pacific, 2016). CHD, the 
most important type of CVD, is manifested when the coronary arteries, become 
narrowed or blocked and cannot supply adequate blood to the heart; This can cause a 
heart attack, angina or heart failure (National Health Service, 2014). CHD accounts 
for 46% of cardiovascular deaths in male and 38% in female globally (Mendis et al., 
2011). It alone caused approximately 380,000 death for both men and women 
(accounts for 1 in 6 deaths) every year in the United States (US) (Murphy et al., 
2013). CHD causes nearly half of all deaths in Europe and 40% in the European 
Union (EU) (Nichols et al., 2014). It continues to be a major cause of mortality and 




per year in the UK (British Heart Foundation, 2015). Near 7 million people are living 
with cardiovascular disease in the UK: 3.5 million men and 3.5 million women 
(British Heart Foundation, 2015). In Asia the CHD-related mortality rate varies from 
103 to 366 per 100 000 adult populations (Wong et al., 2015). Although CHD is the 
most common cause of death in Asian communities, including Iran (the study 
setting), data on incidence of CHD is scarce in the Middle East population (Khalili et 
al., 2014). The Middle East and parts of Eastern Europe probably have the highest 
cardiovascular death rates in the world (Motlagh et al., 2009).  
CHD accounts for nearly 50% of all deaths per year in Iran as a middle income 
country in the Middle East with a total population of over 76 million (World Health 
Organisation, 2014). This figure is similar to the mortality rate caused by 
cardiovascular disease in Turkey (47%) and Saudi Arabia (46%), neighbouring 
countries in the Middle East region (World Health Organisation, 2014). In Tehran, 
the largest city and the capital of Iran with a population of around 8.3 million, more 
than 40% of mortality has been related to CVD (Khalili et al., 2012). Approximately 
20% of adults aged 30 years and over in this capital city have symptoms or signs of 
CHD (Hadaegh et al., 2009). According to a 10-year population-based cohort study, 
the crude CHD incidence rate in men was about twice that in women (11.9 vs. 6.5 
per 1000 person-years) (Khalili et al., 2014). As a comparison, this incidence of 
CHD is lower than Northern Europe and higher than Southern Europe (Menotti et al., 
2000). The incidence of CHD in East Asia during the last decade was much lower 
than that observed in the Iranian population; A study from China showed an age-
standardised incidence of 2.2 in men and 1.2 in women per 1000 persons (Sun et al., 
2012). Another study reported this finding for Japanese aged 40–69 years, equal to 
1.0 and 1.8 per 1000 persons for men and women, respectively (Kitamura et al., 
2008). 
According to the Ministry of Health and Education of Iran, the majority of all 
CVD deaths are attributable to CHD; therefore a policy priority and the long-term 
goal will be the reduction of 25% in cardiovascular mortality rate in the next 10 years 
(Ministry of Health and Education of Iran, 2016). 
High prevalence of and a predicted large rise in cardiovascular disease over the 




studies on primary and secondary cardiovascular prevention. This may help to reduce 
cardiovascular event rates, and should assist in managing the impact of future CVD. 
1.1.1 Impact of Cardiovascular Disease  
Cardiovascular disease has been considered an epidemic chronic condition at 
present and was predicted to remain the single most important disease in the world in 
the terms of mortality, morbidity, disability and economic loss until the year 2020 
(WHO, 2016). In the US, despite population-based prevention programmes over 
previous decades, CHD remains the leading cause of death and early and permanent 
disability (Go et al., 2014). It also has an adverse impact on quality of life (Jneid et 
al., 2012). In spite of the lack of high-quality data, it can be clearly seen that CHD is 
by far the most significant public health issue across Asia and the Middle East, an 
issue that may reach catastrophic prevalence unless confronted efficiently (Ramahi, 
2010). CHD is associated with tremendous morbidity, societal health problem, stress, 
high expense of care, and increased financial burden due to loss of productivity 
(World Health Organisation, 2013).  
Middle Eastern countries have mostly young populations that are at high risk of 
CHD as a result of uncontrolled tobacco smoking and inactive stressful urbanised 
lifestyle and unhealthy eating habits (World Health Organisation, 2016b). The oil 
industry is the main source of income in Iran. Prevention of the financial burden 
caused by CHD is of importance to preserve a productive workforce. According to a 
study, 65% of CHD patients that were admitted to the National Iranian Oil 
Corporation (NIOC) Central Hospital in 1999–2000 were in their most productive 
years of life, between 40 and 55 years old (Larijani et al., 2003). In some Middle 
East countries, obesity, diabetes mellitus, hypertension and lipid disorders are on the 
rise as a consequence of rapid economic growth and increasing urbanisation (Teo et 
al., 2013). An Iranian population-based study showed that well-known modifiable 
risk factors, as the essential preventable parameters of causal diagram for CHD, 
contribute to about 40% and 50% of the CHD risk in men and women, respectively 
(Khalili et al., 2014). The absolute consequence is high prevalence of CVD risk 
factors in large young populations with limited access to prevention strategies and 
facing inadequate and poorly financed healthcare systems. These currently 




and tertiary health care to elderly people with very high prevalence of CVD in future 
(Ramahi, 2010).  
Poor adherence to medications and health recommendations among 
cardiovascular patients is an additional risk factor contributing to the progression of 
disease, complications, rehospitalisation, reduced quality of life, higher morbidity 
and mortality and healthcare expenses (Munger et al., 2007, Piepoli et al., 2016). 
Throwing light on the impact of CHD provides the foundation for the 
development of interventions aimed at primary and secondary prevention of CHD. 
Secondary prevention such as Cardiac Rehabilitation (CR) contains intensive control 
of risk factors, drug treatment, and follow-up visits that play a major role in 
preventing recurrences of CHD and its complications (Achttien et al., 2013, Piepoli 
et al., 2016).  
1.2 Cardiac Rehabilitation (CR) 
CR is an essential part of CHD care recommended by international guidelines 
such as the American Heart Association (2013), the American College of Cardiology 
(2011), the European Society of Cardiology (2016) and the British Association for 
Cardiac Rehabilitation (2017) that includes physical, education and psychological 
input focusing on health and life-style behaviour change, risk factor modification, 
and psychosocial well-being.  
CR as a secondary prevention programme plays an important role among non-
pharmacological interventions to reduce the risk of cardiac recurrence and risk factor 
modifications (Cossette et al., 2012). CR is one of the most cost-effective and 
multidisciplinary disease management service consisting of making required changes 
in lifestyle and appropriate use of medications that assist patients to slow or even 
reverse the development of coronary disease (Anderson et al., 2016, British Heart 
Foundation, 2016). The main goals of CR are to help patients improve both 
physically and psychologically after a cardiac event and decrease the risk for 
recurrent cardiac events (Achttien et al., 2013). Patients who participate in CR have a 
20% relative decrease in cardiac mortality over the following 5 years (Mampuya, 
2012). 
CR should be available as a coherent package of exercise, education, 




secondary prevention services (British Heart Foundation, 2016). While extensive 
research and clinical guidelines support the role of pharmacological treatment and 
the importance of medication adherence, within the secondary prevention of CHD 
these seem a neglected component of the CR programme (Jneid et al., 2012, O'Gara 
et al., 2013, Park et al., 2013). 
1.2.1 Phases of Cardiac Rehabilitation 
Current clinical British guidelines recommend that it is necessary for all CHD 
patients to receive secondary prevention to maximise physical, psychological and 
societal wellbeing (British Heart Foundation, 2016, National Institute for Health and 
Clinical Excellence, 2013, Piepoli et al., 2016). The healthcare system in Iran aims to 
follow current clinical guidelines and provide quality CR services for cardiac patients 
(Sarrafzadegan et al., 2007). CR is commonly divided into either three or four 
phases, with the content of these phases varying between nations (Price et al., 2016). 
CR in Iran includes three phases with different components adapted from American 
Heart Association (2013) and the American College of Cardiology guidelines (2011): 
inpatient recovery period in the cardiac intensive care unit (Phase I), exercise 
programme in outpatient CR clinic (Phase II), and finally long-term follow-up or 
ongoing prevention (Phase III) (see Table 1.1). CR teams generally comprise of 
cardiologists, cardiac rehabilitation nurses, physiotherapists, nutritionists and 
psychologists (Moghadam et al., 2008, Sharif et al., 2012). The programme follows 
progression from hospitalisation after an acute event through to recovery and 
ongoing maintenance where CR is part of the post cardiac event process. Table 1.1 
outlines the phases of CR currently in place in Iran. 
Table 1.1. Description of CR phases in Iran (Moghadam et al., 2008, Sharif et al., 2012) 
CR Phases Description 
Phase I It occurs before hospital discharge or inpatient stage or after a ‘step change’ in the 
patients’ cardiac condition includes medical assessment, verbal and written self-help 
advice and education, risk factor assessment, medication prescription, mobilisation 
and discharge planning with involvement of partner or family.  
 
Phase II  It occurs after four to six weeks of an acute cardiac event, involves supervised and 
structured exercise training in combination with educational and psychological 
support and advice on risk factors. At the first session of this phase, patients receive 
specific education to reduce cardiac misconceptions and encourage smoking cessation 
and weight management; vocational advice and rehabilitation to assist return to work 




CR Phases Description 
Phase III It includes the long-term maintenance of changed behaviour. Involvement with a local 
cardiac support group, which involves exercise in a community centre such as a gym 
or leisure centre, may help maintain physical activity and lifestyle change. 
1.3 Medication Adherence  
This section describes the concept of medication adherence and reviews the 
literature around its terminology, different types of medication non-adherence and 
measurement strategies. Prevalence and background information relating to 
medication non-adherence are discussed with a specific focus on cardiovascular 
medications. Important factors that have an impact on patient medication non-
adherence are considered. Influencing factors related to non-adherence, 
characteristics of diseases, and aspects of the healthcare setting that may impact on 
patient’s non-adherence are presented. 
1.3.1 Medication Adherence Terminology 
Different terminologies exist and are used interchangeably to explain the way 
prescribed medications are taken or not taken by patients. The concept of adherence 
has been defined by the WHO (2003, p3) as: 
“The extent to which a person’s behaviour – taking medication, following a 
diet, and/or executing lifestyle changes, corresponds with agreed recommendations 
from a health care provider.”  
This definition emphasises clearly the active role of the patient in their 
treatment regimen and also requires patient’s agreement on the recommendations. 
Therefore, effective communication and interaction between patient and health 
professional is crucial.  
While the constructs of adherence and compliance have been used 
interchangeably in many conditions, each term definition is quite different; 
adherence includes the patient's acceptance with the recommended therapies, in 
contrast compliance indicates patients’ passiveness. Compliance is a concept that 
implies patients’ dependency and exaggerates power of physician on patients in the 
treatment process. Adherence puts nurses and other care providers in partnership 
with their patients in improving health outcomes (Gould and Mitty, 2010). In the 
present study, the term “adherence” is used to refer specifically to patient’s 




1.3.2 Medication Adherence Measurement 
In current practice, there is no “gold standard” for evaluating medication 
adherence behaviour and it remains a challenging issue (Lehmann et al., 2014, 
McGinnis et al., 2014). When choosing a method of adherence measurement, the 
practicality and reliability of the method should be considered (Stewart et al., 2014). 
Adherence measurement approaches can be divided in two direct and indirect 
methods of measurement:  
Direct Methods  
Direct methods of medication adherence measurement are less common and 
refer to the detection of a metabolite or marker in patients’ blood. This measurement 
strategy is not without drawbacks since a variety of individual factors such as diet, 
herbal treatments, drinking caffeinated beverages or alcohol, taking vitamins, 
pregnancy and intensive exercise can lead to misleading findings. In addition such 
methods are often impractical, costly and invasive (Stewart et al., 2014).  
Indirect Methods 
The most common indirect method of medication adherence measurement is 
patient’s self-report using validated scales, however it has been proposed that 
patients tend to report their behaviour inaccurately or cannot remember previous 
medication consumption, these can therefore distort the results (Berben et al., 2011, 
Stirratt et al., 2015). Other indirect measurements could be implemented based on a 
pill count strategy that refers to counting the number of remaining pills left in the 
patient’s medication container (Stirratt et al., 2015). Although this is a simple 
method, it can also be unreliable; the patients in order to appear adherent to 
medications can change medicines between bottles or throw them out before checks 
are made (Stewart et al., 2014). Counting inaccuracies can also lead to 
overestimation (Brown et al., 2016). Among other approaches, electronic monitoring 
devices like the Medication Event Monitoring System (MEMS) are an innovative 
approach which records the time and date of each opening/closing of the medication 
container (Jose and Jimmy, 2011). However, it is an expensive device and is not 
practical to use widely (Lehmann et al., 2014, Jose and Jimmy, 2011). Alternatively, 
a pharmacy database can be used to see if the patient is (re)filling the initial 




other pharmacies to refill their medications (Stewart et al., 2014). In the present 
study, it was not possible to use the MEMS and pharmacy database as to the 
knowledge of the researcher, such electronic monitoring devices for medication 
taking and electronic pharmacy claim data were not available in Iran during the time 
of this study. Likewise, there were cost constraints. 
According to the literature, triangulation of approaches that combine practical 
self-report measurement and reasonable objective methods could be an effective way 
to measure medication adherence behaviour and increase the reliability and validity 
of the measurement (Brown et al., 2016, Lehmann et al., 2014, Osterberg and 
Blaschke, 2005, Stewart et al., 2014).  
1.3.3 Reasons for Medication Non-adherence 
According to the WHO Multi-dimensional Adherence Model (2003), 
medication non-adherence is a multi-factorial issue (see Section 2.4). Poor adherence 
to medications can be attributed to both intentional and/or non-intentional reasons 
(Berben et al., 2011, Brown et al., 2016). Intentional non-adherence is an active 
process whereby the patient chooses to deviate from the treatment regimen (Brown et 
al., 2016, Gadkari and McHorney, 2012). This may be a rational decision process in 
which the individual weighs the risk and benefits of treatment against any adverse 
effects (Brown et al., 2016). Unintentional non-adherence is a passive process in 
which the patient may be careless or forgetful about adhering to the treatment 
regimen; almost half of the medication non-adherence is unintentional or due to 
forgetfulness, carelessness, complexity of the treatment regimen, problems of 
accessibility, cost and competing life demands (Brown et al., 2016, Gadkari and 
McHorney, 2012). Intentional non-adherence is viewed as being related to people’s 
beliefs about their therapy, illness, prognosis and their expectations towards 
medication consumption (Brown et al., 2016, Osterberg and Blaschke, 2005).  
Based on the Multi-dimensional Adherence Model (2003), the WHO proposes 
that adherence results from the interplay of five sets of factors (dimensions) 
including socioeconomic, therapy, condition, healthcare team/ system, and patient-
related factors  (see Section 2.4).  
Being aware of reasons related to medication non-adherence helps provide an 




actual medication use, barriers, adherence levels, and consequently patient outcomes 
(Berben et al., 2011, Brown et al., 2016). To be more precise, appropriate adherence 
interventions should address multiple barriers to medication adherence (Boswell et 
al., 2012, Brown et al., 2016, Kardas et al., 2013). 
1.3.4 Nurses’ Role in Improving Medication Adherence 
It has been evidenced in the literature that nurses are well placed to provide 
adherence care and follow-up for discharged patients since they are present in all 
healthcare settings and have a close relationship with patients (Linn et al., 2014, 
Najafi et al., 2016, Neubeck et al., 2011, Simoni et al., 2011, Souza-Junior et al., 
2016, Van Camp et al., 2013). Through effective communication skills they will be 
able to provide valuable information as well as support for patients and their families 
throughout their journey from acute care to secondary prevention (Najafi et al., 2016, 
Van Camp et al., 2013). In this way, patients demonstrate higher levels of adherence 
when they are provided with care and support by the same healthcare professional 
over time (Van Camp et al., 2013).  
The early phase of discharge from the hospital is a critical time when many 
patients discontinue medications and ongoing nursing interventions that affect 
adherence early can improve long-term health outcomes (Albert, 2008). Nurses 
should take an active role in assessment, education, care planning, and strategic 
implementation efforts that support patients’ optimal self-care behaviours and 
promote medication adherence (Brown et al., 2016). It has also been advised by the 
Nursing and Health Policy Consultant of the International Council of Nursing (ICN) 
that nurses should provide a link and support through innovative approaches after 
discharge that scale up medication adherence and provide helpful information 
including accurate dosage, routes and frequency pattern of medications as well as the 
importance of maintaining adherence to treatment regimen (Sabaté, 2003). However, 
they currently act as disregarded and underused providers in optimising adherence 
and care outcomes (Van Camp et al., 2013).  
A previous systematic review on interventions to enhance adherence to 
medication among patients with several chronic diseases reported interventions were 
largely pharmacist-delivered and were found to be ineffective (Williams et al., 2008). 




Trial (RCT) to evaluate the effect of nurse-led interventions on chronic medication 
adherence found that nurse-delivered methods were successful in improving 
adherence (Van Camp et al., 2013). These indicate that nurses can play an important 
role in promoting medication adherence and hence evidence-based nurse-led 
approaches should be added to other adherence support strategies in combination 
with the strengths and experience of other clinicians (Brown et al., 2016, Stolic et al., 
2010, Van Camp et al., 2013).  
1.3.5 Overview of Medication Non-adherence  
Poor medication adherence is a complex and prevalent issue among patients 
that has not been sufficiently addressed (Brown et al., 2016, Santo et al., 2016). 
Long-term therapy among chronic patients that is mostly associated with multiple 
drugs prescription indicates an unsatisfying average adherence level of 50% in 
developed countries (Kyanko et al., 2013, Chisholm-Burns and Spivey, 2012). 
Findings from the REACH Registry, a large study in which 69,055 cardiovascular 
patients were recruited from 44 countries worldwide and followed up for four years, 
showed that only 48.6% were fully adherent to cardio-protective medications 
including anti-platelet, statins, and antihypertensive agents (Rodriguez et al., 2013). 
According to this study, greater adherence was observed in North America and 
Europe, whereas participants from Latin America and Asia had lower adherence 
level to their medications. In the PREMIER study that examined the rates of cardio-
protective medication therapy discontinuation among multi-centre prospective cohort 
of 2498 patients experienced acute MI, it was found that more than 1 in 5 patients 
stopped taking aspirin, β-blockers, or statins and 1 in 8 stopped taking all three 
medications within one month after MI (Ho et al., 2006). Similarly, reports of poor 
adherence level have been identified in other conditions such as asthma (Petrie et al., 
2012), diabetes, dyslipidaemia and Human Immunodeficiency Virus (HIV) (Van 
Camp et al., 2013, Langley and Bush, 2014).  
Non-adherence to prescribed drugs contribute to an estimated annual cost of 
£230 million to the UK health care system (National Collaborating Centre for 
Primary Care, 2009). Similarly, in the US non-adherence issue costs $100 billion 
each year (National Community Pharmacists Association, 2013). A study aimed at 




that improving levels of adherence could potentially save around £500 million in 
health-related costs (Trueman et al., 2010). NICE (National Institute for Health and 
Care Excellence) (2013), AHA (American Heart Association) (2013), ACC 
(American College of Cardiology) (2011) and ESC (European Society of 
Cardiology) (2012) clinical guidelines recommend optimisation of drug therapies for 
secondary prevention in cardiovascular patients. There are limited data related to the 
prevalence of medication non-adherence from developing countries, although its 
prevalence in these countries is 2 times greater compared to that reported from 
developed countries (Awad et al., 2017). In Saudi Arabia and other Gulf countries, 
mean medication wastage, in terms of the amount of medication products, was 
estimated to be near 26% and 42%, respectively and on the basis of medication costs, 
was around 20% in Saudi Arabia and 25% in other Gulf regions (Abou-Auda, 2003, 
Moradi‐Lakeh et al., 2016). 
In Iran, around 8,300 independent community pharmacies provide 
pharmaceutical services (Ministry of Health and Medical Education of Iran, 2014). 
Typically, urban Iranians consume 339 unit doses of medicines yearly (Zargarzadeh 
et al., 2005). Approximately 85% of the population has access to essential drugs and 
health insurance (Cheraghali et al., 2003, Zargarzadeh et al., 2007). Insurance 
coverage usually includes all drugs except vitamins, hygiene products, and selected 
imported medications not on the national formulary list. Patients pay about 30% of 
the prescription cost as a co-payment, and the rest is paid by the insurance company 
(Zargarzadeh et al., 2007). In terms of medication adherence, only 46.3% of Iranian 
families completed the entire course of medication prescribed by their physicians 
(Zargarzadeh et al., 2007). This number was similar in Saudi Arabia and Gulf 
countries at 32.7% and 43.7%, respectively (Abou-Auda, 2003, Moradi‐Lakeh et al., 
2016).  
According to a previous systematic review of studies conducted in developing 
countries, pooled cardiovascular medication adherence was found to be minimal 
(equal to 57.5%) that is comparable to that reported for developed countries (equal to 
50%) (Bowry et al., 2011). Therefore, many nations including Iran, are seeking ways 
to address medication non-adherence, which is an important modifiable cause of 




2013). Poor medication adherence can lead to a suboptimal clinical advantage and 
health outcomes and is of significant concern in public health, in terms of quality of 
patients’ lives and health costs (Van Camp et al., 2013). The results of enhanced 
medication adherence are, decreased rate of death and co-morbid problems, reduced 
re-hospitalisation and physician visits, higher life satisfaction and saved more health 
system expenses (Osterberg and Blaschke, 2005, Sarayani et al., 2013, Stevens, 
2015). 
Medication non-adherence is prevalent after hospital discharge among cardiac 
patients since many of the medications are titrated based on their effect on the 
patient's vital signs for optimal mortality benefit during the period in which the 
patient is undergoing CR (National Institute for Health and Care Excellence, 2013, 
O'Gara et al., 2013, Piepoli et al., 2016, Price et al., 2016). Moreover, the primary 
issue of how this group of patients familiarise themselves to their changing 
medications remains and it demands the implementation of adherence optimising 
interventions (Berben et al., 2011, White et al., 2013). In Iran, in addition to 
structured exercise, the first session of outpatient CR programme involves delivering 
information on various topics including medications in a group setting, presenting by 
a physician both verbally and in written form (Moghadam et al., 2008). However, 
evidence reported that educational interventions do not efficiently increase 
medication adherence and no significant differences were found in medication 
adherence following interventions presenting written information about medication 
compared to those that did not (Berben et al., 2011, Conn et al., 2009). In light of the 
complex and changing medication regimens, it would be more effective to focus on 
implementing alternatives to educational interventions especially using innovative 
approaches to improve adherence to cardiovascular medications in the process of CR 
(Gandapur et al., 2016, Pfaeffli Dale et al., 2015, Berben et al., 2011, Conn et al., 
2009).  
1.4 Electronic Health (eHealth) 
The eHealth (also called digital health) encompasses an extensive area within 
healthcare management. The WHO (2016, p. 5) defined eHealth as: 
 “The cost-effective and secure use of Information Communication Technology 




health surveillance, health literature, and health education, knowledge and 
research”. 
The term eHealth is interchangeably used in various contexts to refer to health 
informatics, health information systems, health information technology, telehealth 
(i.e. an expansion of telemedicine), and medical informatics that come from several 
disciplines including information technology, computer science, health, and business 
(Sharifi et al., 2013). 
eHealth also includes a comprehensive range of information systems in health 
care, such as patients electronic health records, payment (ePayment) and billing 
(eBilling) information,  healthcare workers and hospital information, electronic 
prescription and innovations in health care and delivery of quality care (Park, 2011a). 
All operational daily tasks as well as decision and management systems can be 
handled by using eHealth to its full potential; in the other word, eHealth has the 
potential to facilitate mobile health, telemedicine, and other associated activities 
(Park, 2011a, Sharifi et al., 2013).  
The growing application of eHealth delivers a variety of advantages that this 
promising innovation brings to health care that can be classified into different 
categories: clinical, financial, technical, organisational, professional, and patient-
related benefits; the major advantages include reduction in operational expenses, 
rationalisation and high visibility of projects, prevention of fraud, online 
authorisation, availability of data, coordination of health service delivery, and 
privacy protection of data (Sharifi et al., 2013). Although eHealth provides health 
care with promising benefits, it has been less developed in comparison with other 
fields. According to Jordan et al. (2009), major barriers to a successful and 
sustainable eHealth implementation in almost all regions can be categorised into 
political, social, organisational and technical challenges. There is evidence that poor 
standardisation related to eHealth applications as well as financial issues, training 
expenses, and the diversity of platforms are main issues that have an association with 
failures or unsustainable eHealth implementations (Jordan et al., 2009, Mushtaq and 
Hall, 2009, Sharifi et al., 2013). 
According to Sharifi et al. (2013), eHealth in Iran has been initiated since 
medical laboratories began to auto-analyse medical kits and provide a printed copy 




healthcare offices was 5.25-inch floppy disk. Then, in the mid-1990s, the first 
domestic software packages were developed in several hospitals to provide storage 
data from patient registration to discharge. At the end of the1990s, the Social 
Security Organisation equipped its own healthcare centres with informatics 
technology including Health Level 7 (i.e. a framework for the exchange, integration, 
sharing, and recovery of electronic health information) and Electronic Data 
Interchange for Administration, Commerce and Transport standards. During the first 
decade of 2000s, various projects were initiated such as customisation of open source 
standard based on Iranian healthcare needs, the strategic ICT plan for the Iranian 
National Health (its local name is the TAKFAB plan for patients’ electronic health 
records), development and implementation of a software application for cancer 
records in hospitals, and finally pharmacies’ computerisation. Moreover, some 
eHealth pilot projects have been initiated in small-scale and the ICD-10 (i.e. the 10th 
revision of the International Statistical Classification of Diseases and Related Health 
Problems) was introduced to medical centres in order to record patients’ health 
information. Although the Iranian health organisations were supplied with required 
hardware and communication infrastructure, the Electronic Health Records (EHRs) 
needs to be defined, clarified and integrated into hospitals information systems by the 
Ministry of Health and Medical Education. This includes the development of a long-
term plan to gather and record health-related information of Iranian people, that is 
still in its initial stages. 
1.5 Mobile Health (mHealth) 
Mobile Health (mHealth) is a sub-segment of eHealth that is defined by the 
WHO (2011) as:  
“Medical and public health practice supported by mobile technologies such as 
mobile phones and patient monitoring devices, personal digital assistants (PDAs), 
and other wireless devices" (World Health Organisation, 2011, p.6) .  
While mHealth interventions are reported to be used in higher-income 
countries (World Health Organisation, 2011), there is evidence to support/report the 
application of mobile technologies in lower-income countries (Blaya et al., 2010, 
Leach-Lemens, 2009). 95% of countries in the world have mobile phone networks 




2010). mHealth has been used because it offers interactive communication, which 
provides a wide range of opportunities from improving self-monitoring for those 
with chronic diseases to facilitate remote access to data and health records in rural 
areas (Cole-Lewis and Kershaw, 2010, World Health Organisation, 2011). mHealth 
innovations have been developed that address a range of issues such as improving the 
convenience, speed, and accuracy of diagnostic tests; monitoring chronic conditions, 
medication adherence, appointment keeping, medical test result delivery; improving 
patient-provider communication, health information communication, remote 
diagnosis, data collection, disease and emergency tracking and access to health 
records (Adler, 2007, Leach-Lemens, 2009). It has been reported that the use of 
technology as a remote intervention can lead to a 20% reduction in emergency 
admissions, a 14% reduction in hospital length of stay and a 45% reduction in 
mortality rates (Groupe Speciale Mobile, 2012).  
mHealth is a rapidly expanding area of research and practice that is applied to a 
range of functions from support systems of clinical decision making and tools of data 
collection for healthcare professionals (Blaya et al., 2010, Lindquist et al., 2008), to 
providing support for health behaviour change and chronic disease management by 
patients in the community (Cole-Lewis and Kershaw, 2010). Text messaging, the 
most popular form of mHealth, can contribute to health behaviour change since it 
provides prompt and personalised patient-provider interaction and positive health 
reinforcement through regular reminders (Cole-Lewis and Kershaw, 2010, Fjeldsoe 
et al., 2009, Wei et al., 2011). mHealth, the use of mobile technology and Short 
Message Service (SMS) text messaging, is purported to be both cost-effective and 
feasible, thereby having the potential to ease continuing engagement post-
hospitalisation for skilled nursing care (Gephart and Effken, 2013). Nurses, in their 
supporting role, can provide the link between physicians, other healthcare providers, 
and patients; they therefore have a pivotal role in the post-discharge follow-up care. 
Follow-up with patients can be ensured by implementation of evidence-based 
innovative tele-nursing approaches using mobile phone (mHealth) interventions in 
different conditions and settings such as follow-up of medication adherence among 
CHD patients in a CR setting. mHealth also has the potential to overcome the issue 




delivered anywhere and at any time. Whether a CHD patient is trying to adhere to a 
complex medication regimen, nurse-led mHealth approaches may provide support 
for them. 
1.6 Description of the Previous Small-Scale Study 
This PhD study developed and extended ideas from a small-scale evaluation of 
mHealth SMS reminder intervention in patients after hospital discharge following 
Acute Coronary Syndrome (ACS) (Khonsari et al., 2015). The main researcher 
(SKh) developed a text-messaging web-based software for her Master’s research and 
conducted a pilot Randomised Controlled Trial (RCT) at a tertiary hospital in 
Malaysia. A total of 62 ACS patients were recruited and equally randomised to 
receive either automated SMS reminders before every intake of cardiovascular 
medications or only usual care within 8 weeks after discharge. The study showed that 
automated SMS reminders have the potential to improve cardiovascular medication 
adherence among Malaysian patients during the early post-discharge period. 
There are some distinctions between the previous and current study both 
theoretically and methodologically (see Section 5.1). 
1.7 Significance of the Study 
Patients who have recently experienced a cardiovascular event are often 
discharged from the hospital with multiple new cardioprotective drugs including 
anti-platelet, lipid-lowering, beta-blocker and anti-angina agents (Scottish 
Intercollegiate Guidelines Network, 2013). According to international guidelines, all 
CHD patients should be offered secondary prevention and a CR programme. During 
the period of CR, many of the prescribed medications are titrated for optimal therapy 
(Packard et al., 2012). Cardio-protective drugs are important in the management of 
cardiac conditions as part of the preparation for physical activity and exercise 
programmes (The British Association for Cardiovascular Prevention and 
Rehabilitation, 2012). Considering the complexity of changing treatment regimens, a 
nurse-led mobile health intervention may have the potential to play an effective role 
in promoting adherence to cardio-protective medications among CHD patients during 




The potential for mobile phone use in health care is currently being defined; it 
also remains a significant opportunity for future research (Anglada-Martinez et al., 
2015, Gandapur et al., 2016, Kay, 2011). The use of mobile technology to enhance 
medication adherence exclusively for patients with CHD has not been thoroughly 
investigated to date. Furthermore, few researches have been published to date about 
mHealth interventions to promote medication adherence specifically among patients 
who are recruited in the particular setting of CR in Iran.  
The primary intervention for this study is based on the principles of 
Multidimensional Adherence Model adapted from the WHO (2003) and the 
principles of the Bandura’s Self-efficacy Theory (1982) (see Chapter Two). The 
WHO model includes interactions between five sets of factors or "dimensions" 
including: social and economic factors, healthcare team- and system-related factors, 
condition-related factors, therapy-related factors and patient-related factors which 
ultimately affect patient outcomes. According to the Bandura’s Self-efficacy Theory, 
perceived self-efficacy is determined as the most important component in behaviour 
change (Bandura, 2002) and has been examined in different areas of health behaviour 
change such as self-management of chronic conditions and medication adherence. In 
this study, the automated SMS intervention may promote self-efficacy through 
sending medication reminders, serve as a form of social support, and address factors 
related to the most important dimensions of the WHO Adherence Model, such as 
healthcare system- and patient-related factors to enhance cardiovascular medication 
adherence during the first months of CHD post-discharge in parallel with outpatient 
CR programme.  
The Medical Research Council (MRC) framework provides a comprehensive 
and circular process for intervention development and evaluation (Senn et al., 2013). 
The present mixed-methods study comprised of two phases (preclinical phase and 
exploratory phase) guided by the MRC framework (2013). Using this framework 
helped to refine the previously developed mHealth intervention (from the Master’s 
work) in order to make it appropriate to the Iranian context and conduct a pilot 
feasibility trial to evaluate the potential effect of the intervention on medication 




1.8 Structure of the Thesis  
This thesis is divided into seven chapters as below: 
- Chapter One is the general introduction of this study and reviews the 
problems of CHD and medication non-adherence, role of nurses in 
improving patients' medication adherence as well as the potential for 
mobile phone technology (mHealth) to help address the non-adherence 
issue. Significance of the study and the structure of this thesis are presented 
at the end of Chapter one. 
- Chapter Two reviews and critiques the existing theories and their relevance 
to the issue of long-term medication adherence. The theoretical frameworks 
used as a guide in this study including the WHO Multi-dimensional 
Adherence Model and The Bandura’s Self-efficacy Theory are described, 
as well. 
- Chapter Three is a critique of the evidence base presented as a literature 
review with a specific focus on interventions that have been implemented 
to address medication non-adherence in a variety of settings, conditions, 
and populations. 
- Chapter Four describes aim and objectives, operational definition, study 
variables and the research methodology.  
- Chapter Five provides descriptions about the research design, rationale for 
the chosen mixed-methods design, research process, details of data 
collection and data analysis along with the ethical considerations. 
- Chapter Six presents the results of this research, according to each study 
objective.  
- Chapter Seven provides the discussions of the findings and a comparison 
with existing literature. Implications for practice, study limitations and the 




CHAPTER 2: CONCEPTUAL FRAMEWORK 
Conceptual models may contribute to the design of interventions in various 
ways: by enhancing an understanding of health issue, guiding research and assisting 
the progress of transferring an intervention from a health issue, population and 
setting to another one (Bandura, 2012, Davis et al., 2015, Eccles et al., 2005). 
Therefore, this Chapter includes a short description of theories related to medication 
adherence and rationale for choosing the Self-efficacy Theory and the World Health 
Organisation (WHO) Multi-dimensional Adherence Model as frameworks to draw 
upon and inform the study intervention.  
Leventhal et al. (1987) identified five major theoretical frameworks including 
Biomedical model; Rational belief theory; Communications approach; Self-
regulative systems theory; and Social learning theories that can be used to guide 
medication adherence research. These theories are located particularly within the 
concept of adherence to long-term medication; This Chapter explains the main 
features of these theoretical frameworks; and discusses their relevance and 
appropriateness with regards to the study intervention and adherence to long-term 
medication for cardiovascular patients. The empirical evidence supporting the link 
between conceptual models and adherence behaviour change are also discussed.  
2.1 Five Major Theories of Adherence  
In terms of the issue of medication non-adherence, interventions have been 
developed to address the problem, but few of them explain their development 
processes, in particular using a theoretical framework (Munro et al., 2007). There are 
different psychological theories explaining behaviour change, causing challenges 
when selecting the most relevant one when attempting to understand that behaviour 
change within the context of the intervention being developed, implemented and 
evaluated. This is a significant consideration in evaluating existing theories to 
identify their relevance to long-term medication adherence, where the non-adherence 






Five major theoretical perspectives related to adherence were identified from 
the literature: 
1. Biomedical model;  
2. Communications model;  
3. Rational belief (cognitive) models;  
4. Self-regulation models; and  
5. Behavioural (Social-cognitive) models. 
Reviewing health behaviour theories may help shed light on the processes underlying 
behaviour change. Therefore, the following sections review the most commonly used 
behaviour change theories applicable to long-term treatment adherence. The 
characteristics, limitations and implications of each theory in predicting behaviour 
and developing an intervention to promote adherence behaviour are discussed.  
2.1.1 Biomedical Model 
The Biomedical model of disease proposed by Engel (1980), identified that the 
patient’s body is the focus of the treatment. The model associates with the passive 
role of patients as a recipient or follower of doctors' prescriptions (Atkins, 2004, Best 
et al., 2015). The characteristics of the illness such as the severity of the symptoms 
and the prognosis as well as treatment complexity, duration, and side effects of the 
medication regimen are identified as relevant factors to non-adherence (Gadkari and 
McHorney, 2012, Kardas et al., 2013, Rodriguez et al., 2013). This theory motivated 
some innovations to promote adherence such as packaging different medications into 
single pockets and using electronic monitoring devices such as the Medication Event 
Monitoring Systems (Amico et al., 2013, Munro et al., 2007, Sabaté, 2003). It also 
provided guidance to develop the physiological measurement of compliance (e.g. 
detecting drug metabolites in patients’ blood sample). However, it is worth 
considering that high adherence is not always associated with enhanced health 
outcomes (Berben et al., 2011). 
There are some limitations related to the biomedical perspective. The patient’s 
psychological factors, socio-economic environment or demographics as well as the 
effect of healthcare system and healthcare provider’s behaviour are ignored in the 




al., 2007). In the present study, therefore, it was improbable that the biomedical 
theory could assist considerably to develop and refine the mHealth intervention to 
promote cardiovascular medication adherence due to the presumption of the passive 
role of patients and the major concentration on just the biological illness itself.  
2.1.2 Communications Model  
Similar to the biomedical approach, the communications model perspective 
perceives the patient as a trainee who asks for the professional’s advice and seeks 
treatment of the healthcare provider (Manias, 2010). The model emphasises the 
importance of patient-provider communication. The patient’s satisfaction with the 
practitioner’s friendliness, warmth, empathy, interest, and concern associates 
positively with adherence (Kardas et al., 2013, Sabaté, 2003). Although acceptance 
of the prescriptions adherence depends on acceptance of the information about the 
health threat itself, the healthcare provider must also be able to convince the patient 
that the therapy is beneficial via generating positive attitudes toward health advice 
(Kardas et al., 2013, Munro et al., 2007). Health advice must not only be well 
specified in terms of timing, construction, comprehension and clarity of its 
organisation but also it must be delivered in a way that will enable the patient to 
attend to and process it thoroughly (Linsky et al., 2015, Murad et al., 2014). The 
clinician also must have the ability to encourage the patient that the therapeutic 
regimen is beneficial; it means that he must provoke positive attitudes toward the 
recommended advice and action plans (Lee et al., 2013). Action plans not only 
define the accurate actions to be taken such as taking exact dose of a medication at 
their prescribed time, they also suggest how the action can be integrated into the 
patient’s daily routine (Lally and Gardner, 2013). It is possible by determining the 
environmental cues as a trigger to remembering to take them at prescribed time and 
promote its automation (Gardner et al., 2012, Lally and Gardner, 2013).  
While receiving, understanding, digesting, and accepting the therapeutic 
regimen is essential for adherence, it is not enough. The model lacks the description 
of how health-related information actually affects behaviour change and so leads to 
the treatment adherence (Gardner et al., 2012). Moreover, the focus of this model is 




however, the concept of beliefs is not a sufficient determinant of patients’ motivation 
to follow recommended prescribed treatment (Montano and Kasprzyk, 2015). 
Interventions using communication models as a guide may not be successful as a 
single strategy in improving adherence to medications because of the failure to 
account for the influence of the individual’s motivation, as well as external factors, 
such as the availability of social support, accessibility and costs of the treatment that 
may have an important impact on the sustainability of complex behaviours such as 
medication adherence over the longer term (Munro et al., 2007). Although the model 
might provide valuable guidance on the development of the mHealth intervention in 
this study to improve medication adherence through enhancing patient-provider 
communication, unfortunately, it provides limited descriptions related to the role of 
positive reinforcement and factors relating to social support on medication 
adherence. Moreover, the mHealth intervention was not an educational intervention 
indicating that the model would not be the most appropriate to be applied in this 
study. 
2.1.3 Rational Belief (Cognitive) Models 
The Rational Belief (Cognitive) models propose that individuals are more 
likely to choose the action that potentially leads to positive outcomes (Munro et al., 
2007, Montano and Kasprzyk, 2015). The assumption is that human behaviour is 
specified by an objective as well as a logical thought process and hence providing the 
comprehensive information on health risks and the advantages and disadvantages of 
various behaviours, patients will change their behaviours to maintain their health 
(Munro et al., 2007). In this way, it can be predicted that inadequate knowledge of 
the benefits and/or consequences of involving or not involving in prescribed health 
behaviours are more likely to cause adherence/ non-adherence behaviour (Leventhal 
and Cameron, 1987, Montano and Kasprzyk, 2015). A short description of each of 
the relevant models (i.e. Health Belief Model, The Protection Motivation Theory, 
Social Cognitive Theory, Theory of Planned Behaviour/ Reasoned Action and 
Information-Motivation-Behavioural skills (IMB) Theory) will be presented next, 





Health Belief Model 
The health belief model developed in the early 1950s to explain precautionary 
actions, has been developed to be utilised in the study of the compliance in relation 
to health recommendations and treatment regimens with four basic dimensions 
indicating the balance between the barriers to and benefits of action (Leventhal and 
Cameron, 1987, Montano and Kasprzyk, 2015, Munro et al., 2007). The dimensions 
are: (1) perceived likelihood of a hazard or susceptibility to a specific health 
condition; (2) perceived seriousness of the hazard including consideration of health 
and social outcomes; (3) perceived advantages, or the feasibility and effectiveness of 
the specific health behaviour; and (4) perceived limitations, or difficulties to 
engaging in the behaviour (Montano and Kasprzyk, 2015). The first two dimensions 
indicate the person’s risk perception as well as motivation for taking action. The 
third and fourth dimensions imply the cost evaluation of applicable behaviours and 
identify the specific action to be taken (Montano and Kasprzyk, 2015).  
The Protection Motivation Theory 
According to the protection motivation theory (1975), behaviour change may 
be obtained by application of person's fears. The assumption is based on three 
components of fear stimulation:  
- the consequence of threat of a described condition;  
- the likelihood of that condition's happening; and  
- the effectiveness of the defensive response.  
This is the only theory among other cognitive models that explicitly uses the 
advantages of existing and recommended behaviour to anticipate the probability of 
change; however, the influence of social, psychological and environmental factors on 
motivation requires consideration when using this approach (Munro et al., 2007).  
Social Cognitive Theory 
Bandura’s Social Cognitive Theory (1998) postulates a multifaceted causal 
structure in the organisation of human motivation, action and well-being and 
includes adherence predictors and guidelines for its promotion based on a 
continuous, dynamic interaction between the individual, the environment and 




self-influences for change such as beliefs regarding personal efficacy, in addition to 
knowledge of health risks and benefits as change requirements (Bandura, 2004). 
Health behaviour is also influenced by the expected outcomes including positive and 
negative effects of the behaviour or even social approval or disapproval of an action 
(Munro et al., 2007). Behaviour change may be due to the reduction or elimination of 
perceived facilitators and barriers (Bandura, 2004, Sheeran et al., 2017). Therefore, 
this theory describes that behaviours are achieved if people perceive that they have 
control over the outcome, that there are few external barriers and when individuals 
have confidence in their ability to execute the behaviour (Armitage and Conner, 
2000, Sheeran et al., 2017). 
Theory of Planned Behaviour/ Reasoned Action 
Based on the theory of reasoned action and planned behaviour assumption 
(1985), most socially relevant behaviours are under unforced control, and that a 
individual's intention to take a particular action is the immediate and the best 
predictor of that behaviour. The individual’s intention is impacted by attitudes 
towards the action, including the individual's beliefs, evaluations of the behaviour 
outcome, subjective norms or the perceived expectations of important others with 
regard to a person's behaviour and the motivation for a person to comply with others' 
wishes (Ajzen, 2011). This theory fails to consider the fact that behaviour may not 
always be under volitional control; the impacts of past behaviours on current 
behaviours and more conceptualisation, definition and additional explanatory factors 
should be taken into consideration (Stroebe, 2000, Sutton, 2010).  
Information-Motivation-Behavioural skills (IMB) Theory 
This theory includes three components that lead to behaviour change: 
information, motivation and behaviour skills necessary to perform the behaviour 
(Fisher and Fisher, 1992). Information refers to the relevant knowledge about a 
medical condition or prescribed medications, and is a necessary prerequisite for 
behaviour change but not adequate in isolation (Davis et al., 2015, Fisher and Fisher, 
1992). Motivation including both personal and social motivations, is the second 
component and encompasses individual attitudes towards adherence; the patients' 
perception of social support from significant others for the behaviour; and perceived 




Davis et al., 2015). Behavioural skills results from factors such as ensuring that the 
patient has the ability to perform the behaviour task as well as a sense of self-efficacy 
to achieve the behaviour (Davis et al., 2015, Fisher and Fisher, 1992). 
It is necessary to take into consideration that all three components of the theory 
need to be relevant for the desired behaviour to be useful (Fisher et al., 2006, Sabaté, 
2003) A range of moderating factors have been identified that have an impact on 
adherence behaviour such as living situations and access to medical services (Fisher 
et al., 2006). The presence of both information and motivation are thought to develop 
behavioural skills, which ultimately result in desired behavioural change and its 
maintenance (Davis et al., 2015, Fisher and Fisher, 1992, Sabaté, 2003). The main 
advantage of IMB is its clarity. It is a simple theory that was developed and tested 
among people received Anti-Retroviral Therapy (ART) in resource-rich settings 
(Amico et al., 2005).Therefore it may be a promising model for application in the 
promotion of adherence to long-term medication treatment. 
Appraisal of Rational Belief (Cognitive) Models 
Specifically, these theories are largely dependent on rational processes 
focusing only on the norms related to the acceptability of an action. Moreover, the 
impacts of emotions, social support and even religious beliefs on behaviour and the 
hazard’s threat are ignored (Munro et al., 2007, Montano and Kasprzyk, 2015).  
A weakness of the health belief model is that the dimensions are not moderated 
by each other; they also have an additive effect on health behaviour directly and 
remain unmediated by behavioural intentions (Munro et al., 2007). Furthermore, 
determinants of health behaviour, such as the positive effects of risk behaviours and 
social impact, are not included (Stroebe, 2000).  
The Health Belief Model, The Protection Motivation Theory, Social Cognitive 
Theory, Theory of Planned Behaviour/ Reasoned Action and IMB Theory do not 
consider coping skills, in particular; they recognise the perceived absence of skills as 
a ‘barrier’ or ‘cost’ (Leventhal and Cameron, 1987, Montano and Kasprzyk, 2015). 
They focus on perception and logic with an emphasis on conscious and intentional 
behaviour (Munro et al., 2007). However, some behaviours are based on habits rather 




actions that make up so much of individual’s behaviours is ignored (Munro et al., 
2007). Overall, despite the ability of the Rational Belief Models (RBM) to improve 
prediction of behaviour compared to Biomedical and Communications Models, it 
appeared that on the whole the RBM was not sufficient to explain unintentional 
reasons for medication non-adherence. 
2.1.4 Self-Regulation Models 
Self-regulation is a broad term that encompasses a variety of processes by 
which individuals follow and achieve goals. These processes involve both those that 
are commenced intentionally, as well as those that are more unintentional and initiate 
unconsciously (Mann et al., 2013). Leventhal’s self-regulative models (1984) 
conceptualise the individual as an active problem solver whose behaviour such as 
adherence to a health recommendation reflects an attempt to close the perceived gap 
between their current status and a goal, or ideal state. The model identifies three 
stages or sets of variables regulating the adaptive behaviour elicited during a health 
episode. These stages are:  
- The cognitive representation of the health threat, which includes several 
dimensions such as perceived identity of the threat, potential causes, possible 
consequences, and perceptions of how the health threat shapes itself over 
time;  
- The action plan or coping stage, in which the individual formulates and 
begins a plan of action; and  
- The appraisal stage, in which the individual utilises specific criteria to 
measure success of one’s coping actions, with perceptions of insufficient 
progress leading to modifications of the representation and/or coping plans 
(Leventhal and Cameron, 1987).  
Different people will construct different mental representations of the same 
illness threat and may perceive different action plans to be appropriate for the 
containment of the threat (Munro et al., 2007). 
The main limitation of the model is its complexity to use because of its 
multivariate and transactional character (Leventhal and Cameron, 1987, Mann et al., 




and measuring multiple factors in a single study, while there is a lack of standardised 
measurement tools (Mann et al., 2013). The transactional nature forces the researcher 
to decide when a given variable is to be used as an independent or dependent 
measure (Lazarus and Folkman, 1984, Mann et al., 2013). In a study by Munro et al. 
(2007), The sufficiency of the Self-Regulation Models for developing interventions 
to improve long-term medication adherence was reviewed. From the findings, the 
authors concluded that although the Self-Regulation Models seem probably 
appropriate to promote adherence behaviour, it provides inadequate guidance about 
the interventions design. Therefore, the use of the Self-Regulation Models in the 
development of mHealth adherence intervention appeared to be inappropriate since it 
was not clear how these processes could enhance medication adherence. 
2.1.5 Behavioural (Social-cognitive) Models 
Behavioural models, derived from the learning theories were developed by 
Pavlov, Skinner, Hull and Tolman (Leventhal and Cameron, 1987). These models 
describe the effect of the stimuli or cues that elicit behaviour, the rewards that boost 
the behaviour, the progressive structuring or patterning of the behaviour, and its 
maintenance after adequate repetition. Bandura (1977) applied concepts from social 
cognitive theories such as vicarious learning or modelling to add a cognitive ‘thrust’ 
to the behavioural models (Leventhal and Cameron, 1987). The principles of these 
models are based on internal (thoughts) or external (environmental) cues while 
consequences may be negative/ punishments or positive/ rewards for behaviour; The 
likelihood of a patient continuing a specific behaviour will be partially related to 
these variables (Munro et al., 2007, Sabaté, 2003). 
Behavioural approaches have been applied particularly in attempts to change 
unhealthy risk habits or lifestyle such as weight reduction, smoking cessation and 
alcoholism in which the problematic behaviours are changed in response to strong 
internal or external signals (Davis et al., 2015, Gardner et al., 2012, Leventhal and 
Cameron, 1987). Strategies pertaining to improving adherence guided by this 
perspective such as medication reminders have been reported to be effective for 




One of the important drawbacks of the behavioural approaches is high rates of 
relapse after behavioural interventions. It may be due to the discontinuation of 
reinforcements from the person’s environment while cues for the non-adherence 
behaviours remain (Leventhal and Cameron, 1987, Munro et al., 2007). Another 
shortfall of the behavioural theories is the failure to account for the underlying 
psychological mechanisms, conscious and non-conscious, emotional and non-
emotional processes in the modification of health behaviours (Davis et al., 2015, 
Leventhal and Cameron, 1987). The learned approaches must be both automatic and 
unforced to be effective in improving adherence behaviours even after the 
programme has been stopped (Davis et al., 2015, Sabaté, 2003). Interventions guided 
by behavioural theory should follow a multifaceted programme in which reinforcing 
desired behaviours is associated with social influence, cognitive and motivational 
factors of behaviour modification (Davis et al., 2015, Leventhal and Cameron, 1987, 
Munro et al., 2007, Sabaté, 2003).  
The intervention of text message medication reminders that was used in this 
study might be considered as external stimuli to promote patients’ adherence 
behaviour. For the purpose of the present study, Bandura’s Social Cognitive Theory 
provided the framework from which this study approach has been developed. Self-
efficacy is a major element of Social Cognitive Theory because it has an impact on 
patients’ motivation and behaviour learning. 
In order to clarify the reason to choose Bandura’s theory as a guide in this 
study, it is important to describe that how the mobile phone text-messaging might 
improve medication taking behaviour. Mobile phone text-messaging interventions 
can be applied to increase patients’ self-efficacy (e.g. sending medication reminders) 
or establish a form of social support from healthcare professionals. By enhancing 
self-efficacy and facilitating social support, mHealth interventions may affect health 
behaviours and increase self-management of CHD and adherence to cardiovascular 
medications (Bandura, 2012). Text message reminders may have the potential to be 
useful in this context by providing patients with post-discharge follow-up and by 
promoting enhanced adherence to medications, or as a channel of patient-provider 
interaction and support. In addition, medication reminders may enhance CHD 




perform the health behaviours essential to achieve a planned goal (i.e. medication 
adherence behaviour). 
The application of self-efficacy enhancing strategies may result in more 
effective interventions and health promotion programmes. Methods currently 
employed by healthcare professionals in preventive health care and health promotion 
programmes and interventions may already use self-efficacy. However, by focusing 
on the self-efficacy construct, greater success at behaviour change may be obtained. 
Following consideration of aforementioned theoretical frameworks, the merits 
of self-efficacy as a key component of the Social Cognitive Theory and behaviour 
change interventions were judged to outweigh the merits of other possible 
approaches presented. This decision also took into account the practical aspect by 
which an intervention could be administered after hospital discharge during a cardiac 
rehabilitation programme. It is the use of self-efficacy and the theory from it is 
derived that was used to shape the investigation of this study and upon which the 
study mHealth intervention was based. 
2.2 Self-efficacy 
It is important, at first, to define self-efficacy and understand the mechanisms 
that impact medication adherence when developing and evaluating effective 
approaches. Self-efficacy refers to the individuals’ beliefs in their own abilities to 
produce certain attainments that have an impact on a person’s life (Bandura, 2012). 
In a study by Bandura and Locke (2003) exploring how self-efficacy beliefs act in 
agreement with goals, nine meta-analyses were evaluated. The authors concluded 
that perceived self-efficacy and individual goals can promote motivation and 
achievements. They also described that efficacy beliefs influence behavioural 
functioning as well as behavioural changes over time between people with different 
perceived self-efficacy level. Self-efficacy has been recognised as the most important 
predictor for health behavioural change (Bandura, 2012), of which long-term 
medication adherence in chronic illnesses is an example of one. 
Self-efficacy is a major concept and influences level of motivation, affective 
states, and action (Bandura, 2012). Perceived self-efficacy that is modifiable has 




Based on empirical findings and theoretical evidence, perceived self-efficacy can 
have impact on medication adherence in a variety of chronic conditions (Walker et 
al., 2014, Wu et al., 2015, Schoenthaler et al., 2009). For example, Walker et al. 
(2014) studied the effect of self-efficacy on diabetic control, medication adherence, 
self-care, and quality of life. The authors found that higher self-efficacy was related 
to optimised glycemic control (P<0.001), medication adherence (P<0.001), self-care 
(P<0.001) and health related quality of life (P<0.017). Another study undertaken by 
Wu et al. (2015) examined the relationships between self-efficacy and medication 
adherence in patients with Heart Failure (HF), it reported that poor medication self-
efficacy was linked to low medication adherence (P<0.001). Similar findings were 
also shown among hypertensive patients (P<0.001) in a study by Schoenthaler et al. 
(2009). According to a systematic review of 28 studies that provided a systematic 
examination of the effect of self-efficacy on health outcomes among cardiovascular 
patients, it was found that higher levels of self-efficacy have an association with 
improved health outcomes of people with cardiovascular diseases (Gancarczyk et al., 
2014).  
According to Bandura and McClelland (1977), efficacy expectancies are 
gained through the four primary sources: performance attainment, vicarious 
experience, verbal persuasion and physiological state. Perceived self-efficacy has an 
impact on behavioural aspects, such as the attainment of a new behaviour or the 
changing of an existing behaviour (Bandura, 1998, Bandura and McClelland, 1977). 
Bandura (2002) suggested that in order to enhance an individual’s sense of self-
efficacy, self-regulative skills need to be developed. This requires that people learn 
how to monitor the behaviour that they wish to change, or how to set realistic goals, 
and learn how to acquire social support and rewards so that they will be able to 
maintain the attempt required to succeed. 
The development of the mHealth adherence intervention using SMS text-
messaging to enhance self-efficacy in medication taking may improve self-efficacy 
through providing social support (e.g. from nurses or other healthcare providers); or 
enhance social networks (peer support networks) (De Jongh et al., 2012). These 
interventions may improve health behaviours and self-management of chronic 




According to the findings of current empirical studies, mHealth interventions aimed 
at promoting cardiac patients’ self-efficacy, significantly enhanced adherence to 
medications and recommended diet, increased physical activity and ability to stress 
management (De Jongh et al., 2012, Dale et al., 2015, Park et al., 2014). In the 
present study, the goal of sending automated SMS prompts was to provide patients 
with the appropriate self-belief, enhancing self-efficacy, thus enabling them to self-
medicate, and retain control of his or her medicines. According to Holloway et al. 
(2006) who applied theoretical concepts of the self-efficacy construct in developing a 
behavioural change brief intervention to improve problem drinkers’ self-efficacy, 
reducing alcohol consumption would provide a sense of success. This achievement 
would in turn increase the likelihood of improvement in the person’s perceived self-
efficacy level. The authors described that this self-belief could subsequently be 
developed, and built upon through success and mastery, with their efforts leading to 
the reduction in alcohol drinking. Similarly in the case here, it was anticipated that 
improving cardiovascular medication adherence through behavioural change would 
enhance patients’ health outcomes and reduce negative consequences of CHD that 
would consequently provide a sense of achievement and success; the overall effect of 
the SMS medication reminders would be a likely improvement in the patients’ level 
of perceived self-efficacy. The sense of success could potentially build up the 
patient’s self-efficacy in medication taking leading to the adoption and maintenance 
of medication adherence behaviour and ultimately behaviour change. Considering 
the four principle sources of self-efficacy, verbal persuasion is addressed during the 
preliminary educational/ informative session of CR programme. Furthermore, 
prompting of medication using text message reminders was persuading, reinforcing 
and reminding patients to take their medications. Receiving regular medication 
reminders in addition to CR educational session would increase patients’ awareness 
that incorporates physiological state. Moreover, medication reminders serve as social 
support from nurse/ healthcare provider - encouraging patients to take their 
medications that may incorporate social persuasion. In terms of vicarious 
experiences, study participants were not restricted from situations that could affect 
their vicarious experience. During CR sessions, they could talk to other CHD 




medication taking. Regarding performance attainment or mastery experience, 
patients self-monitor their performance and their improvement during CR sessions 
and those who take their cardiovascular medications regularly can start their 
scheduled exercises. In other words, they measure success in terms of self-
improvement. This could be a positive feedback for this group of patients that 
persuade them to be more adherent to their medications. Moreover, all participants 
are routinely assessed at the end of the study and the results are compared to the 
patients’ baseline data. During the follow up session, their improved level of 
medication adherence together with other clinical outcomes (i.e. their achievements) 
would indicate performance attainment or mastery experience. 
It is important to assess the patients’ self-efficacy in medication adherence 
using a validated and reliable tool, thus, a Medication Adherence Self-Efficacy Scale 
(MASES) has been developed by Ogedegbe et al. (2003) to measure patients’ self-
efficacy in taking prescribed medications and determining situations in which people 
have difficulty in following their medication regimen. The MASES has been used in 
this study as a research instrument to evaluate the effect of the mHealth intervention 
to promote patients’ self-efficacy in medication adherence (see Section 5.3). In 
conjuction with the use of self-efficacy, the WHO multi-dimensional model was 
utilised that is described in Section 2.4. When discussing the importance of applying 
the most appropriate behaviour change theory to inform interventions, it is necessary 
to understand the role of specific behaviour change techniques for use within 
interventions. 
2.3 Behaviour Change Techniques  
The intervention components influencing behaviour can be mapped on to 
particular Behaviour Change Techniques (BCTs) to ensure the intervention is 
evidence-based and guided by an appropriate theory (Michie et al., 2014). While 
behaviour change interventions have different scope, design and behaviour change 
techniques, all could benefit from the application of behaviour change science. This 
science applies theoretical frameworks related to behaviour and behaviour change 
that are subjected to rigorous and comprehensive evaluation. There are a variety of 




appropriate for the delivery of health behaviour change. There is limited evidence 
available to support the application of any one theoretical framework in particular. 
For this reason, three routes to behaviour and behaviour change have been identified 
in the Health Behaviour Change Competency Framework (HBCC) by Dixon and 
Johnston (2010): Motivation development to promote skills that help that motivation 
to be transformed into Action; and Prompted or cued routes to behaviour (MAP). The 
route MAP is a valuable model to summarise the main principles of various 
behaviour change theories. Research continues to target one of the MAP routes to 
change by the BCTs delivered across different settings and behaviours including 
medication adherence (Bobrow et al., 2016, Dusseldorp et al., 2014, Kamal et al., 
2015). However, according to the emerging literature focusing on MAP-based 
interventions, there has been criticism that there is not a complete understanding of 
the useful and crucial components of behaviour change interventions (Dixon and 
Johnston, 2010, Kok et al., 2016). A meta-analyses of the influence of using theory 
on the effectiveness of health behaviour interventions showed that generally there is 
a weak relationships between the extent of theory use and the type of the applied 
theory with the intervention effectiveness (Prestwich et al., 2014). Another issue, 
according to Hardcastle (2016), is that the current BCT taxonomies do not elucidate 
the importance of client-provider relationship that could be incorporated into the 
intervention content to improve the intervention effectiveness. Together, these 
critiques highlight that some behaviour change interventions have not been informed 
by the available evidence and that further research is needed in order to formulate the 
most beneficial techniques for improving medication adherence. In this study, the 
mHealth medication adherence intervention targeted the third route of MAP (i.e. the 
prompted or cued route) that supports behaviour (i.e. medication adherence) without 
the need for the constant cognitive attempt required by the other routes (Dixon and 
Johnston, 2010). The intervention also benefited from the application of the 
principles of the WHO Adherence Model (2003) in which both intra- and 
interpersonal factors (e.g. patient-provider communication) have been identified as 





2.4 The WHO Multi-dimensional Adherence Model 
While the focus of the behavioural change theories is mainly on factors 
influencing patients, it has been identified by the WHO Adherence Model (2003) that 
medication non-adherence is a complex and multi-dimensional issue. Application of 
the theories focusing on patients and providers can help to develop theory-based 
interventions focusing on intra- or interpersonal factors to increase adherence; 
however, it is not the only area in which adherence can be promoted (De Jongh et al., 
2012).  
Ecological or multilevel system models not only focus on patient behaviour but 
also on barriers related to environment (Kidd and Altman, 2000). Ecological models 
include intrapersonal, interpersonal, bureaucratic, policy-making, and community 
obstacles such as patient-provider communications, access to health care, medication 
availability, social support, and complexity of medication regimen (Glanz et al., 
2008). The WHO Multidimensional Adherence Model (2003) is an example of 
ecological models that complements the elements of self-efficacy and was therefore 
also adopted to be used in this study.  
In 2003, the WHO described adherence to long-term therapies as a behaviour 
that is influenced by multiple barriers. The model encompasses interactions between 
five sets of factors termed "dimensions" that ultimately affects patient outcomes. 
These dimensions are:  
A. Social and economic factors,  
B. Therapy-related factors,  
C. Condition-related factors, 
D. Healthcare team- and system-related factors and 
E. Patient-related factors. 






Table 2.1. Description of theWHO Multi-dimentional Adherence Model (2003) 
Socioeconomic 
factors  
The main socioeconomic concerns with a great effect on adherence are: 
poverty, difficult accessibility to medical centers and medications, illiteracy, 
lack of social support, thoughts and beliefs about diseases and treatments that 
could affect health service delivery.  
Therapy-related 
factors  
Among therapy-related factors, dose frequency, complicated medication 




Condition-related factors represent specific disease-related needs experienced 
by the patient such as symptoms intensity, level of inability, disease intensity 




Among system-related factors, the way that healthcare systems operate, 
accessible services and resources types, and the way in which healthcare 
providers deliver treatments are of the most important concerns. It was also 
described in the model that there are five main barriers related to healthcare 
system-related factors including lack of awareness and information about 
adherence; lack of approaches to assist patients in modifying maladaptive 
healthy behaviors and learn adaptive ones; lack of efficient interaction between 
patients and healthcare providers 
Patient-related 
factors 
Major concerns related to the patient-related factors are forgetfulness, 
carelessness, anxiety about the complexity of medication regimen, lack of 
motivation, and misunderstanding of treatment instructions. 
 
The WHO Multi-dimensional Adherence Model was relevant to remodel and 
evaluate the intervention used in this study as it emphasises on the presumption of 
the active role of patients in their treatment and considering multiple factors related 
to long-term medication adherence. According to the model, it could not be possible 
for only one determinant to be responsible for medication non-adherence. Therefore, 
appropriate interventions should address multiple barriers to adherence. In this way, 
a nurse-led mHealth medication reminder intervention may have the potential to 
improve cardiovascular medication adherence through addressing most common 
barriers to adherence such as patient-related factors (forgetfulness, carelessness and 
low self-efficacy in taking medications) and healthcare system-related factors 
(patient-provider interaction and social support) during the early phase of hospital 
post-discharge in parallel with outpatient CR programmes.  
2.5 Summary 
The component of health behaviour change is formed by the Social Cognitive 
Theory (SCT) (Bandura, 2004). Self-efficacy, a major construct of SCT and a 
mediator of behaviour change, is the individual’s confidence to operate a desired 




taking into the individual’s daily routine can be facilitated by the use of technology 
to improve behavioural approaches such as self-care management and positive 
reinforcement (Bosworth et al., 2011). mHealth interventions using text message 
reminders as a type of social support from healthcare providers to improve 
medication adherence, (such as the one used in this study), are primarily based on the 
principles of self-efficacy within the SCT, one of the five theoretical perspectives 
related to medication adherence outlined by Leventhal and Cameron (1987). It was 
proposed in this study that receiving SMS text messages about medication reminders 
in addition to educational information about self-care of CHD (provided in the first 
session of hospital-based CR) would enhance patients’ self-efficacy to take cardio-
protective medications as prescribed. 
According to the WHO Multidimensional Adherence Model (2003), there is no 
single determinant that influences medication adherence to treatment and so the issue 
of non-adherence is complex and multidimensional. Interventions aimed at 
improving adherence need to be adjusted to address the patients’ reasoning for non-
adherence to medications (Bosworth et al., 2011, Brown et al., 2016, Costa et al., 
2015). The intervention for this research study was also guided by the WHO 
Adherence Model to improve cardiovascular medication adherence in CHD patients 
by focusing on the leading causes of medication non-adherence that are unintentional 
on the patient’s part (forgetting, carelessness and poor self-efficacy), as well as 





CHAPTER 3: LITERATURE REVIEW 
This chapter includes ten sections in which the literature pertinent to the 
undertaken study is reviewed, critiqued and synthesised. The aim of the review is to 
identify gaps in the current evidence base and develop a research question through 
critiquing literature pertaining to mHealth interventions that have been developed 
and/or implemented to address medication adherence in CVD. This Chapter begins 
with a description of the search strategy followed by a review of the literature 
examining mHealth interventions used to improve medication adherence in chronic 
conditions with a specific focus on using mobile phone-based medication reminders 
for CVD patients.  
In order to develop an effective search strategy (see Table 3.1), the PICO - the 
Patient, Intervention, Comparison and Outcome – criteria/model was used to assist in 
the framing of a “foreground” research question (Sackett et al 1997). From the 
foreground question, separation of the question parts meant the subject area was 
more easy to search (Aslam and Emmanuel, 2010). Once the literature was retrieved, 
a researchable question was identified.  
Table 3.1. Search Strategy 
Group Adults 
Age Over 18 
Gender Male and/ or female 
Year January 2003 to June 2017 
Research 
Methods 
Randomised Controlled Trial, Trial, Pilot, Feasibility, Evaluation, Process 
Evaluation, Literature Reviews, Systematic Reviews, Meta-analysis, Surveys, 
Qualitative and Focus Groups 
Language English Full text, English Abstract 
 
After establishing useful text words and MeSH headings with relevant 
keywords, all possible synonyms and alternative spellings for the specific concepts 
or terms were considered to increase the sensitivity of the search and not miss 
important information (see Table 3.2). Then Boolean Operators were used to 
combine them. Truncation or wildcards was used based on the database's help pages 
to retrieve all possible variations and increase the flexibility and efficiency of the 




appear near each other in a sentence. A list of used keywords can be found in Table 
3.2. 
Before searching the literature, inclusion and exclusion criteria were 
formulated. Publications written in English were included, as the researcher could 
read and understand the language. The time span of the literature search was limited 
to January 2003 to June 2017 for studies that evaluated medication adherence in 
response to mHealth interventions in patients with cardiovascular disease. An email 
alarm was set to receive updates and accepted papers ahead of print. The reason for 
applying a year limit in the search process was to obtain recent and updated 
information about the issue. Moreover, the WHO published a document for the first 
time in 2003 in which medication adherence was defined as a medical and public 
concern that need to be addressed with respect to all chronic conditions regardless of 
their cause. Based on the study focus, the following were set as the inclusion criteria: 
- Review or trial mHealth as the main study focus;  
- Study utilised mHealth by adults (>18 years) of both gender;  
- Be in English language;  
- Be published between January 2003 and June 2017. 
Duplicates were removed and articles were excluded if they exhibited one or 
more of the following characteristics: 
- The patient was not the study target population (i.e., provider-focused);  
- Described a study protocol;  
- Involved children and/or people younger than 18 as the target population;  
- Used mHealth for acute conditions;  
- Used mHealth for assessment, monitoring or measurement;  
- Proposed or developed a model or device. 











diseases/ or heart 
diseases/ or 
myocardial 
ischemia/ or acute 
coronary syndrome/ 
or coronary disease/ 
or angina pectoris/ or 
myocardial 
infarction 
heart or cardi* or coronary or CHD 
or CVD or CAD or "myocardial 
infarction*" or "myocardial 
ischemia*" or angina or 
"cardiovascular disorder*" 
Global Health, PsycINFO, 
Embase, Epub Ahead of Print, 
In-Process & Other Non-Indexed 
Citations, MEDLINE: 5,569,280 
Cochrane: 192,778 
CINHAL: 377,146 
Web of Science for Conference 
Papers: 5,449 
2 Telehealth/ or text 
messaging/ or 
reminder systems/ or 
Telephone or Mobile 
Applications 
telephone* or phone* or 
smartphone* or "text messag*" or 
"mhealth" or SMS or "text 
reminder*" or "medication 
reminder*" or "automatic 
reminder*" or "mobile health" or 
"telemedicine" or "telehealth" 
Global Health, PsycINFO, 
Embase, Epub Ahead of Print, 
In-Process & Other Non-Indexed 
Citations, MEDLINE: 357,550 
Cochrane: 19,618 
CINHAL: 57,026 
Web of Science for Conference 
Papers: 5,854 
3 Patient Compliance/ 
or Medication 
Adherence 
(Medic* or drug$ or pill$ or 
prescri* or treatment$ or pharma* 
or "medic* taking") AND ("non 
adherence" or nonadherence or 
"non compliance" or 
noncompliance) OR (compliance or 
adherence)  
Global Health, PsycINFO, 
Embase, Epub Ahead of Print, 
In-Process & Other Non-Indexed 
Citations, MEDLINE: 467,137 
Cochrane: 37,347 
CINHAL: 60,289 
Web of Science for Conference 
Papers: 937 
4 1 AND 2 AND 3 Total: 4599 , Remove duplicates: 3120, Apply year limit: 2934  
Irrelevant: 2368, Not in English: 54, <18 years old patients: 239, 
Patient is not target population: 25, Protocol study:42, mHealth used for 
assessment, monitoring or outcome measurement:118, Proposed a 
model or develop a device/ program: 9, No mHealth approach: 13, Not 
an Empirical Research: 53                  
Full-text articles assessed for eligibility:13 
 
The abstracts of the publications resulting from all search strategies were 
screened for relevancy. If the abstract did not provide sufficient information, then the 
full text was scanned to determine whether or not the publication met the inclusion 
criteria. The quality of relevant studies was analysed based on critical appraisal tools 




3.1 Data Extraction and Analysis 
The Search Strategy used in this review were assessed by a librarian (RS) and 
two other reviewers (AH, CCh) and corrections were made when necessary. 
Publications were initially screened for potential inclusion based on the review of 
title and abstract by the main researcher (SKh). Inclusion of selected trials were 
finalised separately and then together by consensus among SKh and the second 
reviewer (AH). Information including objectives, types of mHealth intervention 
used, setting, study sample characteristics, outcomes measured, and results reported 
were extracted using Microsoft Excel. Studies were organised for analysis based on 
the study target population (i.e. Chronic Cardiac and Non-cardiac Conditions). 
Usability, feasibility, and acceptability of the mHealth intervention used among 
study groups, the effect on patient adherence to chronic medications, and disease-
specific clinical outcomes of the intervention were reviewed. A descriptive review of 
the studies was performed and the findings from these research studies summarised, 
with emphasis on results reported in trials. Differences between study groups were 
highlighted when these results were available. 
3.2 Search Results 
The electronic databases CINAHL (Cumulative Index of Nursing and Allied 
Health Literature), Cochrane, Campbell Collaboration, Medline, Embase, 
GlobalHealth and PsycINFO were searched and 4599 records were found using the 
keywords/ subject terms noted in Table 3.2. Additional articles were extracted using 
Grey literature databases including OpenGray, GrayLIT Network, MAGiC 
(Managing Access to Grey Literature Collections), ProQuest Theses Global, Web of 
Science for Conference Papers. Government Documents and websites of relevant 
organisations including Charities, Health Institutes as well as International agencies 
such as the World Health Organisation (WHO) were searched as well. 4 articles were 
included through searching grey literature, table of contents and journal indexes and 
the lists of references of relevant articles. 2934 records were included after duplicates 
removed and year limit applied. Then, the title and abstracts were reviewed and 2368 
irrelevant studies were removed. Finally, out of 566 remaining records 553 were 
excluded and identified 13 trials matching selected inclusion criteria (Figure 3.1). For 




publication (see Appendix 2). Table 3.3 presents a checklist of reporting criteria as 
recommended by CONSORT. 
 
  
Figure 3.1. Flow chart of the literature review search 
Full-text articles 
assessed for eligibility  
(n=13) 
Records identified through 
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3.3 Structure of the Literature Review 
The remainder of this Chapter has described the characteristic of the selected 
studies for review in terms of publication years, study setting, target population, 
duration of trials, sample size and outcome measures.  Then, type of mHealth 
interventions used to address medication non-adherence in a variety of settings, 
conditions, and populations is reviewed. Selected trials were categorised and 
discussed based on different types of using mHealth in supporting Medication 
Adherence (MA) of patients to chronic cardiac and non-cardiac disease management. 
After that the feasibility and acceptability of mHealth tools and the limitations of 
trials were reviewed. Theory-based mHealth interventions and the most popular 
theories used in the studies were discussed, as well. In the final sections, the 
discussion and conclusion provides a summary from what has been discussed within 
all Sections in the Literature Review Chapter to highlight the gap in the knowledge 
and the rationale for the study undertaken. 
3.4 Study Characteristics 
Publication years ranged from 2010 to 2016, with an overall increase in articles 
published more recently (Figure 3.2). None of the studies published before 2010 met 
the inclusion criteria. A total of 23.07% (3/13) of studies were conducted in the 
United States (US) (Arora et al., 2014, Park et al., 2014, Vollmer et al., 2014). There 
was one study from each of the following countries: Canada (Pandey, 2015), China 
(Fang and Li, 2016), Denmark (Strandbygaard et al., 2010), France (Quilici et al., 
2013), Iran (Zolfaghari et al., 2012), Jordan (Akhu-Zaheya and Wa’ed, 2016), New 
Zealand (Dale et al., 2015), Pakistan (Kamal et al., 2015), South Africa (Bobrow et 





Figure 3.2. Studies published over time 
In these studies, 61.5 % (8/13) targeted CVD patients. Other studies evaluated 
various chronic diseases, including asthma (Strandbygaard et al., 2010), diabetes 
(Arora et al., 2014, Zolfaghari et al., 2012) hypertension (Bobrow et al., 2016), and 
stroke (Kamal et al., 2015). Duration of trials ranged from 1 to 12 months. Sample 
size ranged from 26 to 21,752 individuals. Four studies had a sample size of less than 
100. The most popular method of research subjects’ recruitment was non-probability 
convenience sampling. Individuals who have been recruited by convenience 
sampling were mostly hospital in-patients or out-patient and primary care practice 
patients.  
Less than one third of the studies were nurse-led (Akhu-Zaheya and Wa’ed, 
2016, Fang and Li, 2016, Park et al., 2014, Zolfaghari et al., 2012) and Medical 
Doctors (MDs) were main investigators of the majority of the mHealth studies. 
With regards to outcome measures, around 77% (10/13) of the included trials 
examined medication adherence as the primary outcome. The majority of the studies 
measured medication adherence using the self-reported Morisky Medication 
Adherence Scale (MMAS) (Morisky et al., 1986). One study (Park et al., 2014) 
assessed medication adherence by Medication Event Monitoring System (MEMS) in 
addition to MMAS. MEMS is an electronic monitoring device that indirectly records 
date and time of removing a dose of a medication (El Alili et al., 2016). Bobrow et 
al. (2016) calculated adherence score, using the Proportion of Days of medication 




based on the fill dates and days’ supply for each fill of a prescription (Choudhry et 
al., 2009). A modified version of PDC (mPDC) was used in a study by Vollmer et al. 
(2014) including the whole follow-up period as the denominator time frame rather 
than time from first dispensing. Objective measurement of medication taking was 
reported in only three studies (Arora et al., 2014, Zolfaghari et al., 2012, Quilici et 
al., 2013). Quilici et al. (2013) measured patients’ adherence to aspirin using 
Arachidonic Acid-induced platelet Aggregation (AA-Ag) testing after intervention. 
Arora et al. (2014) and Zolfaghari et al. (2012) measured changes in Glycosylated 
haemoglobin (Hb A1C) level over the study time in addition to the self-reported 
questionnaire related to diabetes medications adherence. Strandbygaard et al. (2010) 
assessed adherence to asthma treatment using medicine count on the inhaler device 
and pharmacy reports.  
The control arm in 10 studies was standard therapy. Fang and Li (2016) 
compared the text message intervention with a control arm using an additional 
monthly telephone call to remind them of their medication schedule and upcoming 
appointments. In the study undertaken by Pandey (2015) there were two intervention 
arms receiving the same text message reminders but in two different time frames to 
mitigate a potential trainer effect while there was no control group. Zolfaghari et al. 
(2012) compared two different interventions (i.e. telephone follow-up with Short 
Message Service (SMS) on type 2 diabetes adherence with no control arm.  
In terms of using a conceptual framework to develop the intervention, less than 
one third (4/13) of the studies (Arora et al., 2014, Dale et al., 2015, Kamal et al., 
2015, Park et al., 2014) were theory-based. The Health Belief Model, Bandura’s 
Self-Efficacy Theory, and Social Cognitive Theory were the most common theories 
or models used. 
3.5 Types of mHealth Adherence Interventions 
There was considerable variation in the mHealth adherence intervention 
characteristics. For the purposes of this review, mHealth-based interventions are 
classified into four main categories including passive TM reminder; interactive TM 
reminder; mHealth interventions other than TM reminder; and comparison between 





Figure 3.3. Types of mHealth adherence interventions 
3.5.1 Passive TM Reminders 
Near half of the trials passively sent regular reminders to patients’ mobile 
phones to improve medication adherence. In Denmark, Strandbygaard et al. (2010) 
sent passive daily TM to participants’ mobile phones for 12 weeks to remind them of 
taking their anti-asthmatic medication. Although asthma is a non-cardiac chronic 
condition, this study has been selected in this review because the type of the mHealth 
intervention is of particular relevance to this thesis.  
A total of 26 patients aged 18-45 years, with a clinical history of asthma and a 
positive Methacholine Challenge Test (as they were described by the authors) were 
recruited via advertisements in free local newspapers and randomised to receive, or 
to not receive the TM medication reminders. Reminders, at a fixed predetermined 
frequency, were delivered to the TM group with the following content:  
‘‘Remember to take your asthma medication morning and evening. From the 
Respiratory Unit’’.  
The absolute difference in mean adherence rate (the primary outcome of the 
study) between the two randomisation groups after 12 weeks was 17.8% with 95% 
Confidence Interval (CI) of 3.2-32.3, P=0.019. There were no significant differences 
between the two study groups for the secondary outcomes including reimbursement 
of asthma medication, and changes in exhaled nitric oxide levels, lung function 
measurement, and airway responsiveness to inhaled methacholine. The study authors 




asthma control and treatment and by implementing this awareness in a patient’s daily 
routine the adherent behaviour is improved. A daily TM reminder, in this Danish 
study, showed rather larger effect on medication adherence compared to the clinical 
outcomes. The percentage of the medication taken by the participants measured 
using a medication usage recorder, the discos Seretide device. The validity of this 
method of measurement is highly dependent on patients’ credibility as they could 
remove unused medications from their devices before the follow-up visits. Hence, 
reported results may indicate that there are still ambiguities relating to the effect of 
TM medication reminders on adherence and clinical outcomes and reliable stable 
measure or triangulations between subjective and objective measures may probably 
have shown differences even after a short period of using a mHealth intervention. 
This study conducted with a small sample size and short-term follow-up indicating 
that the findings may not be generalisable to a similar chronic condition. All these 
considerations were taken into account prior to the implementation of the present 
PhD research when formulating the study objectives and selecting outcome 
measures.  
Similarly, Quilici et al. (2013) used personalised unidirectional SMS reminders 
for one month with different formulation every day for aspirin intake in Acute 
Coronary Syndromes (ACS) patients who underwent percutaneous coronary stenting. 
Five hundred and twenty two patients of those who were admitted to an Antiplatelet 
Monitoring Unit in France, 30 days after hospital discharge, randomised to receive or 
to not receive SMS medication reminders. It was shown that daily computer-
generated motivational reminders were likely to significantly improve self-reported 
aspirin adherence, Odds Ratio (OR) [95%CI]: 0.37 [0.15–0.90]; P=0.02 and platelet 
function testing, OR [95%CI]: 0.43 [0.22–0.86]; P=0.01, at one month compared to 
standard care alone. The authors described that transition to home with experiencing 
post-discharge anxiety and depression may impact on patients’ medication adherence 
and so such inexpensive, widely available SMS-based intervention may offer the 
potential to improve adherence behaviour and health outcomes. There was no 
example of text-message content used in this study and explanation of the system 
development or SMS formulations. Moreover, the study took place with a short 




behaviour changes or clinical outcomes. According to Lally et al. (2010), an average 
time needed to reach the automaticity of a desired behaviour is 66 days. In the 
present PhD study, 12 weeks were considered to evaluate the effect of the mHealth 
intervention on medication taking behaviour in CHD patients; all stages of 
intervention development and piloting work were formulated and described based on 
the Medical Research Council (MRC) guidance for evaluating complex interventions 
(2015) (see Methods Chapter).  
In another study by Arora et al. (2014), a one-way TM intervention called 
“TExT-MED” system was developed that sent TM as a trigger for diabetic patients in 
Los Angeles County to engage in self-care activities and medication adherence. In 
this study, 153 diabetic patients, aged 18 years or older were identified using the 
Emergency Department Information System of whom 128 were randomised in either 
intervention (n=64) or control group (n=64). The TExT-MED sent daily messages 
(available in both English and Spanish) with maximum 160 characters to 
participants’ mobile phones twice a day at specific times for 6 months. Message 
contents were developed based on an iterative process using current National 
Educational Materials, multidisciplinary expert advice, previous mHealth experience 
and work with target population for their specific interests. They developed four 
categories of messages including Educational/motivational, Medication reminders, 
Healthy living challenges and Trivia (Questions & Answers) that were sent to the 
patients at a different frequency. For example, medication reminders were planned to 
be delivered to patients 3 times per week to increase adherence with prescribed 
medications with following sample:  
“Medication reminder! Don’t leave home without your medications”. 
 It seems that such variety in the developed TM types can be problematic in 
investigating which message components were most effective and engaging while 
they reported on the overall programme. Although TExT-MED did not show a 
statistically significant difference in the primary outcome of Hb A1C, investigators 
supported their intervention and described that the system requires minimum 
investment, making them especially appealing to under-resourced organisations. 




based interventions can be brought to a community scale rapidly in comparison with 
Smartphones. Although the target population of this study is not cardiac patients, the 
type of the mHealth intervention, its development and TM reminders’ contents are of 
particular relevance to this thesis.  
In a three-phase study conducted by Pandey (2015), a computer-based TM 
reminder system developed as a potential solution to improve adherence to 
medications in Canadian patients with Coronary Artery Disease (CAD). The 
researcher described the three phases of their study;  
Phase 1: testing the technical reliability and feasibility of the TM reminder 
system in 4 volunteers with different phones and service providers over a two-month 
period;  
Phase 2: pilot testing in 25 healthy participants divided into two groups to 
receive TM reminders in four predetermined times per day in either week one or 
week two; and  
Phase 3: evaluating the intervention in 30 cardiac patients equally divided into 
two groups to receive TM reminders according to their medication regimen in either 
month one or month two.  
It was described that the system was designed to address forgetfulness and 
unintentional causes of non-adherence. Nevertheless, it showed a significant effect 
on improving adherence, with all of stable cardiac patients demonstrating reduction 
in non-adherence with an average relative risk of 64% in this group of patients 
(P<0.01). The researcher asked participants to record their medication taking in 
specially designed and supplied logbooks as the only instrument for outcome 
measurement. This method of measurement may overestimate patients’ adherence 
since the majority of patients do not tend to report undesired behaviour of medication 
non-adherence in order to make their care providers pleased. There was no example 
of text-message content or explanation of factors considered in formulation of TM 
reminders. The small sample size and short-term follow-up may have impaired the 




A more recent study conducted by Akhu-Zaheya and Wa’ed, (2016) in the 
North of Jordan aimed to evaluate the effect of SMS reminders on adherence to 
medication, diet and smoking cessation among adult cardiovascular patients.  
Hundred and eighty participants were recruited by a nurse from outpatient 
clinics and randomly assigned to experimental, placebo, and control groups by 
shuffling numbers allocated to each patients (n=60 per group). Participants in the 
intervention group received three types of SMS reminders about medications, healthy 
diet and quitting smoking with the following template, as an example, for a 
medication reminder message:  
“Mr. /Ms. (patient name), please it is the time to take (medication name), 
(dose) (number of tablet) at (time)”. 
There was no information regarding the timing and frequency of SMS 
reminders. Participants in the placebo group received health-related general 
messages in their mobile phone. The Control group did not receive any types of 
intervention.  
Participants’ adherence to medication, healthy diet, and smoking cessation 
were assessed by Morisky self-report questionnaire (MMAS), Mediterranean Diet 
Adherence Screener (MEDAS), and Readiness to Quit Ladder, respectively at the 
start-point and after 3 months of the study. According to the study findings, there 
were significant differences between study groups in medication adherence 
(P=0.001) and adherence to diet (P<0.0001); however, no significant difference was 
observed between the three groups, in terms of readiness to smoking cessation 
(P=0.327), and/ or amount of smoking (P=0.34). Using self-report measure as the 
single approach to assess adherence may lead to the self-reporting bias that alter the 
validity of study findings.  
As it was described by the authors, in developing countries, there are limited 
post-discharge follow-up at home and so SMS may have the potential to be an 
accessible way to improve cardiovascular patients’ discharge follow-up. However, 
further research is needed to support the effectiveness of SMS with a rigorous design 




Fang et al. (2016) used text messaging along with Micro Letter (ML), an online 
platform messenger service accessible for participants through the Internet Portal via 
scanning a code or searching the platform name. A total of 280 CAD outpatients 
from Chengdu City, China, were randomised to three groups: SMS only (n=95), 
SMS plus ML (n=92), and phone (control) (n=93).  
CAD-related information and medication reminders were sent to participants at 
intervals regularly under a nurse and doctor supervision. This information was 
delivered to patients in the form of text messages, images, and media content related 
to the disease. Investigators assessed medication adherence using Morisky self-report 
questionnaire as the only method of outcome measurement that the results are highly 
dependent on patients’ honesty and may artificially inflated the level of adherence. 
Both intervention groups showed better Statins adherence after six months than the 
control group who received one telephone call per month to remind them of their 
medication schedule and appointments, SMS only vs. Control OR [95%CI]: 0.069 
[0.032–0.151]; P<0.001 and SMS + ML vs. Control OR [95%CI]: 0.339 [0.183–
0.629]; P=0.001.  
The authors discussed that the study intervention provided an easy-to-use, self-
service learning platform that participants were able to access the information 
frequently at their preferred convenience time. However, it needs to be taken into 
consideration that such intervention approaches may limits rural participants because 
they are required to have access to cellular networks for SMS and ML information. 
They also have to be educated and competent with computer and the Internet. 
Moreover, providing accurate and timely health-related information through SMS 
and ML requires adequate time, resources and staff training.  
In the studies using TM medication reminders as a form of mHealth 
intervention, it was shown that mobile phone text-messaging have the potential to be 
widely available, easy-to-use and inexpensive. It is a rapid, convenient 
communication method and allows sending medication reminders as well as 
dissemination of disease-related information in a user friendly format with less effort 
on the part of health care staff or personnel (Thakkar et al., 2015, Gandapur et al., 




been mixed. Most of the trials were conducted in a short duration with a small 
sample size. It indicates that reported findings may not necessarily be generalisable 
to cardiac medications and so uncertainty remains about the effect of text message 
reminders to improve medication adherence in cardiovascular patients. Moreover, 
review of these papers suggested that TM reminder as a mHealth intervention has 
been evaluated on a small-scale, mainly in developed countries and has done little to 
add to the existing body of knowledge. Further research is needed to evaluate the 
effect of mHealth intervention on medication adherence in developing countries.  
3.5.2 Interactive TM Reminders 
In these studies, 31% (4/13) used interactive TM medication reminders. Park et 
al. (2014) used personalised interactive TM reminders twice a day to take antiplatelet 
and statin medications and/or one-way health education three times a week in 
patients with Coronary Heart Disease (CHD) in Northern California for 30 days.  
A convenience sample of 90 patients with CHD who were introduced by other 
cardiologists or nurses were recruited and randomised to one of three study groups 
by generating random allocation sequence using blocks of 6. Study groups comprised 
of 30 participants who received TM Reminders plus TM Health Education; 30 
participants who received TM Health Education Alone; or 30 participants who did 
not receive TM.  
Personalised TM reminders were sent at patients’ preferred times based on 
their medication schedule. There was a difference in the number of delivered 
messages in the two intervention groups. 74 messages over the time of the study 
were delivered to the TM Reminders plus TM Education group, while 14 messages 
were sent to the TM Education only group. Patients were required to reply back to 
confirm the delivery of the TM reminder. Here is an example of reminder content:  
‘‘John, take Plavix 75 mg at 9:00 AM. Respond with 1.’’  
The primary outcome of the medication adherence using electronic monitoring 
devices, Medication Event Monitoring System (MEMS), revealed patients who 
received TM for antiplatelets had a higher percentage of correct doses taken 
(P=0.02), percentage number of doses taken (P=0.01), and percentage of prescribed 




revealed no significant differences between groups. Study findings showed better 
adherence to antiplatelet medications (but not to Statins) in the two experimental 
groups who received TM for medications compared to those who did not. The 
authors described that this result was consistent with the poor adherence generally 
seen with Statin medications. The similar finding was reported that there was a 
significant lower participants’ response to Statins reminders compared to antiplatelet 
medications. Investigators discussed challenges of obtaining complete MEMS data. 
Patients did not use MEMS properly due to experiencing higher levels of stress with 
using MEMS in addition to the anxiety relating to a new diagnosis of CHD and 
hospital discharge (as they were described by the authors). Some patients tended to 
use a pill box or were not comfortable in carrying the MEMS device with them while 
they were away from home. Moreover, MEMS and TM patients’ responses may not 
have indicated the actual medication consumption as patients could have replied to 
the TM and opened the MEMS without actually taking the medicine. The Hawthorne 
effect is another limitation of using MEMS or other electronic medication monitoring 
devices (as they were discussed by the authors). It means that using such devices 
may have attracted attention to regular medication intake behaviour unintentionally 
for all groups including the control group. The relatively small sample size and short-
term follow-up may have weakened the study power and external validity of the 
findings, as well.  
A similar study carried out by Wald et al. (2014) in London involved an 
automated computer program to send two-way text messages to CVD patients 
receiving Blood Pressure (BP) and lipid-lowering medications daily for 2 weeks, 
alternate days for 2 weeks and weekly for another 22 weeks over the six months 
period of the study.  
Three hundred and three patients were recruited from eligible people who were 
identified from electronic lists of patients. Investigators sent an invitation TM to 
6884 patients asking them to respond back if they were interested in participating in 
the trial. Another 120 patients were identified when attending their primary health 
care practice. Participants were randomly assigned in blocks of 4 to receive (n=151) 
or to not receive TMs (n=152). This method of recruitment might lead to enrolling 




comparison with other patients in general. Moreover, this may limit the power of the 
study to show statistically significant results in improving medication adherence. 
It was mandatory for participants to response back to each TM reminder, 
reporting whether they had/ had not taken their drug, or whether they are reminded to 
take it by TM if they had forgotten. Patients’ text reply was filed by the developed 
computer program automatically. Participants, who had not taken their medications 
or not replied, received a phone call to identify whether they had a reason for it, and 
if so, to discuss and resolve the issue. The TMs were tailored to the time that 
participants consumed their medication but the TM frequency was not automatically 
modified based on the patients’ response. 
The finding of this study that examined a two-way TM reminder increased 
adherence to the use of BP and/or lipid-lowering medication significantly in the 
intervention group compared to the control, 16% with 95% CI (7%–24%), P<0.001. 
Medication adherence, in this study, was determined by querying patients regarding 
any medication discontinuation or missed doses at primary care practice visits or 
using electronic prescription records of the General Practice (GP). Although self-
report adherence measure is low cost and easy-to-use, there are concerns about the 
validity of these measures. That is because self-report measures are vulnerable to 
social desirability, question phrasing and recall biases that may overestimate the 
degree to which patients take medications in comparison to other methods (Stirratt et 
al., 2015). However, acceptable relationships with health outcomes and other types 
of adherence assessment have been shown in well-validated and rigorously 
developed self-report tools, namely Morisky Adherence Questionnaire 8 item 
(MMAS) (Morisky et al., 1986, Morisky et al., 2008, Voils et al., 2011). Utilising of 
multiple measures in adherence study can triangulate intervention effects through 
comparisons with one another (Stirratt et al., 2015, Velligan et al., 2010). 
Dale et al. (2015) developed and evaluated a form of a mHealth intervention 
called “Text4Heart” aimed at improving adherence to cardio-protective behaviours in 
adults diagnosed with CHD. The investigators included medication taking, stopping 
smoking, physical activity, healthy eating, and limiting alcohol consumption as their 




A total of 123 CHD patients were identified by a trained researcher before 
discharge from 2 hospitals in Auckland, New Zealand. Participants were randomised 
to the intervention (n=61) or the control (n=62) group in a 1:1 ratio. The researchers 
supplied patients with a mobile phone for the duration of the trial. However, having 
access to the Internet was one of the requirements to participate in the study. This 
could be one of the limitations of the study that excluded those patients who did not 
have the Internet access.  
In addition to usual care (i.e. Cardiac Rehabilitation), the intervention group 
received a 24-week mHealth programme. They received 7 daily TMs per week and 
had access to a supporting website. The frequency of TMs decreased over the period 
of the study. Between weeks 13 and 24, patients received 5 TMs per week. 
Intervention group also were given a pedometer to monitor their physical activity on 
their own. Investigators personalised TMs to patients’ name and preferred time of 
day to receive TMs. Participants were asked to send their pedometer step counts on a 
weekly basis and to text in their questions or ask for feedback on other behaviours. 
Then, based on their achievement relating to the number of steps, they received 
automated responses. Their questions were answered individually by the study team 
within 2 days. Participants received reimbursement for any TM-related expenses. 
Adherence to healthy lifestyle behaviours and medications was measured by a 
self-reported composite health behaviour score and Morisky questionnaire (MMAS) 
after 3 and 6 months from the study start point. Significantly higher medication 
adherence scores were reported by the intervention group compared to the control 
(mean difference: 0.58, 95% CI 0.19-0.97; P=0.004). The Text4Heart intervention 
showed a significant improvement in adherence to healthy behaviours at 3 months 
(Absolute Odds Ratio (AOR) 2.55, 95% CI 1.12-5.84; P=0.03), but not at 6 months 
(AOR 1.93, 95% CI 0.83-4.53; P=0.13). This can be related to the likelihood of 
occurring deterioration in unhealthy behaviours due to the decrease in the frequency 
of text messaging over time. With regards to the usability of two-way text 
messaging, it was reported that only 38% of participants texted in questions or 
comments to the research team (23/61). This low rate of patients’ responses might be 
due to the anxiety and depression usually occur after hospital discharge from a 




impact on patients’ active involvement in such studies. The Study demonstrates the 
effectiveness of the intervention in this particular population in New Zealand; 
however, the findings cannot be generalisabale to other populations or settings such 
as low and middle income countries. The Morisky instrument is used to measure 
medication adherence over time and would appear to be the instrument of choice for 
measuring adherence due to high reliability and validity. 
Another similar parallel group, assessor-blinded RCT study was conducted by 
Kamal et al. (2015) among stroke survivors in Pakistan. The investigators sent 
automated SMS reminders to the intervention group for 2 months to improve 
medication adherence for stroke. Daily medication reminders were tailored to the 
participants’ prescriptions. In addition, health-related information text messages were 
sent 2 times per week. The participants were required to reply to each SMS 
confirming whether they have taken or not taken their medicines. The costs of 
sending the text response were returned to the participants by giving them prepaid 
credit previously. Patients in control group did not receive any kind of the 
intervention. Their clinic appointments were reminded to both study groups couple 
of days before the due date via SMS and/or phone. 
Two hundred Participants were randomly assigned to either intervention 
(n=100) or control group (n=100) in a 1:1 ratio with block size of 10. Medication 
adherence was measured at baseline and after 2 months using the Morisky 
questionnaire (MMAS). After 2 months, the intervention group showed a significant 
increase in medication adherence compared to the usual care group, mean difference 
was 0.54 (95 % CI; 0.22–0.85) (P=0.01). No report was found relating to the 
patients’ response rate to the SMS reminders.  
The investigators used a self-reported measure as the only adherence 
assessment tool that is highly dependent on patients’ credibility in responding the 
adherence questions. Moreover, it was described by the authors that participants in 
the intervention group were disclosed to the reception of SMS and were well-
instructed and seemed to be motivated to medication adherence compared to the 
control group. This may lead to inherent or performance bias that may artificially 




Almost all studies proposed SMS reminders as a scalable, cost-effective, 
widely available and attractive approach for patients after discharge from hospital to 
improve medication adherence. Although using two-way TM reminders as a form of 
mHealth intervention provided the possibility of communication between patients 
and providers, response rate in aforementioned studies showed lower interest in 
patients to reply text-messages.  One of the reasons may be related to the text-
massaging costs when participants are not reimbursed for such expenses. Moreover, 
some patients are only able to read TMs and they are not literate enough or 
competent to type and send TMs. Bidirectional TM reminders are highly relying on 
the active engagement of patients and providers. It also needs to be considered that 
many patients experience some degrees of anxiety and / or depression after hospital 
discharge from a cardiac event and prompting them to send reply messages may 
cause intrusion in their life as an additional source of stress (Shemesh et al., 2009, 
Tully and Baker, 2012). Having acknowledged limitations, caution is needed when 
asking patients to respond back to the TMs in mHealth studies. In the present study, 
one-way TM medication reminder was considered as a preferred mHealth 
intervention based on the findings from the survey study conducted in CHD patients 
prior to the trial.   
3.5.3 mHealth Interventions other than TM reminder 
One trial used a type of mHealth intervention other than text messaging. 
Vollmer et al. (2014) used a 2 Electronic Medical Record (EMR)-linked automated 
phone reminder for 1 year to improve adherence to cardiovascular medications in 
patients from 3 regions of the Kaiser Permanente (KP) health plan: Northwest, 
Hawaii, and Georgia in the USA.  
In this study, 21,752 diabetic and/ or CVD patients aged 40 years and older and 
due or overdue for an Angiotensin-Converting Enzyme Inhibitors/Angiotensin 
Receptor Blockers (ACEI/ARB) refill were recruited based on the study eligibility 
after being identified using EMRs of each region. Computer-generated 
randomisation assignments were stratified by region. All participants were 




mHealth interventions, regular Interactive Voice Response (IVR) (n=7247) or 
enhanced IVR (n=7250).  
Participants in usual care group received usual services offered in each region, 
including education and efforts to motivate Statin and ACEI/ARB medication taking. 
Regular IVR group received automated phone calls lasted 2 to 3 minutes to remind 
patients to refill ACEI/ARB prescriptions. Enhanced IVR involved automated phone 
calls plus personalised reminder letters (if a patient was 60-89 days overdue), a live 
outreach call (if a patient was more than 90 days overdue), EMR-based feedback to 
the primary care providers, their current BP report, cholesterol level and additional 
health-related informative mailed materials.  
There were small but statistically significant improvements in ACEI/ARB 
adherence among both IVR interventions versus usual care, with OR for enhanced 
IVR of 1.21 (95% CI 1.10-1.32) and OR for regular IVR of 1.12 (95% CI 1.02-1.23) 
compared to usual care. The difference between enhanced and regular IVR groups 
was not statistically significant. Although the improvements were statistically 
significant within intervention groups, the overall effect was small. No significant 
changed reported in either Systolic BP or overall BP measures among subgroups.  
Medication adherence was measured using the Medication Possession Ratio 
(MPR) at baseline and a modified version of PDC at the end of the study based on 
pharmacy records (as they were described by the authors). To calculate these 
measures, patient’ prescribed medication’ name, days supplied, and at least two fill 
dates are needed. However, there are two different formulas for each measure to find 
the final result (Choudhry et al., 2009). This indicated that there was an 
inconsistency between pre- and post-study adherence measurement and so the 
findings should be treated with caution.  
It was mentioned by the authors as one of their study limitations that there was 
a considerable number of patients who were never reached by phone calls. This may 
be related to perceptions of patients towards the effectiveness versus intrusiveness of 
the IVR interventions that may have impact on their interests in receiving calls. It 
needs to be taken into consideration that patients who live in remote areas may have 




often very poor to hear the voice. IVR or similar mHealth interventions using voice 
call reminders should be designed in recognition of mentioned limitations.  
3.5.4 Comparing two mHealth Interventions  
In these studies, 15% (2/13) compared the effect of two types of mHealth 
interventions on treatment adherence in their target population. Zolfaghari et al. 
(2012) conducted a quasi-experimental study for 3 months to evaluate and compare 
the effect of two mHealth interventions (SMS versus telephone calls) on improving 
HbA1c levels and adherence to treatment in Iranian diabetic patients.  
Participants aged 18–65 years old were identified from the Iranian Diabetes 
Association. 80 eligible patients who had their own personal mobile phones were 
randomised by using a random number table and assigned to either SMS group 
(n=39) or telephone group (n=41). 
The investigators sent 6 messages with maximum 160 characters per week 
(excluding weekends) to the SMS group providing information about healthy diet, 
physical activity, medication adherence, stress management and blood glucose self-
monitoring. Here are two examples of messages relating to medication adherence: 
Sample one: “Please, consume your drugs at prescribed times”; 
Sample two: “Take your recommended diabetic medication timely”. 
Participants in the telephone group received phone calls with the average 
length of 20 minutes per contact at least 2 times a week for the first month and once 
a week for the second and third month with the same contents as the SMS group. 
HbA1C levels were assessed in patients’ blood test and adherence was 
measured by a self-care diabetes questionnaire at the beginning, after 3 and 6 months 
of the study. There were significant improvements in HbA1C levels within SMS 
groups over the time of the study, with a mean change of −1.01; SD±0.01 (P<0.001) 
and within telephone group with a mean change of −0.93; SD±0.13 (P<0.001). 
Significant changes were reported in adherence to diabetes-related recommendations 
including medication taking comparing pre- and post-test results within SMS group 
with a mean change of 15.65; SD±2.72 (P<0.001) and within the telephone group 




showed that there were no statistically significant changes in HbA1C (P=0.227) and 
adherence to diabetes control recommendations including medication taking 
(P=0.508) between the two study groups. The absence of a non-intervention control 
group may reduce the power of the study in identifying the actual effect of the 
intervention on adherence to medication and other diabetes control 
recommendations.  
It can be concluded from this study that SMS has the potential to be as 
effective as telephone follow-ups. Telephone follow-up relies on synchronous 
patient-provider communications. Studies reported that 15–27 per cent of patients 
were never reached by phone after several call attempts (Gray et al., 2010, Hwa and 
Wren, 2013). It also requires more time and labour such as a nurse or other health 
care staffs than the other methods to call and follow-up with patients (Armstrong et 
al., 2014, Zolfaghari et al., 2012). The delivery of predefined SMS messages can be 
obtained via an automated system regularly and without the necessity of extra 
programmes and time for clinical staff trainings (Bobrow et al., 2016). According to 
the findings of a systematic review conducted by Cutrona et al. (2010), person-
independent interventions (delivered via electronic interface such as programmable 
reminders, or computer-generated personalised interventions) were the most 
successful mode of delivery for interventions to improve cardiovascular medication 
adherence rather than person-dependent interventions (non-automated). As it was 
described by Zolfaghari et al. (2012), in developing countries including Iran there is 
a shortage of nurses and health care providers. It seems that low-cost methods 
require less labour’s efforts and so SMS-based mHealth intervention may have the 
potential to be designed and examined as an alternative method to address these 
issues.  
In a more recent single-setting, three-arm RCT conducted by Bobrow et al. 
(2016) in South Africa, the effect of automated SMS-based adherence program (sent 
via an open-source web-based EMR system) on adult patients with hypertension was 
evaluated for 12 months. The investigators utilized two types of mHealth 
intervention to deliver BP-lowering medication adherence support including one-way 




Potential patients with high blood pressure aged 21 or older who had access to 
a mobile phone and could send SMS were identified by clinic staff in outpatient 
chronic disease services of a public clinic. A total of 1372 eligible patients were 
assigned to one of the three study groups, one-way SMS (n=457), interactive SMS 
(n=458), or usual care (n=457) using a web-based software algorithm in a 1:1:1 ratio. 
Research assistants (who collected data), statisticians, investigators and clinic staff 
were blinded to patients’ allocation (as they were described by the authors). 
Although they were all trained to not ask patients about the types of SMS, patients 
might have discussed the text messages contents with the research team. This may 
have altered the blinding and affected the actual outcomes of the patients in the trial.   
Participants allocated to the unidirectional SMS group received motivational 
weekly text-messages related to prescription refill and medication taking that 
contained educational information about high blood pressure and its treatment. The 
investigators also sent additional SMS messages to remind patients of clinic 
appointments or medications refill. Patients in the interactive SMS group were sent 
the same informative text-messages at weekly intervals as the one-way SMS group 
but could also reply to selected text-messages containing the request of free-to-user 
“Please-Call-Me”. Participants in all randomised groups received non-health related 
SMS every six weeks.  
Study primary outcomes including mean systolic BP (mean of the five systolic 
BP excluding the first reading), BP-lowering medication adherence (via calculating 
PDC based on pharmacy records) were measured at baseline and at 12 months.  
It was found that mean SBP declined from the start-point to 12 months within 
all study groups. At the end-point of the study, the mean SBP changes in comparison 
with usual care was −2.2 mm Hg 95% CI (−4.4 to −0.040), with one-way SMS and 
−1.6 mm Hg 95% CI (−3.7 to 0.6) with tow-way SMS. The researchers did not report 
the difference in systolic BP measured between the study groups. This may reduce 
the power of the trial in terms of lack of the size of the study intervention effect. 
The study showed a significant difference in the proportion of participants who 
had higher PDC in the one-way SMS group (62.8%) compared to usual care (49.4%) 




P=0.002. The measure of PDC used to assess adherence was based on pharmacy or 
clinic records that indicates dispensing in the clinic than the actual act of consuming 
medication by patients. Moreover, the investigators recruited a group of hypertensive 
patients rather than identifying those with poorly controlled BP. This may limit the 
extent to which BP improvement was possible.  
The findings in this trial showed that one-way SMS might be as effective as 
interactive SMS in providing medication adherence support. It also provided 
evidence that automated adherence program delivered via either unidirectional or 
bidirectional text-messaging may have a small effect on BP control as a clinical 
outcome in comparison with usual care in hypertensive patients within a lower-
resource setting. However, considering the acknowledged limitations in outcome 
measurements, caution is needed when interpreting the study findings.  
3.6 Acceptability of mHealth Interventions  
Slightly less than half of the studies (6/13) reported the acceptability and 
satisfaction of receiving mHealth intervention in their target study population.  
In a study conducted by Strandbygaard et al. (2010) that evaluated the effect of 
12-week passive daily TM on anti-asthmatic medication adherence in Denmark (see 
Section 3.5.1), no data were shown relating to the perception of participants towards 
receiving a daily SMS reminder. However, they discussed merely that participants in 
the intervention group perceived SMS reminders positively. They found that the 
majority of participants were not satisfy with SMS receiving time (10 am) that 
indicates improvement is needed in further studies. It may be useful to personalise 
the SMS timing to each participant to enhance the intervention effect, or survey 
patients prior to the study implementation to obtain their preferences regarding the 
delivery of mHealth intervention.  
Quilici et al. (2013) who undertaken a study to examine the effect of one-
month personalise6d unidirectional daily SMS reminders for aspirin intake in French 
ACS patients (see Section 3.5.1), provided a short general report of patients’ 
feedback about the intervention. At the end of the study, it was found that 92% of 




support program was valuable. The authors did not describe in detail how they 
collected the data relating to the patients’ experience on receiving the intervention. 
Similarly, in  the TExT-MED study by Arora et al. (2014) that evaluated the 
effect of a one-way TM intervention on diabetic patients’ self-care activities and 
medication adherence in Los Angeles County (see Section 3.5.1), program 
acceptability at the 6-month follow-up visit were explored. The satisfaction rate with 
the TExT-MED intervention was high (as they were reported by the authors). The 
majority of patients answered that they strongly agreed (25.5%)/ agreed (68.1%) that 
the TExT-MED was a good way to obtain information about diabetes. It was 
reported that participants in the intervention group enjoyed the TExT-MED (40.4% 
strongly agreed and 53.2% agreed). Slightly more than half of patients strongly 
agreed and around 37% agreed that the TMs’ contents were easy-to-understand. As it 
was reported in the study, all of participants who received the TExT-MED 
intervention would recommend it to other diabetic patients. There was no particular 
information about the selection of the survey questions or the method used to obtain 
the survey data. 
Park et al (2014) also evaluated the satisfaction of 53 CHD patients in Northern 
California who received personalised TM reminders after 30 days of the study by the 
Mobile Phone Use Questionnaire. The investigators developed the questionnaire 
specifically for the study to explore participants’ experience with utilising mobile 
phone devices for medication reminders and/or receiving health-related information. 
It was reported by the authors that both experimental groups (reminders plus 
educational TMs and educational TM only) were highly satisfied with receiving the 
intervention. The majority of patients strongly agreed/ agreed that receiving TM for 
health and medication taking were helpful and promoted the feeling of being cared 
for. Although 88.6% strongly agreed/ agreed that the mobile phone-based TM 
intervention was easy-to-use, around 8% reported technical issues with receiving 
TM.  
In another study, qualitative interviews were conducted by Vollmer et al. 
(2014) with participants and stakeholders of health plan including physicians, health 




the 12-month EMR-based automated cardiovascular medications phone reminders 
(see Section 3.5.3).  
The investigators recruited stakeholders by email or letter, and an additional 
phone call, for open-ended, semi-structured interviews. An interview guide was 
developed to undertake interviews either in person or over the phone. A trained 
qualitative researcher analysed the transcribed interviews using content analysis. A 
survey also was conducted in 498 patients at the one-year follow-up to evaluate their 
satisfaction with the study intervention.  
According to the study findings, around 70% of participants thought automated 
phone reminders were useful or very useful and 71% would like similar calls to be 
continued in the future. Seventy eight percent of the 379 participants who received 
enhanced IVR including additional informative mailed materials found the 
intervention useful or very useful, and would like to receive similar materials in the 
future.  
Similar findings were found from in-depth qualitative interviews with 49 
patients. Sixty three percent of interviewees perceived that phone calls were a useful 
service to help stay on track with their medication refills, and 31% thought the calls 
were valuable when getting older and forgetful. In this study, 57% of 30 respondents 
who received enhanced IVR reported that the mailing materials were useful in 
providing education and knowledge of the medication adherence importance. Ninety 
four percent of all interviewees believed the intervention should be carried on as a 
continuous service, and near 70% felt at least some of the mailings which were more 
personalised should be sustained. 
Of 45 stakeholders interviewed, near 70% found the intervention as a helpful 
and important service for increasing medication adherence. It was reported by the 
authors that slightly less than half of the stakeholders thought the intervention was a 
proper utilisation of an inexpensive technology, and 27% believed that the 
intervention had the potential to provide outreach to patients who may slip through 
the cracks in different circumstances. 
Another similar RCT conducted by Kamal et al. (2015) to examine automated 




survivors (see Section 3.5.2). After 2 months of the study, satisfaction and 
acceptability of the intervention were measured using specific tools that determined 
the effects and challenges of utilising this technology.  
The investigators developed a self-reported questionnaire based on Roger’s 
four attributes from the Diffusion of Innovations theory (Rogers, 2003) to identify 
the success of an innovation. The questionnaire reported satisfaction as percentage.  
Roger’s Diffusion Theory seeks to describe how innovations are adopted in a 
population (Rogers, 2003). As it was described by Robinson (2009), four attributes in 
the Diffusion Theory are:  
 Simplicity that refers to the extent to which an innovation is thought as 
difficult-to-use;  
 Compatibility is the second attribute that is defined as innovation consistency 
with the values, previous experiences, and potential users’ needs;  
 Observability of an innovation results that helps reduce the uncertainty in 
individuals; and 
 Relative advantage of an innovation that may have an impact on the rate of 
innovation adoption by users.  
The authors described that they also designed another questionnaire according 
to previous literature that measured satisfaction as proportions. Patients reported a 
high score satisfaction with intervention with a mean percentage of 96.07 %. In terms 
of Diffusion characteristics of mHealth intervention, the mean score was 95.6 % 
(7.6/8). The Roger’s four attributes scores were 1.91/2, 1.91/2, 1.9/2 and 1.95/2 for 
simplicity, compatibility, observability and relative advantage, respectively.  
To sum up, the majority of studies have established feasibility and high 
satisfaction with a mobile phone-based intervention among patients with chronic 
disease and in different settings. However, limited studies have been undertaken to 
assess mHealth acceptability in developing countries including Iran and there is still 
uncertainty in the existing body of knowledge. Therefore preliminary studies are 
needed focusing on the feasibility and acceptability of mHealth medication 
adherence interventions from patients and healthcare professionals’ perspectives in 




3.7 Theory-based mHealth Studies 
Of thirteen studies selected for review, only 30% used a theory-based mHealth 
intervention to improve medication adherence. One of the importance of conducting 
a theory-based study is that it contributes to provide a framework for interventions 
development and evaluation (Abraham and Michie, 2008). This also assists in 
identifying the mediating-factors in behaviour change and the reasons for 
intervention success or failure (Lubans et al., 2008). 
In the study conducted by Arora et al. (2014), the Health Belief Model of 
health behaviour (Janz and Becker, 1984) was applied in the development of a 
unidirectional TM–based mHealth intervention (TExT-MED) for diabetic patients in 
the US. Based on this model, the intervention used in this 6-month trial emphasised 
education to impact on perceptions of patient with uncontrolled diabetes in favour of 
the appropriate health behaviour (i.e. improvement in HbA1C, medication adherence, 
self-efficacy and understanding of diabetes-related information) and used triggers to 
promote the desired action. As it was fully described in Section 3.5.1, the results 
demonstrated that at 6-month follow up the TExT-MED did not significantly 
improve HbA1C in the intervention group compared to the usual care group.  
In a study conducted in the US, Park et al. (2014) compared the effect of a 30-
day interactive TM-based intervention on antiplatelet and statin adherence in three 
randomised groups (educational TM only, educational TMs plus reminders, No TM). 
The study intervention developed for patients with CHD, based on the Self-efficacy 
Theory (Bandura, 2004). As it was described by the authors, using TM medication 
reminders in combination with CHD –related educational TMs including self-care 
components may improve self-efficacy and confidence in patients to be adherent to 
their prescribed medication regimen. The two intervention groups showed higher 
adherence to antiplatelet medications compared to the control group, but not to 
Statins medications (see Section 3.5.2). 
Similarly, Dale et al. (2015) developed automated daily bidirectional SMS-
based intervention and a supporting website (Text4Heart) based on the principles of 
the Social Cognitive Theory (Bandura, 2004) and self-efficacy major mediators to 




healthy, and limiting alcohol-drink) in New Zealand patients with CHD. As it was 
described by the authors, the Common Sense Model (Cameron and Jago, 2008) was 
applied to develop the study intervention, as well. They used this model to provide 
coping strategies for changing patient perceptions and the harmful emotions that 
appear with a health threatening condition. The Text4Heart intervention group 
reported significant changes in adherence to healthy lifestyle behaviours compared to 
the usual care group at 3 months. However, the effect was not sustained at 6 months 
(see Section 3.5.2).  
In Pakistan, Kamal et al. (2015) also developed and evaluated automated 
interactive SMS reminders based on the Health Belief Model and Social Cognitive 
Theory to improve medication adherence in stroke patients. SMS contents comprised 
of personalised medication reminders according to patients’ prescriptions and health-
related information specified by the Taxonomy of Behavioural Change for increasing 
physical activity and healthy eating (Michie et al., 2011). The investigators used the 
Health Belief Model in which behaviour change could be predicted based on 
multiple major determinants including perceived susceptibility, seriousness, 
advantages and obstacles of taking action, triggers to taking action and self-efficacy 
(Rosenstock, 1974, Rosenstock et al., 1988). It was described by the authors that 
SMS contents were developed according to these themes to encourage participants to 
change their behaviour. After 2 months, a significant improvement was found in 
medication adherence in patients who received SMS reminders compared to the 
control group (see Section 3.5.2). The results were an early report of the study 
findings (as they were described by the authors) and as such no data were available 
from which the sustainability of the intervention effect could be evaluated. 
Limited mHealth interventions were developed by theory or frameworks that 
showed mixed results. This indicates that the mHealth studies have fallen short of 
attempting to explore the mechanisms of why the intervention would be effective or 
not, and be replicable in other research studies. Therefore, a need exists for research 
that develops an appropriate theory-based mHealth intervention and evaluates its 
effectiveness on improving medication adherence and the relevant health outcomes 
in CHD patients and in the particular setting of developing countries. In doing so, 




reminder intervention based on the principles of Bandura’s Self-efficacy Theory and 
the World Health Organisation (WHO) Adherence Model (see Chapter 2).  
3.8 Intervention Contents 
While in designing the content of the reminder messages special considerations 
are required, the majority of the experimental studies do not provide detail required 
for reliably identifying intervention content. Reporting of intervention content in the 
selected studies for the literature review was brief and imprecise. For example, 
Akhu-Zaheya and Wa’ed, (2016) who evaluated the effect of SMS reminders on 
adherence to medication, diet and smoking cessation among adult cardiovascular 
patients in North of Jordan, provided an example of three types of text message 
templates about medications, healthy diet and smoking cessation (see Section 3.5.1). 
They did not describe the development process of the reminders’ contents. Providing 
inadequate detail of intervention content limits the possibility of identifying the 
effective ingredients within the intervention.  
In contrast, Arora et al. (2014), in their TExT-MED study on diabetic patients 
described that they developed some general, short (with maximum 160 character) 
and simple text messages through an iterative process; According to the authors, the 
development process comprised of combining 4 items including: (1) the National 
Diabetes Education Program materials; (2) multidisciplinary experts’ opinions; (3) 
the target population’s interests; and (4) findings from previous mHealth pilot study. 
The majority of participants in this study strongly agreed/ agreed that the TMs’ 
contents were beneficial and easy-to-understand (see Section 3.5.1). This indicates 
the importance obtaining healthcare professionals’ opinions and incorporating 
participants’ feedback to generate message content (i.e. shared decision making) 
before its implementation to enhance the intervention effect. 
The majority of the studies used general, short and simple SMS medication 
reminders that were more acceptable from the perspective of their recipients. For 
example, the SMS content in the study conducted by Kamal et al. (2015) among 
Pakistanis stroke patients (see Section 3.5.2) was:  
“This is a reminder about your drug time. Please take your medicine. Have 




According to the authors, patients’ survey showed a high score satisfaction 
with the intervention. Similarly, Park et al. (2014) who used interactive TM 
reminders among CHD patients in Northern California for 30 days received positive 
feedback from their study participants. An example of the medication reminder was: 
 ‘‘John, take Plavix 75 mg at 9:00 AM. Respond with 1.’’ 
Strandbygaard et al. (2010) delivered 12-week passive daily TM to asthmatic 
patients in Denmark (see Section 3.5.1) with the following content and participants 
reported high satisfaction with the intervention:  
‘‘Remember to take your asthma medication morning and evening. From the 
Respiratory Unit’’. 
Since past studies that kept the content of the reminders straight-forward and 
simple have associated with greater patients’ satisfaction, future studies should pay 
attention to these suggestions.  
While SMS-based interventions have shown promise in improving adherence, 
it is not clear through which mechanisms they work. As it was described in Section 
3.7, less than one third (4/13) of the studies (Arora et al., 2014, Dale et al., 2015, 
Kamal et al., 2015, Park et al., 2014) used a conceptual framework to develop the 
intervention content. In accordance with the Bandura’s self-efficacy theory and the 
WHO adherence model (see Chapter 2), SMS messages may have the potential to 
positively influence adherence in three important ways. First, at the most basic level, 
SMS messages may serve as a pure reminder function to address forgetfulness (i.e. 
patient-related factor based on the WHO model). Second, the message content can 
provide social support/ persuasion (i.e. health system-related factor based on the 
WHO model) through reinforcement which in turn may increase patient’s self-
efficacy in taking medications especially during the early phase of hospital 
discharge, based on the Bandura’s self-efficacy theory underlying this study. Third, 
reminders (as external cues/ triggers) can also make the importance of drug 
adherence more salient and tangible leading to the retention and sustainability of the 
medication taking behaviour. Considering the mechanisms in which SMS reminder 
interventions may influence medication adherence would be a helpful step for 





Overall, based on the literature, mHealth approaches may have the potential to 
improve medication adherence in long-term conditions. However, there were some 
weaknesses and conflicting findings that became apparent in the review of the 
existing research presented in the literature. These included using self-reported 
measure as a single approach to assess medication adherence, conducting a small-
scale trial with an insufficient follow-up period and sample size and lack of a 
conceptual framework in forming the study intervention. The number of studies on 
cardiac medication adherence is also limited. The majority of mHealth studies were 
also conducted in developed countries and as such cultural and economical 
differences must be acknowledged when considering the results. It was evident from 
the literature that although mHealth interventions showed promise in improving 
medication adherence in different patients, there is no consensus to identify which 
form of mHealth intervention were the most effective (Santo et al., 2016, Sarabi et 
al., 2016, Thakkar et al., 2015).  
Despite being supported in the literature that nurses are well placed to 
encourage patients to be adherent to prescribed medications (Albert, 2008, Najafi et 
al., 2016, Stolic et al., 2010), most of the mHealth medication adherence 
interventions were evaluated by Medical Doctors. Patients may be unwilling to tell a 
doctor about missing doses and timing of the medications and how often and why 
they do not take the medication (Albert, 2008). The roles of nurses and medical 
doctors can be complementary, with nurses providing ongoing nursing interventions 
after discharge to encourage higher medication adherence (Bosworth, 2015, Larsen 
and Lutsep, 2013, Zolfaghari et al., 2012). 
The majority of adherence interventions developed to address medication non-
adherence focused on intentional non-adherence and their aims were to educate 
people and change their attitudes and beliefs (Haynes et al., 2008). However, even 
motivated people can forget; forgetfulness is the most common causes of 
unintentional non-adherence (Anderson, 2010, Clifford et al., 2008, Unni and Farris, 
2011). There are limited studies that revealed expected results on patients’ health 
outcomes and user satisfaction. With technology evolving rapidly, the use of older 




technologies may arise. Currently, SMS reminders are increasingly being 
implemented in mHealth interventions aimed at improving adherence as mobile 
penetration is high globally. The effectiveness is influenced by patients’ willingness 
to receive SMS reminders. The majority of included studies evaluating electronic 
reminders reported such interventions were well accepted by patients (see Section 
3.6). There are, however, differences in the electronic reminders sent. Therefore, 
more studies are needed to investigate the influence of the content of reminder 
messages on adherence behaviour. 
3.10 Conclusion and Rational for the Study 
Similar to any new innovation, mHealth for improving medication adherence 
in CHD patients is a work in progress. Knowledge and application of this new 
approach is on the rise in both developed and developing countries. However, there 
is a need of rigorous evidence from well-developed and implemented theory-based 
studies, focusing on patient’s medication adherence self-efficacy and most common 
reasons to be non-adherent to treatment. 
In Iran, medication adherence studies particularly using mHealth intervention 
among CR patients are limited. There is a need to understand and consider perceived 
patient barriers and their expectations in tailoring the design and implementation of 
such interventions (Toh et al., 2010, Nair et al., 2011, Almane et al., 2016). 
Intervention ease-of-use is one of the important aspects that reported as an ideal from 
the patients’ perspective (Cutrona et al., 2010, Misono et al., 2010). The intervention 
needs to be developed to fit the patient and the cultural context (Lambert-Kerzner et 
al., 2012, Nieuwlaat et al., 2014). Difficulties in access to affordable mobile 
technologies or the knowledge to operate mobile devices are the criticism of mHealth 
(Dale et al., 2014).  
The effectiveness of technology-based approaches in a particular setting of 
Cardiac Rehabilitation (CR) should be examined along multiple aspects: feasibility, 
acceptability, effectiveness, safety, user satisfaction, implementation and outcomes. 
Moreover, there is a lack of understanding regarding medication adherence and its 
assessment during CR programme. Typically the literature does not mention 




are offered during CR are less effective for those who unintentionally fail to adhere 
to medication (Touchette and Shapiro, 2008). Therefore, this study aimed to achieve 
an effective strategy to address medication non-adherence problem by sending 
triggers; in this case mobile phone reminders based on the principles of Bandura’s 
Self-efficacy Theory and the WHO Adherence Model (see Chapter 2). The 
intervention focused on the most common patient-related factors (forgetfulness, 
carelessness and low self-efficacy), as well as healthcare system-related factors 
(patient- health care provider interaction and support) to improve patient medication 
adherence and health outcomes. This will assist nurses not only to improve 
interaction with patients after discharge from hospital, but also provide evidence 
based research regarding the most appropriate form of mHealth intervention 
implemented based on the MRC guideline for evaluating complex interventions 
(2013). The results from both qualitative and quantitative phases will also extend 
existing knowledge regarding the feasibility and acceptability of a mHealth 











CHAPTER 4: RESEARCH METHODOLOGY 
The theoretical background and literature review in the preceding chapters 
revealed that poor adherence to medications and health recommendations among 
cardiovascular patients remain a significant issue for patients and healthcare 
providers in both developed and developing countries including Iran. With complex 
and changing medication regimens after hospital discharge among cardiac patients, 
innovative approaches such as mHealth may have the potential to improve 
medication adherence in the process of Cardiac Rehabilitation (CR) that have not 
been thoroughly investigated in Iran to date.  
Technology-mediated interventions are usually not systematically developed, 
refined, or evaluated (Hoffmann et al., 2014, Moore et al., 2015). Using a systematic 
process in the development and evaluation of an innovative approach may be useful 
in identifying what is the process of any observed effect of an intervention, who and 
in which settings may benefit from such an intervention and who should deliver it; it 
also helps to inform and optimise the development, implementation and evaluation of 
further interventions (Moore et al., 2015). One of the helpful frameworks that have 
been proposed to address the issues in defining, developing, and evaluating 
interventions is the Medical Research Council (MRC) framework originally 
published in 2000 and updated in 2008 and 2013. The first version of MRC 
framework (2000) proposed a model comprised of different phases commonly 
applied in the evaluation of new medications from the first phase of preclinical 
research through to marketing stages. The updated MRC framework (2013) adjusts 
the previous model to a more flexible one with less linearity and greater focus on 
development and early piloting phase. 
The research design for this study draws from the MRC framework (2013) that 
provides guidance on the development, evaluation and implementation of 
Randomised Control Trials (RCTs). Using the MRC framework, it appeared that a 
pilot mixed-method study would provide an appropriate design to refine and evaluate 
a previously developed mHealth intervention (from the master’s study) to improve 
cardio-protective medication adherence based on the principles of Self-efficacy 




Multidimensional Adherence Model. This study was undertaken to inform a future 
definitive multi-centre RCT. 
4.1 Structure of the Methodology Chapter 
In this Chapter, the methods and design of the study are described. A brief 
description of the MRC framework and rationale for a mixed-methods research 
approach are presented. The mixed-methods research paradigm and the philosophical 
assumptions underlying this approach are discussed, accordingly.  
4.2 Aim and Objectives  
The research aim of this mixed-methods study was: 
- to develop and evaluate a nurse-led mHealth intervention to promote 
cardiovascular medication adherence in Iranian adult, male and female CR 
outpatients. 
To achieve the research aim, the objectives of this research were defined based 
on each phase of the study using the MRC guideline: 
Phase1: Preclinical and Modelling Phase 
1. to identify the pattern of ownership and utilisation of mobile phones in 
Iranian CHD patients;  
2. to identify a preferable design for the study intervention based on CHD 
patients’ opinions in Iran; 
3. to explore Iranian cardiac nurses’ perspectives of the potential effect of a 
mHealth intervention among Iranian CHD patients; and 
4. to explore barriers and facilitators to implementation of the mHealth 
medication adherence intervention through which such interventions may 
affect cardiovascular medication adherence in an Iranian context. 
Phase 2: Exploratory Trial Phase 
5. to evaluate the effect of a 12-week mHealth intervention on medication 
adherence of Iranian male and female CHD patients participating in CR; 
6. to evaluate the effect of a 12-week mHealth intervention on the secondary 
outcomes: Medication Adherence Self-Efficacy (MASE); cardiac Ejection 




readmission/mortality rate and Health-related Quality of Life (HR-QOL) of 
Iranian male and female CHD patients participating in CR; 
7. to explore the association between socio-demographic factors of the subjects 
and medication adherence in both intervention and control groups; 
8. to explore the perception of participants in the intervention group towards the 
received mHealth intervention at the end of the study; and 
9. to identify the recruitment and retention rate and inform the sample sizes 
required for a future definitive RCT. 
4.3 Operational Definition 
 Cardiac Rehabilitation: A hospital-based CR programme (Phase II) 
for CHD patients that usually occurs 4-6 weeks after discharge from the 
hospital setting. 
 CHD patients: refers to all patients who attend the CR programme for 
the first time following discharge from hospital. 
 mHealth intervention: A web-based software that sends written 
medication reminder (via text-message) to participant’s mobile phones 
automatically at predefined times to remind medication taking. 
 Medication adherence: refers to the scores of the self-reported 
Morisky Medication Adherence Scale (see Section 5.2.1): high 
adherence (=8), medium adherence (6 to <8) and low adherence (< 6).  
4.4 Study Variables 
All research projects are based around variables which are the characteristics or 
attributes of an individual, group, educational system, or the environment that is of 
interest in a research study and measured by study instruments (Polit and Beck, 
2013). The independent and dependent variables for investigation in this study are 





Table 4.1. Study variables 
Independent Variables Dependent Variables 
mHealth Medication Reminders Intervention  Medication Adherence Level (Categorical) 
 Medication Adherence Self-Efficacy (Numerical) 
 Cardiac Ejection Fraction (EF) (Numerical) 
 Cardiac Functional Capacity (FC) (Categorical) 
 CHD-related Readmission/Mortality Rate Categorical) 
 Health-related Quality of Life (HR-QOL) (Numerical) 
 
4.5 Medical Research Council (MRC) Framework 
The MRC framework for the development and evaluation of RCTs, suggests a 
phased approach that includes both quantitative and qualitative methodologies 
(2013). In this study, to develop and evaluate the mHealth intervention, a mixed-
methods approach was considered in which quantitative and qualitative studies are 
combined. More specifically, an “embedded design” was used (Clark and Creswell, 
2011). This design is characterised by adding a qualitative strand within a 
quantitative design in order to enhance the overall design to address the primary 
purpose of the study (Clark and Creswell, 2011). The MRC framework entails a 
recursive process of development, feasibility and pilot testing, evaluation and 
implementation of the intervention. Hence, before any formal efficacy assessment 
can be performed, comprehensive preparatory work is conducted (Senn et al., 2013). 
The original model of the MRC comprised an investigative sequence of five phases: 
 First, theory and evidence are assessed in order to provisionally identify the 
steps and the key components of the intervention (Preclinical Phase).  
 Second, an understanding of the intervention and its possible effects is 
developed (Phase I: The modelling phase). 
 Third, the feasibility of key components is assessed, and the recruitment 
procedures and measurements of outcomes are tested (Phase II: The 




 Fourth, RCTs are conducted to evaluate the impact of the complex 
intervention. These trials require adequate power, adequate randomisation, 
appropriate outcome measures and other standard features of well-designed 
trials (Phase III: the definitive RCT).  
 Finally, separate studies are conducted to establish the long-term and real-life 
effectiveness of the intervention (Phase IV: the long-term implementation). 
Figure 4.1 provides a phased process of the development, evaluation, and 
implementation of interventions and RCTs, according to the MRC framework 
(2013). 
 
Figure 4.1. A phased process of the development, evaluation, and implementation of interventions and 
RCTs, according to the MRC framework (2013, p. 589) 
 
This study focuses around the first 2 stages of the MRC framework to refine 
and evaluate a mHealth medication adherence intervention; Phase I as part of the 
preclinical and modelling phase consisted of three stages: (1) exploring a relevant 
theory (Chapter 2) and identifying evidence base (Chapter 3), (2) conducting a self-
completion survey among Iranian CHD patients (3) conducting qualitative focus 
groups with participation of Iranian cardiac nurses in order to tailor the intervention 
to the local context. Findings from the study phase 1 informed the second phase (i.e. 
Exploratory Trial). A logic model is provided to present key steps and the activities 
required for each step based on the MRC framework adapted from Corry et al. 









Figure 4.2. Logic model for developing and evaluating a nurse-led mHealth intervention based on the 
MRC framework adapted from Corry et al. (2013) 
Aim: to refine 
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4.5.1 Preclinical and Modelling (Phase 1) 
During the first phase of the study, a theoretical background and evidence base 
relating to the issue of medication non-adherence among CHD patients and the 
effectiveness of mHealth intervention for this group of patients were reviewed (see 
Chapter 3). Details on the use of the self-efficacy theory and the WHO adherence 
model as well as identifying the evidence base to inform the development of a nurse-
led mHealth medication adherence intervention for Iranian CHD patients have been 
presented in Chapters 2 and 3.  
A self-completion survey study was undertaken to identify the pattern of 
ownership and utilisation of mobile phones among Iranian CHD patients; and to 
explore a preferable design for the study intervention from Iranian CHD patients’ 
perspective (objectives 1 and 2). Then, Focus Group Discussions (FGDs) were 
conducted to explore Iranian cardiac nurses’ views and their experiences about 
mHealth intervention (objectives 3 and 4) (see Section 4.2).  
4.5.2 Exploratory Trial (Phase 2) 
Phase II included a 12-week pilot RCT (pre-test, post-test parallel group design 
experiment) to evaluate the mHealth intervention in terms of its effect on 
cardiovascular medication adherence (primary outcome) and secondary outcomes 
among CHD patients in an Iranian CR setting, recruitment, retention, acceptability, 
and to inform the sample sizes required for a larger more definitive RCT (Objectives 
5-9) (see Section 4.2). 
4.6 Method Rational 
A mixed-methods design, so called the third research paradigm, was chosen as 
an appropriate method in this study since it was helpful to bridge the schism between 
quantitative and qualitative research in order to refine and evaluate a mHealth 
intervention to promote cardiovascular medication adherence, based on the MRC 
framework (Onwuegbuzie and Leech, 2005, Creswell, 2013). Philosophically, it is 
the third research movement that moves past the paradigm wars by offering a logical 
and practical alternative (Johnson and Onwuegbuzie, 2004). Mixed-methods’ logic 
of inquiry includes the use of induction (or discovery of patterns), deduction (testing 




set of explanations for understanding one's results) (Creswell, 2013). Mixed methods 
research also is an attempt to legitimate the use of multiple approaches in answering 
research questions. Research methods should follow research questions in a way that 
offers the best chance to obtain useful answers. Many research questions and 
combinations of questions are best and most fully answered through mixed research 
solutions (Creswell, 2013, Johnson and Onwuegbuzie, 2004). 
Although the desire of all forms of human research and inquiry is to understand 
and make sense of the world, a distinction has traditionally been made between 
quantitative and qualitative methods (McEvoy and Richards, 2006). Qualitative 
approaches (in this study: qualitative focus groups) are associated with the 
constructivist paradigm identifying the lived experience or beliefs of social actors (in 
this study: Iranian CHD patients and cardiac nurses) (Blaikie, 2009). Quantitative 
approaches (in this study: pilot RCT) that incorporate standardised measures and 
statistical techniques are usually associated with a positivist paradigm that is linked 
with the natural sciences (Creswell, 2013, McEvoy and Richards, 2006). It is 
believed that pragmatism is the best philosophical basis of mixed-methods research; 
according to the methodological pragmatists, neither quantitative nor qualitative 
methods alone are sufficient to develop a complete analysis (Johnson and 
Onwuegbuzie, 2004, Tashakkori and Teddlie, 2010). Therefore, they need to be used 
in combination, so that they can complement each other (Creswell, 2013).  
In the fields of health and social research the use of mixed-method approaches 
is widely advocated (Creswell, 2013, Johnson and Onwuegbuzie, 2004, Tashakkori 
and Teddlie, 2010). Johnson and Onwuegbuzie (2004) provided a concise and clear 
list of the advantages and disadvantages of mixed-methods research that is presented 
in Table 4.2. 
A mixed-methods approach employs strategies of inquiry that involve 
collecting data either simultaneously or sequentially to best understand research 
problems (Creswell, 2013). The data collection also involves gathering both numeric 
information as well as non-numeric information so that the final database represents 





Key rationale for combining quantitative and qualitative methods is: 
1. seeking convergence and confirmation of results from various approaches 
studying the same problem (triangulation); 
2. results from one method could be used to elaborate on results from the other 
method (complementarities);  
3. results from one method could be used to develop or inform the other method 
(development);  
4. results from one method could be reshaped to questions or results from the 
other method (initiation); and  
5. the range of inquiry could be extended by using different methods for 
different inquiry components (expansion) (Hanson et al., 2005, Fetters et al., 
2013).  
Table 4.2. Strengths and Weaknesses of Mixed Research (Johnson and Onwuegbuzie, 2004, p.21) 
Strengths Weaknesses 
 Words, pictures, and narrative can be 
used to add meaning to numbers 
 Numbers can be used to add precision 
to words, pictures, and narrative 
 Provides quantitative and qualitative 
research strengths 
 The researcher may generate and test a 
grounded theory 
 Answers a broader and more complete 
range of research questions because the 
researcher is not confined to a single 
method or approach 
 In a two-stage sequential design, the 
Stage 1 results can be used to develop 
and inform the purpose and design of 
the Stage 2 component 
 The researcher can use the strengths of 
an additional method to overcome the 
weaknesses in another method by using 
both methods in one research study 
 Can provide stronger evidence for a 
conclusion through the convergence and 
corroboration of findings 
 Can add insights and understanding that 
might be missed when only a single 
method is used 
 Can be used to increase the 
generalisability the results 
 Produces more complete knowledge 
o Can be difficult for a single researcher to 
carry out both qualitative and 
quantitative research, especially if two or 
more approaches are expected to be used 
concurrently; it may require a research 
team 
o The researcher has to learn about 
multiple methods and approaches and 
understand how to mix them 
o appropriately 
o Methodological purists contend that one 
should always work solely within either a 
qualitative or a quantitative paradigm. 
o More expensive 
o More time consuming. 
o Some of the details of conducting mixed 
research remain to be worked out fully 





In this multi-stage developmental mixed-methods study, results from 
qualitative method of cardiac nurses’ focus groups and descriptive CHD patients’ 
survey helped to develop and inform the quantitative method of pilot RCT. Also the 
study rationale is in accord with Punch (2013) who suggested that mixed-methods 
investigations may be used to better understand a research problem by converging 
numeric trends from quantitative data and specific details from qualitative data.  
4.6.1 Rational for Conducting Survey in the Quantitative Stage 
This research study employed a descriptive self-completion survey of CHD 
patients along with the qualitative focus groups in the modelling phase to inform the 
pilot RCT. Survey research is among popular research designs in health studies, 
although it has roots in social research with positivist theoretical perspective within 
objectivist epistemology (Polit and Beck, 2013).  
Surveys are a non-experimental research strategy designed to estimate certain 
parameters or provide information about the prevalence, dispersion, and associations 
of variables in the selection of a large sample of individuals from a predefined 
population (Polit and Beck, 2013, Rea and Parker, 2014). According to Polit and 
Beck (2013), in general methodology the word survey only covers quantitative 
studies that primarily aim at describing numerical distributions of variables (e.g. 
prevalence rates) in the population.  
Most survey analyses are inductive, neither iterative and not multi-source nor 
very sophisticated theoretically. It is, first of all, a simple research design, not for the 
study of social structures and processes but for the study of diversity in a population 
(Jansen, 2010). In this study, descriptive information from the survey questionnaire 
identified and quantified the data regarding key factors that would influence the 
feasibility and acceptability of using mobile phones as an adherence aid for CHD 
patients receiving cardio-protective medications in an Iranian setting.  
One of the advantages of survey research is to provide data based on real-
world experiences (Polit and Beck, 2013). The breadth of inclusion of many 
individuals (e.g. hospitalised male and female CHD patients) shows that this method 
allows researchers to gather data, based on a representative sample, and can 




approaches (Rea and Parker, 2014). Surveys are not expensive and provide a vast 
range of data for many purposes in a short period of time (Polit and Beck, 2013). 
Surveys are very useful when exploring topics that are difficult to access using other 
strategies and mostly rely on self-reporting (Jansen, 2010, Rea and Parker, 2014). 
Considering these factors, a self-completion survey was chosen as a part of the 
overall mixed-methods embedded design to describe the ownership and usage of 
mobile phones among Iranian CHD patients and their expectations/ preferences 
towards a mobile phone-based medication adherence intervention. Using the survey 
results, the researcher was able to further refine the mHealth intervention and 
evaluate it utilising a pilot RCT involving Iranian CHD patients during their CR 
programme. 
4.6.2 Rational for Conducting Focus Groups in the Qualitative Stage 
In this mixed-methods study, qualitative focus groups were conducted to 
produce data to complement the data from the patients’ survey in the modelling 
phase, to inform the pilot RCT. Focus groups have been used by researchers in many 
qualitative research traditions and in the study of health problems (Polit and Beck, 
2004). They can play a particularly important role in obtaining the viewpoints of 
many individuals in a short time (Kidd and Parshall, 2000).  
Focus group sessions are carefully planned discussions that take advantage of 
group dynamics for accessing rich information in an efficient manner (Polit and 
Beck, 2004). Moreover, focus groups capitalise on the fact that members react to 
what is being said by others, thereby potentially leading to richer or deeper 
expressions of opinion (Polit and Beck, 2004). Also, focus group interviews are 
usually stimulating to respondents rather than either self-administered open-ended 
surveys or structured group interviews with less spontaneous interaction (Bristol and 
Fern, 1996). Focus group members comment on each other’s point of view, often 
challenging each other’s motives and actions in a real discussion (Kidd and Parshall, 
2000). Studies of focus groups have shown that they are similar to individual 





In this study, focus groups aimed to explore cardiac nurses’ perception (as 
professional bodies that have close relationships with their patients) towards 
developing a nurse-led mHealth medication reminder intervention and its potential 
effect on medication adherence among Iranian CHD patients. The study focus was 
primarily on nurses’ experience of using mHealth, their potential role and the 
possible challenges in developing and delivering the study intervention to CHD 
patients in an Iranian context. Taken together with the lack of knowledge 
surrounding mHealth among healthcare professionals as well as the little mHealth 
improvement on the delivery of health care in Iran, conducting focus groups helped 
the researcher to obtain a thorough understanding of practicality and acceptability of 
the mHealth medication adherence interventions, from the perspective of nursing 
staff and across their levels of experience.  
Focus group findings together with information obtained from patients’ survey 
were used to understand how a mHealth medication adherence intervention would be 
appropriate in the Iranian context. This knowledge was essential to developing a 
feasible and acceptable mHealth intervention. 
4.6.3 Rational for Conducting Pilot RCT in the Quantitative Stage 
Since this research used a quantitative-dominant mixed-methods approach with 
a focus on the pilot RCT as the core component, it is important to explore what an 
RCT is. An RCT is a type of evaluation that seeks to determine whether an 
intervention resulted to the intended effect on study participants (Polit and Beck, 
2013). 
 Elements of true experiments are manipulation, control, random assignment, 
and random selection (Polit and Beck, 2013). The most important of these elements 
are manipulation and control. Manipulation means an action which is purposefully 
implemented by the researcher in the environment; The action is termed “an 
experimental treatment/ intervention” and is the independent variable within the 
study (Houser, 2013). In this study, a mHealth medication adherence intervention is 
the experimetal intervention (see Section 5.1.1). Independent and dependent 




Control is used to prevent outside factors from influencing the study outcome 
(Houser, 2013). When something is manipulated and controlled and then the 
outcome happens, it makes the researcher more confident that the manipulation 
“caused” the outcome (Polit and Beck, 2004). Moreover, highly controlled nature of 
the experimental study and its systematic conduct eliminates error and bias and 
enhances researchr’s confidence that the manipulation “caused” the outcome 
(Houser, 2013). One method of applying such control is through the use of a control 
group that is not subjected to the independent variable. In the hospital setting, there is 
not a total absence of the care relating to the experimental intervention, consequently 
control group is subjected to routine conventional interventions (i.e.usual care). In 
this study, the control group received the usual care in order to contribute to evaluate 
the effect of the mHealth-delivered medication reminders. 
Random assignment is another essential element of a true experiment (Polit 
and Beck, 2004). The procedure of random assignment means that participants are 
randomly assigned to the study groups or interventions if there are different groups 
or interventions in the study. This indicates that participants have an equal chance of 
getting into all of the groups in an experiment regardless of who the study individual 
is. The advantage of this process is that the researcher is confident about 
homogeneity of the groups or treatments at the beginning of the study so that there is 
more certainity that the manipulation (experimental intervention) “caused” the 
outcome and this also prevent selection bias (Parahoo, 2014).  
In choosing an appropriate design to meet the aim of the second phase of the 
study (i.e. exploratory trial), the researcher considered to incorporate manipulation, 
control and randomisation. These factors considered, a RCT design was deemed to 
be appropriate for the quantitative part of the study. 
A pilot trial briefly refers to a small background research study for helping to 
inform a further confirmatory study (Arain et al., 2010). Large RCTs often take place 
in multiple settings and involve the integrated efforts of different investigators, 
research directors, healthcare professionals, and patients (Whitehead et al., 2014). A 




funding bodies to provide an assurance that larger trials are developed in an optimal 
level and can be implemented in practice (Arnold et al., 2009).  
There are a variety of objectives in conducting a randomised pilot trial 
including a study of feasibility, an assessment of the inclusion and exclusion criteria 
and recruitment efficiency for a further RCT, and/or an evaluation of outcome 
measures (Arain et al., 2010, Arnold et al., 2009, Whitehead et al., 2014). For 
example, in the present study, the feasibility of undertaking a definitive RCT 
evaluated in a pilot RCT that simulated different aspects of the larger trial of the 
mHealth medication reminder intervention in an Iranian context, from the 
recruitment process to measurement of outcomes and data collection (Whitehead et 
al., 2014).  
Overall, pilot study findings can provide invaluable awareness into the 
potential determinants and issues of a study protocol for a future definitive RCTs. 
Table 4.3 summarises the advantages and disadvantages of pilot trials adapted from a 
study by Arnold et al. (2009).  
Table 4.3. Advantages and disadvantages of pilot studies adapted from Arnold et al. (2009, p. S73) 
 Advantages Disadvantages 
Feasibility  Pilot trials can predict the 
feasibility and acceptability 
of protocol implementation 
in a future trial 
o Feasibility and acceptability 
assessments may be misleading if 





 Objectives of pilot trials 
focused on feasibility can 
often be met with relatively 
few patients 
o Pilot trial results are unlikely to 
provide reliable estimates of the 
sample size required for the full 
trial 
Cost  Pilot trials help to ensure 
that financial investments in 
large trials are allocated 
responsibly 
o Complex pilot trials can be 




 Large trials of potentially 
harmful interventions may 
be averted by a pilot trial 
clearly demonstrating harm 
o Pilot trials are rarely powered to 
confidently detect harm with 




 Reporting a threshold signal 
of a surrogate outcome may 
be justified when examining 
mechanisms 
o By design, pilot trials are usually 
underpowered to determine 
reliable estimates of effect on 





Using the MRC framework, in the second phase of this study or as a 
quantitative part of this mixed-methods research, a pilot RCT was conducted to 
evaluate the feasibility and acceptability of the mHealth intervention in an Iranian 
CR setting to inform a full-scale RCT (see Section 5.3). 
4.7 Mixed-Methods Research Paradigm 
Paradigms refer to beliefs patterns or philosophical assumptions which are 
characterised by ontology (the nature of reality), epistemology (the nature of 
knowledge) and methodologies are used to study a phenomena (Weaver and Olson, 
2006).  
A third perspective of reality appeared in the Ancient World, but different from 
Plato/ Socrates (singular or universal truths or approaches to viewing the world) and 
the Sophists (multiple or relative truths). Mixed-methods research has been given a 
position between the extremes Plato (quantitative research) and the Sophists 
(qualitative research), with mixed research seeking to value both of these viewpoints’ 
wisdom while also attempting a useful middle solution for various issues (research) 
of interest (Johnson et al., 2007). According to Teddlie and Tashakkori (2010), 
Aristotle (384-322 B.C.) who used both deductive (i.e. the process of reasoning from 
a general logic) and inductive reasoning (using particular measurable facts to reach a 
general conclusion) in his research has been considered a mixed methodologist. 
Aristotle’s principle of the “golden mean” that refers to balancing ideological 
extremes reflects a pragmatist paradigm underlying many modern mixed-methods 
approaches (Johnson et al., 2007). Pragmatism is a philosophical tradition in which 
the truth of a hypothesis, based on inductive reasoning and constant empirical 
verification, is in continual transformation and revised when new findings are 
identified (Tashakkori and Teddlie, 2010).  
A major assumption of this study was that neither a quantitative nor qualitative 
approach used alone could capture the significant factors that play a role in refining 
and evaluating a mHealth medication adherence intervention. It was assumed that 
results from focus groups qualitative study (with interpretivist-constructivist 
assumption) and descriptive CHD patients’ survey would help to refine the mHealth 




inform the pilot RCT (with positivist assumption). Although this research used the 
mixed-method research strategy (i.e., using heterogeneous paradigms between 
quantitative and qualitative research), the quantitative research was dominant as the 
research core component. Therefore, the main paradigm of this research was based 
on the quantitative research paradigm. Quantitative assumptions are in line with 
positivist paradigm in which social observations should be considered as entities in 
the same way that physical scientists deal with physical phenomena (Tuli, 2011).  
4.7.1 Epistemological Considerations 
For positivists that are emerged mostly from 19
th
 century, scientific explanation 
is the main purpose of research (Tuli, 2011). From a positivist perspective, social 
science is seen as a formulated approach for integrating deductive reasoning into 
precise empirical findings related to individual’s behaviour in order to explore and 
confirm a group of plausible causal laws that can be applied to make predictions 
about common models of human activity (Creswell, 2013). A primary assumption of 
this paradigm is that the science goal is to establish the most objective approaches 
possible to achieve the most accurate reality approximation (Tuli, 2011). Researchers 
who conduct a study from this point of view describes in quantitative terms how 
variables interact, form events, and lead to outcomes; these explanations are often 
developed and tested in experimental studies (Creswell, 2013).  
In the present study, following the refinement and modification of the mHealth 
intervention in order to make it appropriate to the Iranian context, based on the 
cardiac nurses’ opinions and CHD patients’ preferences (i.e. modelling phase), it was 
important to pilot the intervention among CR patients. For this reason, a positivist 
perspective offered a useful theoretical lens through which the effect of a nurse-led 
mHealth intervention on improving medication adherence among CHD patients in an 
Iranian CR setting was examined. 
4.7.2 Ontological Considerations 
The nature of reality is the ontological concerns in social science research 
(Creswell, 2013, Tuli, 2011). An investigator with a positivist views perceives reality 
as being “out there” in the world that needs to be explored using objective ways 




reality (Tashakkori and Teddlie, 2010). Research findings are often described in a 
quantitative form, in figures that speak for themselves (Tashakkori and Teddlie, 
2010, Tuli, 2011). 
The main reason of using realist/objectivist ontology in this research was to 
focus on variables measurement (e.g. medication adherence). It was also helpful to 
measure the intervention effects, especially through group changes. In this way, the 
data collection approaches mainly focused on collecting hard data (i.e. in the form of 
numbers) to allow evidence to be demonstrated quantitatively. 
4.8 Reliability, Validity and Rigour 
It is the researchers’ responsibility to make a significant effort to obtain 
systematic, reliable, coherent and transparent research outcomes. This research study 
comprised both quantitative and qualitative research strategies. Reliability and 
validity in quantitative and trustworthiness in qualitative research play an important 
role in ensuring the quality of the research (Parahoo, 2014). 
According to Polit and Beck (2008), validity (or internal validity) that mainly 
concerns the soundness of the study’s evidence refers to the “degree to which 
inferences made in a study are accurate and well-founded”(p.768). In qualitative 
research, this usually refers to “how well the research represents the actual 
phenomenon”(Morse, 2015, p.19) . 
Reliability is defined as the “accuracy and consistency of information obtained 
in a study” (Polit and Beck, 2008, p.196). It usually concerns the ability to achieve 
the same findings if the researcher repeats the study (Morse, 2015). In medical and 
nursing researches, the concern is no longer related to the value of the research 
methods but it is about ensuring or enhancing the reliability and validity (Creswell, 
2013).  
In assessing the quality of quantitative research, there are checklists that play a 
crucial role such as the CONSORT – CONsolidated Standards Of Reporting Trials 
(see Appendix 1). They provide guidance on important queries that need to be asked 
to help those unfamiliar with this method to evaluate or review quantitative works 
and in reminding researchers of the need for a quality approach. In this study, the 




quantitative research portion of this study (i.e. pilot RCT). The reliability and validity 
of all research instruments (i.e. questionnaires) used in this study are reported in 
Section 5.3. 
Both criteria of reliability and validity are important to obtain rigor (also called 
trustworthiness) in qualitative research (Morse, 2015). To ensure the rigor of the 
qualitative data, Lincoln and Guba’s Evaluation Criteria, including creditability, 
dependability, transferability, and conformability, was used (Speziale et al., 2011).  
For creditability of findings, the prolonged involvement of the researcher with 
the research and data and member checking (i.e. the transcribed interviews were 
emailed to the participants to obtain verification of information accuracy) were done. 
Maximum variations in age, experience of the participants, and type of cardiology 
ward worked by the nurses also helped to increase the credibility of data.  
In qualitative inquiry, transferability (i.e. generalisability) refers to the 
application of the findings to another situation or population (Speziale et al., 2011). 
The over-reaching research goal was not to establish precise cause and effect 
relationships regarding which factors contribute to changes in medication adherence. 
Quantitative data analysis procedures, such as multiple logistic regressions, were 
used to examine tentative relationships between patients’ socio-demographic 
characteristics and self-reported medication adherence. The qualitative data were 
mainly used to inform the exploratory trial phase. The focus of the research was on 
potential transferability of the findings, not on generalisability since the study was 
conducted among specific group of patients (i.e. CHD patients) and in a specific 
context (i.e. an Iranian CR setting). For transferability of findings, important quotes 
and socio-demographic characteristics of the nurses were reported. 
Conformability was also assessed by two experts familiar with qualitative 
research in addition to the main researcher; they reviewed the transcripts 
independently and confirmed the coding and categories and checked the researcher’s 
interpretations. For dependability, the researcher provided enough information and 






This chapter has introduced and critiqued the rationale to select a multi-stage 
developmental mixed-methods design. Based on the MRC framework, both 
quantitative and qualitative data used in two phase (modelling and exploratory trial) 
to refine and evaluate the nurse-led mHealth intervention on improving 
cardiovascular medication adherence in an Iranian CR setting. The effect of the study 
intervention was best understood by using a combination of both qualitative and 
quantitative data; however, the quantitative pilot RCT was the core component of 
this study. Additionally, a developmental quantitative-dominant mixed-methods 
design underpinned by positivist epistemology and objective ontology was selected 
because results from qualitative nurses’ focus groups and descriptive CHD patients’ 
survey (undertaken in modelling phase) were used to develop and inform the 
quantitative pilot RCT of the mHealth intervention. Moreover, this mixed method 
research has attempted to assure the reliability and validity of quantitative study via 
statistical strategies and the rigour and quality of qualitative study by considering 
Lincoln and Guba’s Evaluation Criteria. In the following chapter, research methods, 
procedures undertaken for data collection and data analysis as well as ethical 





CHAPTER 5: METHODS, DATA COLLECTION AND ANALYSIS 
The aim of this chapter is to provide a description of the methods for 
implementation of the patients’ perception survey, qualitative focus groups and pilot 
RCT of the mixed-methods study. The procedure for sample recruitment, study 
setting, negotiation access and procedure for collection of the data, data collection 
instruments, and methods of data analysis used in each study are described. A visual 
model of procedures used in this mixed-methods study is displayed. The research 
permission and ethical considerations pertinent to this study are also discussed. 
A description of the refinement and evaluation of the previously developed 
mHealth intervention (Khonsari et al., 2015) used in this study to promote the 
cardio-protective medication adherence among CHD patients in an Iranian CR 
setting, using the first 2 phases of the MRC framework is provided. The work 
reported here was done to inform the design of an intervention that will be tested in a 
future definitive RCT. Table 5.1 summarises the refinement and evaluation of the 
intervention through the stages of the MRC framework process.  
Table 5.1. Studies undertaken based on the phases of the MRC framework (2013) 
Study stages based on the MRC 
framework 
              Studies undertaken 
1. Preclinical/ Modelling Phase: 
1.1 Identifying Evidence Base and 
Exploration of Relevant Theory 
 
 Reviewed the background information and 
epidemiological evidence related to CVD, 
CHD, CR, medication adherence among 
patients suffering from CHD and mHealth with 
a particular focus on the Iranian context; 
 Reviewed existing evidence and theories 
related to medication adherence to identify an 
appropriate theory and behaviour change 
techniques; 
 Improved understanding of the issue of non-
adherence among cardiovascular patients and 
previous interventions that enhanced 
adherence in different chronic conditions 
including CHD through identifying and 
reviewing existing literature. 
1.2 Modelling process  Self-completed survey was conducted to 
identify the pattern of ownership and 
utilisation of mobile phones and a preferable 
design for the intervention, based on Iranian 





 Qualitative study with Iranian cardiac nurses 
was conducted to refine the intervention 
content. This included focus groups with 
nurses (who would deliver the intervention) to 
explore their perspectives about the potential 
effect of a mHealth intervention among Iranian 
CHD patients; and to determine barriers and 
facilitators to implementation of the mHealth 
medication adherence intervention through 
which such interventions may affect 
cardiovascular medication adherence in the 
Iranian context. 
2. Exploratory Trial Phase 
(Assessing feasibility and piloting methods) 
2.1 Pilot-testing the study procedure, 
preliminary intervention, its delivery and 
acceptability 
 Tested the intervention for feasibility and 
acceptability and final adaptation of the 
intervention through conducting a 12-week 
pilot trial of the intervention in the Iranian CR 
setting 
 Self-completed survey was conducted at the 
end of the pilot trial to explore the perception 
of participants in the intervention group 
towards the received mHealth intervention 
2.2 Estimating recruitment and retention 
and identifying any potential barriers to 
these  
 Recruitment through outpatient CR clinic to 
identify the effectiveness of the method. 
 Pilot trial over 12 weeks to estimate the 
recruitment and retention rate. 
2.3 Determining sample size by 
anticipating the effect sizes in a pilot study 
 Identifying the effect of the intervention on the 
primary outcome of the study (i.e. medication 
adherence) to inform the sample sizes required 
for a further larger trial 
 
Prior to presenting each phase of the study, it is important to provide a 
description related to the mHealth intervention used in this study. 
5.1 mHealth Medication Adherence Intervention 
A mobile phone/ mHealth medication adherence intervention has been 
developed in 2013 as part of the researcher’s master project (see Section 1.6). The 
intervention effectiveness was piloted among Acute Coronary Syndrome (ACS) 
patients in Malaysia that showed significant results (Khonsari et al., 2015). 
Theoretically, in this PhD, the same intervention was remodeled and modified based 
on the dimensions of medication adherence suggested by the WHO and principles of 
the Bandura’ Self-efficacy Theory (see Chapter Two) and then piloted among adults 




Methodologically, the Medical Research Council (MRC) framework was used 
as a guide to refine and evaluate the study intervention and to inform a future 
definitive RCT. The intervention was refined after exploring the perspectives of both 
Iranian CHD patients (by conducting a cross-sectional survey) and experienced 
cardiac nurses (by conducting focus group discussions) about potential effects and 
challenges of mHealth implementation and then piloted for the first time among 
Iranian CR patients.  
In the present study, a multi-stage mixed-methods design was used to refine 
and evaluate the mHealth intervention on cardiovascular medication adherence. The 
evaluation of qualitative and quantitative data improved and tailored the intervention 
to the local context and ensured it could be applied to this group of patients. 
In this PhD, the researcher evaluated the effect of the mHealth intervention on 
a variety of self-reported and objective outcomes among CHD patients over the 
period of 12 weeks.  For example, the effect of the SMS reminders was examined on 
patients’ self-efficacy in taking their prescribed cardiovascular medications over the 
study time period, cardiac Ejection Fraction and Health-Related Quality of Life 
(HRQoL) as a sensitive outcome variable within and between the study groups (i.e. 
usual care vs. usual care plus SMS medication reminders) (see Section 5.3). These 
outcomes were not evaluated in the previous study. 
5.1.1 Components of the Study Intervention  
The mHealth intervention used in this study was software with no specific 
hardware dependency, thus offered maximum portability and ease of use. The system 
consisted of various parts that were responsible for gathering and managing the 
information related to the patients and their medications, storing data, scheduling, 
sending text messages and recording delivery reports (see Picture 5.1). All these 
tasks were managed automatically to minimise the manual effort. It also provided 
additional features such as query, advanced search and generating report that were 
exportable to many standard formats. Picture 5.2 demonstrates an image of the 





Picture 5.1. Patients’ information and scheduled text message reminders 
 




In terms of the intervention workflow, the first step was to add patient data and 
notifications. The scheduler service then executed the SMS sender program at pre-
scheduled times. It would in turn access the patient information database to generate 
correspondent text messages according to the desired template as well as notification 
data. Finally, a connection to an external SMS gateway was established to send 
generated messages. The SMS sender program was also responsible for collecting 
delivery reports and updating the database. To sum up, the intervention comprised of 
delivering automated daily medication reminders based on a predefined template, 
starting from the date of patient’s recruitment. Figure 5.1 shows the intervention 
















Intervention components were demonstrated to participants at recruitment. All 
participants were informed to not respond to the reminder text messages since the 
















participant. The length and number of characters in the reminder message were short 
and the content was simple and easy to understand. When the course of medication 
was completed, a message was sent reminding patients to have their prescribed 
cardioprotective medications refilled. 
Frequency, timing, content and the method of the delivering medication 
reminders were finalised based on the findings from the first phase of the study (see 
Section 6.1.3) to support patients remember taking their newly prescribed 
cardioprotective medications, prevent forgetfulness and carelessness and improve 
medication adherence self-efficcy. The major element of the intervention involved 
medication adherence enhancement together with consequent improvement in the 
study secondary outcomes (i.e. Medication Adherence Self-Efficacy (MASE); 
cardiac Ejection Fraction (EF); cardiac Functional Capacity (FC); CHD-related 
readmission/mortality rate and Health-related Quality of Life (HR-QOL)).  
Table 5.2 presents some examples of reminder contents based on the principles 
of the study theoretical frameworks. 
Table 5.2. Reminders ‘objectives and contents 
Study Stage Message Objective Example 
Pilot Trial 
(12 weeks) 
Based on the Self-efficacy Theory: 
 To promote patient’s self-efficacy in taking 
their newly prescribed medications via sending 
automated daily reminders (as a form of social 
support from a healthcare provider) to their 
mobile phones 
Based on the WHO Adherence Model: 
 To prevent forgetfulness, carelessness and 
promote self-efficacy (patient-related factors) 
 To maintain patient-provider connection and 
provide social support (system-related factor) 
‘‘Please don’t forget to 




To remind patien of having prescription refilled  ‘‘Please don’t forget to 
refill prescription”. 
 
To validate the stability and reliability of the intervention functioning in Iran, 
text messages were sent two times daily (10am and 10pm) to four healthy volunteers 
with different mobile phones and different mobile phone providers over a one-week 




throughout this one-week intervention stability assessment. Participants were asked 
to send a reply back at the time of receipt of the text message when it arrived on their 
mobile phones. 100% of text messages were successfully delivered to volenteers’ 
mobile phones. 
5.2 Phase 1 - Study 1 & 2 (Preclinical/ Modelling) 
The first phase of the study as part of the preclinical/ modelling phase started 
with a comprehensive literature review. The background information and 
epidemiological evidence related to CVD, CHD, CR, medication adherence among 
patients suffering from CHD and mHealth with a particular focus on the Iranian 
context were reviewed. Next, existing evidence and theories related to medication 
adherence to identify an appropriate theory and behaviour change techniques were 
identified. A thorough understanding of the issue of non-adherence among 
cardiovascular patients and previous interventions that enhanced adherence in 
different chronic conditions was achieved through identifying and reviewing existing 
literature. Background information, details on the use of the self-efficacy theory and 
the WHO adherence model as well as identifying the evidence base to inform the 
development of a nurse-led mHealth medication adherence intervention for Iranian 
CHD patients have been presented in Chapters 1-3.  
During the first phase of the study, a self-completed survey of CHD patients 
and cardiac nurses’ focus groups were conducted to inform the second phase of the 
study (exploratory trial). 
5.2.1 Study 1 - Patients’ Perception Survey 
A self-completion survey conducted among male and female CHD patients, 
aged 18 and over in one hospital affiliated to Tehran University of Medical Sciences. 
The study setting provides routine cardiovascular treatment and support to patients 
in Tehran, the capital city of Iran. CHD patients attend the outpatient CR clinic 
approximately 3 times in a week for the hospital-based exercise and routine follow-






Specifically, the survey aimed to identify:  
 the pattern of ownership, utilisation of mobile phones in Iranian CHD 
patients (Objective 1); and 
 a preferable design for the study intervention based on CHD patients’ 
opinions in Iran (Objective 2). 
Sample and Setting 
123 male and female patients aged 18 years and over with primary diagnosis of 
CHD (Myocardial Infarction (MI), angina or revascularisation) presented at CR 
clinic were recruited by the researcher (SKh) and asked to complete the survey 
independently before starting their exercise programme. On average, the CR clinic 
has over 100 new admissions per month for a 24-session exercise programme. The 
convenience sample included all eligible participants. Patients were excluded if they 
had developmental or cognitive disabilities that impacted on their ability to provide 
informed consent, or if they did not have the physical capacity to provide informed 
consent. The study was conducted over a period of three weeks in September 2015. 
CHD patients recruited from outpatient CR clinic of an educational research and 
medical centre for cardiovascular disease affiliated to Tehran University of Medical 
Sciences with 420 beds dedicated to the diagnosis and therapy of coronary and heart 
diseases. About 360,000 outpatients, 16,000 heart surgery and 50,000 angiography 
and angioplasties have taken place in this centre in recent five years (Tehran Heart 
Centre, 2015). It is one of the largest referral centres for heart bypass surgery in Iran 
in which almost more than 3500 heart surgeries (3000 cases of coronary and 500 
cases of valve and congenital surgeries) are carried out every year. 
Procedure 
The researcher (SKh) met with the CR Clinic Manager (MN) and the CR Head 
Nurse (MS) regarding the study after receiving ethical approval and permission letter 
from the hospital (i.e. the study setting) (see also 5.4). Both were satisfied with the 
ethical approval and all permissions granted by the Ethics Committees of the 
hospital, Tehran University and the university were the researcher was based and 




The researcher and the CR Clinic Manager arranged a mutually suitable day 
and time for the researcher to attend the CR clinic. The 132 subjects attending the 
CR clinic were informed of the study by the Clinic Manager following their first out-
patient CR appointment. Of 132 subjects, 123 (see Section 6.1.1) consented and 
agreed to complete the questionnaire (see 5.3.2) and were subsequently introduced to 
the researcher in a side-room of the clinic. The researcher provided an explanation of 
the purpose of the study and instruction on completion of the questionnaire. 
Confidentiality was assured to all participants with the understanding that they could 
withdraw at any time. Participants then completed the questionnaire and returned it 
to the researcher on leaving. 
Data Collection  
The survey instruments were: 
 A socio-demographic questionnaire (see Appendix 3): 
Socio-demographic factors such as age, gender, education level, marital status, 
employment, living arrangement, monthly income and receiving health insurance 
services were asked to be completed by patients. 
 Electronic Supplementary Material adapted for use from a similar study (Shet 
et al., 2010) (see Appendix 4):  
The survey questionnaire completed by the patients during a face-to-face visit 
and consisted of 21 items that covered two main domains of enquiry; what is the 
pattern of ownership and use of mobile phones among CHD patients; what might a 
patient-preferred design for a mobile phone-based intervention to influence 
medication adherence look like. Respondents were briefed that there was no right or 
wrong answer and they chose the best answer for each question based on their 
personal experience/ preferences. The context established by the questionnaire and 
the wording of questions have important effects on how questions are understood and 
answered by the individual respondents (Polit and Beck, 2013). Therefore, the 
questionnaire as a survey instrument should be designed precisely. It means that in 
the process of preparing the questionnaire, the researcher should maintain the focus 




population of interest (Engel and Schutt, 2012). The questionnaire should be 
considered as a structured tool, in which each part and every single question deliver a 
clear purpose in association with research objectives and each part correlates other 
parts (Polit and Beck, 2013). By considering these points, the survey questionnaire of 
this study was translated into the local language and back-translated into English, 
then piloted initially in the hospital clinic following which the validity of the 
responses were reviewed, and questions edited as necessary. Two experts with 
clinical and scientific expertise (one was a Professor in Nursing and the other one 
was a Critical Care Nurse Specialist) to help validate the translated questionnaire. 
Content validity of this instrument was evaluated by calculating an Average Content 
Validity Index at the summary score level (S-CVI/Ave). The S-CVI/Ave is the 
average of the proportion of items that received a ‘relevant’ rating by the experts 
(Waltz, 2005). The S-CVI /Ave of the survey questionnaire were 0.9 (see Appendix 
5). As the generally accepted cut-off is 0.9 or higher (Waltz, 2005), the content 
validity of the survey instrument was deemed to be acceptable. Based on the experts’ 
opinion, item 1 was replaced by item 3. Questions 6 and 6a were removed to prevent 
survey complexity. 
 Morisky Self-Reported Medication Adherence Scale (Appendix 6): 
Measuring the adherence of patients could be a challenging problem for 
clinicians. There are different tools to determine adherence to medications. One of 
the reliable and widely used scales in this regard is the 8-item Morisky Medication 
Adherence Scale (MMAS-8) (Morisky et al., 2008). The 8-item scale with a 
reliability of 0.83 and good concurrent and predictive validity is a self-report 
questionnaire (with good predictive validity in patients at risk of cardiovascular 
disease) to assess medication-taking behaviour and adherence (Morisky and 
DiMatteo, 2011, Morisky et al., 2008). This measure has been found to positively 
correlate with pharmacy fills (Continuous Single-interval Medication Availability 
(CSA), Medication Possession Ratio (MPR), and Continuous Multiple-interval 
Medication Gaps (CMG) was ≥75% ) (Krousel-Wood et al., 2009).  
Since its introduction, the MMAS-8 has been studied in different conditions 




the Persian-version of the MMAS-8 reported using Cronbach’s α coefficient that was 
0.697 and the test–retest reliability showed satisfactory reliability and stability of the 
instrument with Spearman’s rank correlation coefficient of 0.940 (P< 0.001) 
(Moharamzad et al., 2015). Regarding the known groups’ comparison, the results 
showed that the Persian MMAS-8, has an acceptable construct validity (Moharamzad 
et al., 2015). Overall, the Persian-version of the MMAS  is a reliable and valid tool 
for Persian-speaking patients for using in cardiac conditions as well as other 
disciplines to study medication adherence in other chronic conditions which 
necessitate long-term taking of medication(s) by the suffering patient (Moharamzad 
et al., 2015).  
This instrument measures non-adherence to medications due to the reasons like 
forgetfulness, carelessness, feeling better, or feeling worse (AlGhurair et al., 2012). 
According to the literature, there is no “gold standard” to measure the medication 
adherence behaviour (Jimmy and Jose, 2011, Ho et al., 2009). The most common 
indirect methods are the patient’s self-report that is simple, inexpensive and the most 
practical method in the clinical setting and represented the standard practice (Jimmy 
and Jose, 2011). The questionnaire was completed by all participants. The validated 
Persian translation of the MMAS-8 had been asked from Prof. Donald E. Morisky, 
the owner of this scale, as well as permission to use the scale in this study (see 
Appendix 7). 
 Short Form Health Survey Version 2.0 (SF-12v2) (Appendix 8) 
The concept of Health-Related Quality of Life (HRQoL) is regarded as a 
sensitive outcome variable in health outcome measurement studies (Anderson and 
Burckhardt, 1999). HRQoL is a multidimensional concept that refers to function and 
well-being on various dimensions of health, including physical, emotional, social and 
spiritual aspects of life (Anderson and Burckhardt, 1999, King and Hinds, 2011) The 
SF-12v2® Health Survey (Fleishman et al., 2010, Ware et al., 2002) is a brief, 
generic, well-tested instrument used worldwide that was developed from the 36-item 
SF-36v2® Health Survey (Ware Jr, 2000). The SF-12v2 is a multi-purpose Short 
Form (SF) generic measure of health status that uses a Likert scale format and is used 




standard four-week recall period version was used.  The SF-12v2 is comprised of a 
12-item subset of the SF-36 version 2 (SF-36v2) categorised in eight domains: 
Bodily Pain (BP), General Health (GH), Vitality (VT), and Social Functioning (SF) 
with one item each. In addition, Physical Functioning (PF), Mental Health (MH), 
Role Physical (RP), and Role Emotional (RE) domains are represented with two 
items each (Ware et al., 2002). The information obtained from the eight health 
domain scales is then aggregated to provide summary measures of the respondent’s 
physical and mental health. The internal consistency reliability of the SF-12v2 
estimates 0.91 for the physical (Physical Component Summary/ PCS) and 0.87 for 
the Mental Component Summary (MCS) measures. When used with one or more 
disease-specific measures, the SF-12v2 provides information that can help evaluate 
patients with common chronic conditions (in this case, CHD), as well as monitor and 
compare their outcomes over time. Since its introduction, the SF-12v2 has been 
studied in different conditions and languages including Persian (Montazeri et al., 
2011). Regarding the reliability of the Persian-version of the SF-12v2, the results 
showed that both summary measures (PCS-12 and MCS-12) exceeded the 0.70 level 
for Cronbach’s alpha indicating satisfactory results (0.87 and 0.82 respectively) 
(Montazeri et al., 2011). Known-groups comparison showed that the SF-12v2 
discriminated well between subgroups of people who differed in their health 
condition; this supports that construct validity of the scale is acceptable (Montazeri et 
al., 2011). Overall, the SF-12v2 is a reliable and valid measure of HRQoL among 
Iranians and could be used in health outcome studies (Montazeri et al., 2011). The 
questionnaires were completed by all survey participants. The validated Persian 
translation of the SF-12v2 and permission to use was asked from the QualityMetric 
Inc. (License Number: QM029383) (see Appendix 9). 
Data Analysis 
All data were analysed using the computer program Statistical Packages for 
Social Sciences (SPSS) version 21. The significance level in this study is α=0.05. 
Both descriptive and inferential analysis were carried out using SPSS.  
Quantitative/ statistical analysis, in this survey study, comprised of sufficient 




inferential analysis. The raw data obtained during the data collection period were 
coded in preparation for analysis. Data processing was undertaken through the 
utilisation of a previously prepared codebook. The codebook was developed to 
provide not only the codes associated with the various values given to the study 
variables, but also the codes given to data which required transformations in order 
that statistical analyses could be carried out. Following processing, data were verified 
for errors and corrected prior to the execution of any atistical analyses. Screening 
procedures assisted the researcher in optimising data so that the analysis procedure 
produced the most accurate and efficient estimates (Pallant and Manual, 2007).  
After cleaning data, frequencies and percentages were used to present detailed 
information on nominal and ordinal (categorical) data (such as gender, marital status, 
educational level, employment status, mobile phone ownership). Mean and Standard 
Deviation (SD) were used to describe continuous variables such as age, length of 
hospital stay, and number of daily medications. Categories of data were also 
presented in tables or graphs to provide a pictorial description of the sample, the use 
of descriptive statistics to further describe individual variables, and the use of 
statistical analysis for the purpose of looking for relationships among categories or 
variables (Polit and Beck, 2004, Wood and Ross-Kerr, 2010).  
5.2.2 Study 2 - Focus Groups 
Qualitative focus groups were conducted among 23 male and female nurse 
staff with at least six months work experience in cardiology or/ and CR wards, in 
three hospitals affiliated to Tehran University of Medical Sciences. Principal Nurse 
Supervisors/ Matrons in the study sites were asked to invite potential participants, 
provide a brief explanation of the study to nurses and arrange a date and venue for 
the Focus Group Discussions (FGDs).  
FGDs specific objectives were to explore: 
 Iranian cardiac nurses’ perspectives about the potential effect of a mHealth 
intervention among Iranian CHD patients (Objective 3); and 
 Potential barriers and facilitators to implementation of the mHealth 




affect cardiovascular medication adherence in an Iranian context (Objective 
4). 
Sample and Setting 
According to Kidd and Parshall (2000), for purposes of peer-reviewed social 
and health research, confidence in focus group findings almost always can be 
enhanced by conducting multiple groups (ideally from multiple sites) and by 
including other data sources. Therefore, the researcher (SKh) asked the gatekeepers 
(i.e. Principal Nurse Supervisors/ Matrons) in each study site (i.e. two heart centres 
and one tertiary hospital affiliated to Tehran University of Medical Sciences) to 
invite cardiac nurses verbally from CR clinics and arrange a date and venue for the 
focus group discussions. There was a range of 7-10 staff nurse working in CR clinic 
of each study site. Of those invited through the gatekeepers (the number was not 
recorded), 23 male and female nurse staff were recruited. 
Two Cardiovascular, Medical and Research Centres were considered as study 
settings for the focus groups, these were among the largest specialist and 
subspecialist centres in the Middle East. One is the same location in which the 
survey was conducted. The other one, with a total of 601 beds served, 70 
hospitalisations, 20 surgical operations, 80 Catheterisation Laboratory procedures, 
and 40 Electrophysiology procedures on an average daily basis. The Centre currently 
enjoys the services of over 1700 staff members, 92 full-time medical faculty 
members, and 169 residents, specialist fellows, and subspecialist fellows in various 
cardiovascular disciplines. The third study site is a tertiary hospital in the centre of 
Tehran with a capacity of about 1400 hospital beds. The centre has faculty staff 
(n=270), nursing staff (n=1103), medical students (n=97), residents (n=402), 
subspecialty trainees (n=110) and stagers (n=135). There was a total number of 
870,000 patients were admitted and approximately 31,000 surgeries were conducted 
in that hospital in 2010. 
Data Collection  
Before the start of the FGDs, the researcher introduced the study, highlighting 




demographic questionnaire (Appendix 10) was provided for each participant at the 
beginning of each session.  
An interview guide was developed to structure FGDs (Appendix 11). 
However, while a structured protocol was employed to guide FGDs, all responses 
were open-ended and the discussions were flexible allowing pursuit of issues raised 
by the participants that were not in the original FGD protocol. Specifically, 
participants were asked to reflect on (1) their experience with applying mHealth (2) 
positive and negative aspects of mHealth (3) challenges of using mHealth for 
patients and healthcare providers (4) strategies for best implementing a mHealth-
based intervention to improve cardiac medication adherence.  
The focus groups were conducted in the native language of participants, which 
was typically Farsi. They were conducted and facilitated by the researcher (SKh) in 
three different days in November 2015. All focus groups were audio-recorded with 
permission from participants and transcribed verbatim after each session. The 
average interview time was fifty minutes (minimum 40 minutes and maximum 60 
minutes). As a validity check, the researcher asked participants to verify a verbal 
summary of the key points (Krueger and Casey, 2014). 
Data Analysis 
Qualitative data were analysed for all focus groups. Data analysis involved an 
initial reading of the three focus group transcripts. The methods used to code and 
categorise focus group data were adapted from approaches to qualitative content 
analysis discussed by Graneheim and Lundman (2004). Following steps have been 
taken to interpret the data: 
The transcript was read and brief notes were taken in the margin when 
interesting or relevant information was found. After that, the notes made in the 
margins were reviewed and the different types of information were listed. The next 
step was to read the list and categorise each item in a way that offered a description 
of what it was about. Then it was identified whether or not the categories can be 
linked anyway and they were listed as major or minor categories. At this stage, the 
various major and minor categories were compared and contrasted. Finally, all of the 




merged or if some need to then be sub-categorised. All original transcripts were 
reviewed and all steps were taken several times to ensure that all the information that 
needs to be categorised has been so. 
The main researcher (SKh) identified themes that emerged from the data for 
cardiac nurses. ARN (Professor in nursing) and BKh (Master's in nursing) 
independently analysed one fourth of the scripts (different scripts for each person) to 
identify themes for each of the three focus groups. There was a high level of 
agreement between the researchers on the nature of the themes. 
5.3 Phase 2 - Study 3 (Exploratory Trial) 
A two-arm (parallel), pretest-posttest pilot RCT with an equivalent comparison 
group was conducted among male and female adult Iranian CR patients of one 
Cardiovascular, Medical and Research Centre affiliated to Tehran University of 
Medical Sciences. This study was conducted between February and April 2016. The 
intervention group received automated timely mHealth medication reminders based 
on a predefined template every morning (This pattern was defined according to the 
phase I study findings), starting from the date of patient’s recruitment for 12 weeks. 
The 12 weeks of the intervention was selected as it takes approximately 10 weeks 
(based on daily repetition) for participants to adopt new behaviours (in this case, 
medication taking) (Gardner et al., 2012). Moreover, between one and three months 
after discharge is when cardiac patients are most susceptible of discontinuation of 
their medications (Airoldi et al., 2007, Balaguer-Malfagón et al., 2006, Park et al., 
2014). 
Pilot RCT specific objectives were to: 
 to evaluate the effect of a 12-week mHealth intervention on medication 
adherence of Iranian male and female CHD patients participating in CR 
(Objective 5);  
 to evaluate the effect of a 12-week mHealth intervention on the secondary 
outcomes: Medication Adherence Self-Efficacy (MASE); cardiac Ejection 
Fraction (EF); cardiac Functional Capacity (FC); CHD-related 
readmission/mortality rate and Health-related Quality of Life (HR-QOL) of 




 to explore the association between socio-demographic factors of the subjects 
and medication adherence in both intervention and control groups (Objective 
7); 
 to explore the perception of participants in the intervention group towards the 
received mHealth intervention at the end of the study (Objective 8); and 
 to identify the recruitment and retention rate and inform the sample sizes 
required for a further larger trial (Objective 9). 
 
Study Sample and Setting  
CHD patients were recruited from an educational research and medical centre 
for cardiovascular disease affiliated to Tehran University of Medical Sciences, the 
same place in which the survey and one of the FGDs were conducted. A convenience 
sample of newly diagnosed CHD patients was recruited by the researcher. Eligible 
participants were Iranian male and female adults (ages 18 years and older) with a 
documented diagnosis of CHD (Myocardial Infarction (MI), angina or 
revascularisation) who met the criteria for usual CR care and had at least a basic 
mobile phone to receive text messages. Exclusion criteria were (a) unwilling to 
participate in the study; (b) being illiterate for reading reminders; (c) not being 
available for the 12 weeks period of the study (including being unavailable by phone 
and/or travelling out of the country), (d) being diagnosed with a level of cognitive 
impairment such that the process of informed consent may be obscured, (e) being 
physically unwell or diagnoses with a terminal illness. 
Sample size 
A major reason for conducting the pilot study was to determine initial data for 
the primary outcome measure (e.g. medication adherence), in order to perform a 
sample size calculation for a larger definitive RCT (Lancaster et al., 2004). Setting 
an appropriate sample size for any study is important. If a study is too large it may be 
judged to be unethical as participants may be unnecessarily exposed to risks and 
burdens (Thabane et al., 2010). There is the additional issue that setting the sample 
size too high may lead to a preventable failure to reach the recruitment target 




estimated variance, which could impact on the design of a future definitive study 
(Julious, 2005). With considering these factors, recommendations by Lancaster et al. 
(2004) on sample size estimation in feasibility study were considered. According to 
their justification, a general rule of thumb is to take 30 patients or greater to estimate 
a parameter. It was estimated to recruit a sample of 100 CR patients in this study. 
Control  
The control group received usual care. They were not exposed to the study 
intervention. All participants were offered the standard outpatient CR programme 
provided by hospitals, which involved education classes and supervised exercise (See 
Section 1.2.1). 
Definition of Usual Care 
For the purposes of this study, usual care was defined as the CR care that was 
currently provided for CHD patients 4 to 6 weeks after discharge from hospitals in 
Iran which involved supervised and structured exercise training in combination with 
educational and psychological support and advice on risk factors.  
According to the Iranian CR protocol obtained from the study setting, all 
patients complete the 24 sessions in an average of 8 weeks. The first session of 
outpatient CR programme involves a baseline assessment by a physician and 
delivering information on various topics including cardio-protective medications in a 
group setting, presenting by a physician both verbally and in written form. Each 
exercise session consists of endurance training on a cycle ergo-meter for 10 to 12 
minutes, an arm ergo-meter for 8 to 10 minutes and treadmills for 10 to 15 minutes. 
Each step includes warm up, training at constant workload, cool down, and post 
exercise recovery (Moghadam et al., 2008).  
In all sessions, electrocardiogram and heart rate are supervised by telemetry 
monitoring. At the beginning, exercise intensity is set at 40 to 55% of the individual 
maximum Heart Rate (HR) obtained in the patients’ pre-study graded exercise test, 
and then will be increased progressively to reach 70 to 85% maximum HR. 
Progressive updating of the exercise prescription is according to the patients' HR, 
tolerance level and cardiac symptoms (Moghadam et al., 2008). All patients undergo 




fraction prior and at the end of the CR programme. No mHealth adherence 
intervention was provided to patients who received the usual care.  
Intervention 
The participants in the intervention group received mobile phone/ mHealth 
medication adherence intervention over the 12 weeks of the study. A detailed 
description of the study intervention is presented in 5.1.1. The researcher also 
followed up with the participants in the intervention group via telephone calls once 
every two weeks during the study to reassure the delivery of reminders and to 
enquire about any patient’s emergency readmission. 
Random Allocation 
All participants were randomised to achieve groups that are similar in terms of 
socio-demographic characteristics and treatments except receiving the study 
intervention. A random numbers table was used to generate the random allocation 
sequence (based on the daily admission rate, 20 random numbers were generated for 
each day). Patients were asked to choose between sealed non-transparent envelopes 
with a number inside. Odd numbers were allocated to the intervention group and 
even numbers to the usual care group.  
Blinding 
Due to the nature of the intervention, it was impossible to blind either the 
participants or the researcher to the study group assignment. To prevent potential 
bias in the results of the study, participants’ follow-up visits took place after they 
were visited by cardiologists and CR specialists who were unaware of the study 
group assignment to assess the participants’ EF and FC based on treadmill test or 
exercise test and echocardiography reports at the end of their hospital-based CR 
sessions. 
Data Collection  
All participants were assessed by the researcher in the study site two times: at 
baseline (pre-test, T1) and at the endpoint of the study (post-test, after 12 weeks, 
T2). At each point in time, the primary and secondary outcomes were measured. The 




complete cardiac medication regimen at 12 weeks measured using the Morisky Self- 
Reported Medication Adherence Scale (Morisky and DiMatteo, 2011, Morisky et al., 
2008) (see Appendix 6). Secondary outcomes were Medication Adherence Self-
Efficacy (MASE) (see Appendix 12); Cardiac Functional Capacity (FC) (see 
Appendix 13); Cardiac Ejection Fraction (EF); CHD-related Readmission/Mortality 
Rate, Health-related Quality of Life (HR-QOL) (see Appendix 8) and patients’ 
perception about the applied intervention (see Appendix 14). At the endpoint of the 
study, patients who received the mHealth medication reminder intervention were 
asked to complete a survey about their satisfaction with the intervention. Research 
data were collected using the instruments below: 
1. Sociodemographic Questionnaire (see Appendix 3)  
Sociodemographic data was obtained at the recruitment time. Socio-
demographic factors such as age, gender, education level, marital status, 
employment, living arrangement, monthly income and receiving health insurance 
services were asked only in the pre-test questionnaire. 
2. Self- Reported Medication Adherence Scale (see Appendix 6) 
A complete description of the instrument has been provided in Section 5.3 
under Data Collection sub-section. Two questionnaires, one pre-test, one post-test, 
were completed by all participants. For comparability, questions at post-test were 
mostly similar to those at pre-test.  
3. Medication Adherence Self-Efficacy (MASE) (see Appendix 12) 
Self-efficacy has been found to influence a variety of health behaviours 
including medication adherence in chronic conditions (Saffari et al., 2015). Self-
efficacy can be assessed using relevant instruments that have been developed and 
used in different chronic diseases such as antiretroviral therapy (Colbert et al., 2013), 
inflammatory bowel disease (Izaguirre and Keefer, 2014), mental illness (Sánchez et 
al., 2016) and diabetes (Sleath et al., 2016). The Medication Adherence Self-Efficacy 
Scale (MASES) has been developed by Ogedegbe and colleagues to measure and 
identify the patients’ concerns related to self-efficacy in adherence to prescribed 
medications in hypertensive African–American patients (Ogedegbe et al., 2003). The 




consistent measure of self-efficacy with Cronbach’s alpha coefficient of 0.95 
(Ogedegbe et al., 2003).  
As a research instrument, the MASE can contribute to provide an important 
outcome variable. For example, self-efficacy can be evaluated over time as an 
outcome of a specific intervention, and hence the tool can be applied to assess within 
group or between group differences in self-efficacy over the study time (Ogedegbe et 
al., 2003). The Persian version of the MASE was used in this study to evaluate the 
effect of the mHealth intervention designed based on the Bandura’s Self-efficacy 
Theory to enhance CHD patients’ medication adherence self-efficacy. The Persian 
version of this scale was validated and reliable with Cronbach’s alpha coefficient of 
>0.92 (Saffari et al., 2015).Two questionnaires, one pre-test, one post-test, were 
completed by all participants. They were provided with a description that they need 
to choose their level of confidence in taking their cardio-protective medications in 
different situations using a three-point Likert scale (1= not at all sure, 2= somewhat 
sure, and 3= very sure). A summary score of all responses was calculated with 
greater scores illustrating higher self-efficacy. It only took 5 minutes to answer the 
questionnaire during their recruitment session and follow-up visits and the questions 
were easy to understand for the patients. Permission to use of the MASE and its 
Persian version were obtained from the owners (see Appendix 15). 
4. Functional Capacity (FC) (see Appendix 13) and Ejection Fraction (EF) 
The patient's functional classification may improve as recovery from an acute 
event, such as Myocardial Infarction (MI), occurs or as intervention is optimised. 
Conversely, it declines with worsening or non-adherence to the treatment regimen 
(Woods, Froelicher, & Motzer, 2000). The NYHA classification system has an 
adequate validity and reliability in measuring functional status, assessing symptom 
severity and monitoring the effects of treatment in patients with cardiac disease and 
correlates with other measures of function, such as maximal aerobic capacity 
(VO2max), the Specific Activity Scale (SAS), and the 6-minute walk test (Cutrona et 
al., 2010, Bennett et al., 2002). The role of this measuring tool has expanded over 
time from classification of heart failure patients to categorise all patients experienced 




2002). NYHA classification scheme as a clinical outcome measure of this study 
includes multiple criteria for assessment. These criteria are varied from vital sign 
changes interfere with daily activities to objective assessment recommended in the 
ninth edition, by the Criteria Committee of the American Heart Association, New 
York City Affiliate (1994), which is based on measurements such as 
electrocardiograms, stress tests, x-rays, echocardiograms, and radiological images. 
The objective assessment can address the question of subjectivity which is a common 
critique of this measure.  
In the present study, Left Ventricular Ejection Fraction (LVEF) was considered 
as one of the objective secondary outcomes of the study. Acute Coronary events 
including Acute Myocardial Infarction (AMI) can pathologically increase Left 
Ventricular (LV) mass and volume (i.e. LV remodelling) characterised by functional 
decline or reduced LVEF that is associated with increased risk of chronic heart 
failure, morbidity and mortality (McGregor et al., 2015). In CHD patients, adherence 
to medical treatment improves functional myocardial recovery and clinical outcome 
and eliminates the risk of CHF (McGregor et al., 2015, Tendera et al., 2009). 
Patients’ functional status and LVEF were recorded at the baseline and at the end-
point of the study based upon the most recent patients’ documents, to reduce the 
limitations of self-reporting.  
5. Short Form Health Survey Version 2.0 (SF-12v2) (see Appendix 8) 
A complete description of the instrument has been provided in Section 5.2.1 
under Data Collection sub-section. Two questionnaires, one pre-test, one post-test, 
were completed by all participants. For comparability, questions at post-test are 
mostly similar to those at pre-test.  
6. Other Study Measures  
CHD-related readmission and mortality rate were compared at the end point of 
the study between the two study groups using the most recent patients’ medical 
documents.  
To evaluate the acceptability of the mHealth intervention, participants who 
received medication reminders were asked to complete a self-administered survey 




multiple choice questions, 4 questions with 5-point Likert scales answers and 1 open-
ended question to identify the patients’ perceptions about the applied mHealth 
intervention. The survey design was primarily based on the principles of the Roger’s 
Diffusion Theory that consisted of four major attributes to describe how innovations 
are perceived by their recipients (e.g. CHD patients) (Rogers, 2003). These attributes 
are: (1) simplicity (the extent to which an innovation is thought as easy/ difficult to 
use), (2) compatibility (the innovation consistency with the potential users’ needs), 
(3) observability (any observable effect of an innovation over time) and (4) relative 
advantage of an innovation that may have an impact on the rate of innovation 
adoption by users. It took less than 5 minutes for patients to answer the survey 
questions (Appendix 14). 
Variables 
The study instruments measured the key variables. The independent and 
dependent variables for investigation in this study are presented in Section 4.4. 
Data Analysis  
 The data analysis is intended to provide the answer to the research question. 
Thus, it must be planned ahead along with the rest of the study (Polit and Beck, 
2004). All data were analysed using the computer program Statistical Packages for 
Social Sciences (SPSS) version 21. The significance level in this study is α=0.05. 
Both descriptive and inferential analysis were carried out using SPSS.  
Quantitative/ statistical analysis, in this pilot RCT, comprised of sufficient data 
screening methods to identify miscoded and missing data, descriptive and inferential 
analysis. After coding, processing and cleaning the raw data obtained during the data 
collection period, frequencies and percentages were used to present detailed 
information on nominal and ordinal (categorical) data (such as gender, marital status, 
educational level, employment status, mobile phone ownership). Mean and Standard 
Deviation (SD) were used to describe continuous variables such as age, length of 
hospital stay, and number of daily medications.  
Inferential statistical analysis was applied in order to evaluate the effectiveness 




two variables, a correlational procedure was performed (e.g. self-efficacy and 
medication adherence).  
The normality of the distribution of scores related to primary and secondary 
outcomes was assessed using the Kolmogorov-Smirnov test. Patients’ characteristics 
are compared between the study groups (control and intervention) using independent 
samples t-tests for continuous variables or χ
2
 tests for categorical variables. The 
primary outcome from the MMAS provided categorical data including high 
adherence (score of 8), medium adherence (score of 6 to <8) and low adherence 
(scores of <6).  
All secondary outcomes results were provided in categorical data including 
patient’s cardiac FC (Class I: no symptoms, II: mild symptoms, III: marked 
limitation and IV: severe limitations), as well as death and hospital readmission rates 





applied for MMAS, cardiac FC and death/ hospital readmission rates in order to 
determine the statistical significance of the observed association in a cross-
tabulation. One of the assumptions underlying the use of chi-square is to ensure the 
cell sample size is adequate. Cases where more than 20% of the cells had an 
expected frequency of less than five subjects were reduced by grouping patients into 
smaller numbers of categories (Pallant and Manual, 2007). Cells with no frequencies 
were treated similarly. The Cramer’s Phi (φ) or V and the Relative Risk (RR) were 
reported as magnitude of the intervention effect.  
In order to determine any significant changes in primary and secondary 
outcomes in each group over the study period, a Mann-Whitney U test (for 
continuous data) or Wilcoxon signed-rank test (for categorical data) was performed. 
The Multiple Logistic Regression was used to assess any association between socio-
demographic variables and medication adherence. 
To calculate the PCS-12 and the MCS-12 from the scores of perceived quality 
of life, the QualityMetric Health Outcomes Scoring Software 2 was used. The 
software uses all the 12 items of SF12V2 to produce scores for the PCS-12 and the 
MCS-12 and applies a norm-based scoring algorithm empirically derived from the 




In theory the possible scores for the PCS-12 and the MCS-12 could be ranged from 0 
(the worst) to 100 (the best). The t-test was used for comparison.  
5.4 Ethical Considerations 
To develop a sound knowledge and understanding of the ethical principles 
underpining research is the responsibility of researchers. Such knowledge and 
understanding facilitates the design of ethically acceptable research (Bradbury-Jones 
and Alcock, 2010). The Nuremberg Code and the World Medical Association 
Declaration of Helsinki provided general ethical guidelines for research involving 
human subjects , adopted in 1964 mainly from the history of abuses of human 
research subjects and then later revised (seventh version), most recently in 2013 
(Muthuswamy, 2014, Ndebele, 2013). By changing the format and including several 
subsections, the revised declaration enhances and improves clarity regarding specific 
issues. By so doing, the Declaration of Helsinki is a better and more important 
authority at what it is aimed at achieving, providing guidance on conducting medical 
research involving humans (Ndebele, 2013).  
Most disciplines including nursing have established their own code of ethics 
and there is considerable overlap in the basic principles articulated in these 
documents such as requirements of guaranteed anonymity and/or confidentiality, 
informed consent, maintenance of dignity and an overall benefit to the 
individual/society rather than harm (Polit and Beck, 2004).  
For both types of research (i.e. quantitative and qualitative methods), the 
Economic and Social Research Council (ESRC) (2015), the UK’s principal body for 
funding social science research, suggested six key principles of ethical research that 








Table 5.3. Key principles of ethical research (ESRC, 2015, p.4) and steps undertaken to address 
ethical concerns 
Key principles of ethical research Steps undertaken to address ethical concerns 
1 Research participants should take part 
voluntarily, free from any coercion or 
undue influence, and their rights, dignity 
and (when possible) autonomy should be 
respected and appropriately protected. 
 Obtained ethics approval from the School 
of Health in Social Science Ethics 
Committee at the University of Edinburgh 
and the Institutional Review Board of the 
University in Tehran. 
 All participants were fully informed about 
this research, such as its purpose and 
process both verbally and written by 
providing participants’ information sheets. 
 Participants were assured of the anonymity 
of their participation. 
 Their participation in this research was 
requested in a relaxed atmosphere.  
 During all phases of this research, any 
potential harm or risk could be inflicted 
upon the participants were reviewed, and 
the participants were frequently asked about 
their feelings regarding participation in this 
research. 
 This research was independent from 
sponsors or funders, and no conflicts of 
interest were encountered during the course 
of this research. 
 In case of any unpredicted ethical issue, a 
plan was established to contact the PhD 
principal supervisor and the School of 
Health in Social Science Ethics Committee 
at the University of Edinburgh and Tehran 
University of Medical Science in order to 
respond immediately and 
actively to ethical issues, should they 
emerge. However, no ethical issue emerged 
in the duration of this research. 
2 Research should be worthwhile and 
provide value that outweighs any risk or 
harm. Researchers should aim to 
maximise the benefit of the research and 
minimise potential risk of harm to 
participants and researchers. All potential 
risk and harm should be mitigated by 
robust precautions. 
3 Research staff and participants should be 
given appropriate information about the 
purpose, methods and intended uses of the 
research, what their participation in the 
research entails and what risks and 
benefits, if any, are involved. 
4 Individual research participant and group 
preferences regarding anonymity should 
be respected and participant requirements 
concerning the confidential nature of 
information and personal data should be 
respected. 
5 Research should be designed, reviewed 
and undertaken to ensure recognised 
standards of integrity are met, and quality 
and transparency are assured. 
6 The independence of research should be 
clear, and any conflicts of interest or 
partiality should be explicit. 
 
One of the most fundamental ethical principles in research is that of 
beneficence that contains multiple dimensions and follows the principle of doing 
good in terms of that which would help, improve and benefit the individual (Polit and 
Beck, 2004). The results of this research increased existing knowledge and 
understanding within this area in the Iranian context. This knowledge will be 
disseminated internationally in order to help shape clinical practice in the future. 
Although this research may benefit future patients, it is also important to consider the 




Minimising all types of harm and discomfort and achieveing  a balance 
between the potential benefits and risks of being a participant should be considered 
by researchers as an important dimention of beneficence (Polit and Beck, 2004). An 
exclusion criterion was created for the study in order to protect those patients deemed 
vulnerable/inappropriate for the experiment. The researcher is a nurse whose clinical 
judgement was used during recruitment to exclude those who were ill and might have 
been harmed, and during the administration of interventions. 
According to the priciple concerning justice, participants have the right of fair 
treatment and privacy before, during, and after their participation in the study (Polit 
and Beck, 2004). In this study, the experimental intervention however, was an 
addition to the usual care which cardiac patients received after discharge from a 
hospital. Thus, no treatment was withheld from patients which they should have been 
entitled to during their period of care. At the end of the quantitavie pilot RCT, a text 
message was sent to all participants in the intervention group in order to convey the 
appreciation of their participation in the study and inform them that no more 
medication reminder would be sent to their mobile phones, but that they still needed 
to continue their medication taking according to their prescriptions. Additional 
information were also provided for all participants so that they could contact CR staff 
with any further questions or concerns related to their medications. 
Confidentiality of participants in both qualitative and quantitative research 
were maintained. Data was managed in accordance with the University of Edinburgh 
guidelines. The confidentiality of all data that was collected, processed and stored for 
the purposes of the study was maintained in compliance with Good Clinical Practice 
(GCP) guidelines and the principles of Data Protection Act 1998. Participants were 
assigned a unique study number on all digital and typed forms of data to ensure 
anonymity. A file of study numbers linked to participants identifying information 
were stored separate from other data, including consent forms. All written data were 
kept in a locked filing cabinet and all computer data were password protected. It was 
also agreed with the text message service provider that patients’ mobile phone 
numbers would not be sold or passed on to a third party in any case without explicit 




5.4.1 Ethical Approval 
 Ethical approval obtained from The School of Health in Social Science, The 
University of Edinburgh Research Ethics Committee (Ethics Approval Code: 
NURS006) (see Appendix 17) and the Institutional Review Board of the University 
in Tehran (Ethics Approval Code: 92-04-28-28802-145738) (see Appendix 18). 
Study was carried out in accordance to the principles outlined in the Declaration of 
Helsinki. The anonymity of every patient was guaranteed because all data were 
coded. Written informed consent were obtained from each participant. 
5.4.2 Consent Form 
Respect for human dignity is an ethical principle that includes the right to self-
determination (i.e. participants’ right to decide voluntarily whether to participate, 
without treatment alteration) and the right to full disclosure (i.e. providing a full 
description about the nature of the study, the right to refuse participation, the 
researcher’s responsibilities, and likely risks and benefits) (Polit and Beck, 2004). 
Participants’ information sheets (Appendix 19) were developed for the purpose of 
each study phases. These information sheets guaranteed participants' confidentiality, 
provided them with a description of the study, the reason for the study and what 
would be involved if they agreed to participate. The participants’ information sheets 
received approval from the Institutional Research Ethics Committee in Edinburgh 
and Tehran. Patients' consent was obtained after allowing  enough time (range: 10-
15 minutes) to particpants to read the information sheet and both participant and 
researcher agreed together that the participant had all the relevant information to 
make an informed choice regarding their decision to participate. The consent forms 
(Appendix 20) used had been provided according to the template accessed via 
Institutional Research Ethics Committee, highlighting the participant's right to refuse 
without compromising his/her clinical treatment and again highlighted the assurance 
of confidentiality.  
5.5 Negotiating Access  
 Since this study took place outside the UK (place of education), it was decided 
to secure an external support that would strengthen access negotiations by choosing 




Science in Iran. In April 2015, a teleconference was arranged to connect PhD 
supervisors in the University of Edinburgh with Prof. ARN so that they could 
discuss the research project and how the researcher could gain access to potential 
study sites. Following the discussion, the researcher travelled to Tehran for obtaining 
Ethical Approval, identification of potential study setting and initial negotiations 
with gatekeepers in May 2015. Ethical Approval (Ethics Approval Code: 92-04-28-
28802-145738) (see Appendix 18) as well as a letter of permission (see Appendix 
21) obtained from the Tehran University of Medical Sciences. A letter of ethics 
approval was also obtained from the hospital in which the pilot RCT was conducted 
(see Appendix 22). Following receipt of permissions, the researcher (SKh) met with 
CR clinic manager, Principal Nurse Supervisors/ Matrons of three hospitals (two 
cardiovascular, medical and research centres and one tertiary hospital covering a 
large mixed urban and rural area with a diversity of social groupings)  affiliated to 
Tehran University of Medical Sciences and the Director of Iranian Cardiac Nurses’ 
Association involved with permission for access requested. These meetings had been 
arranged by Prof. ARN in Tehran University of Medical Sciences in advance. 
During the meetings, SKh introduced herself, explained about the research proposal, 
and identified needs, expectations and potential benefits from this particular 
collaboration. This allowed the researcher to familiarise herself with hospital 
regulations and discussions with experts regarding the conduct of the study to take 
place. There were no similar programme to the mHealth medication adherence 
intervention employed by those hospitals for cardiovascular patients. This was 
important in order to  control for the effects of potential sample contamination 
caused by such existing programme.  
5.6 Visual Model of the Research Process and Data Collection 
In this mixed methods study a visual model was used to show the research 
process and phases of the study, along with the data collection and follow-up 
procedures. Figure 5.2 in the next page presents the visual model of this mixed-





Figure 5.2. Visual model of the research process and data collection 
Focus Group with 
Cardiac Nurses 
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This chapter has introduced and critiqued the rationale to select a multi-stage 
mixed methods research design (i.e., the patients’ perception survey (quantitative), 
focus group discussions with cardiac nurses (qualitative) and pilot RCT 
(quantitative)) as a research strategy to enable the refinement and evaluation of the 
mHealth medication reminder intervention to promote cardio-protective medications 
among CHD patients in an Iranian CR setting. Particularly, the MRC framework was 
used as a guide to develop the preclinical/ modelling phase and the exploratory trial 
phase of the study.  
This chapter also explained the data collection and analysis processes of each 
phase of this study in detail. Moreover, this mixed method research has attempted to 
assure the ethical considerations. A visual model of the data collection procedure was 
presented to visualise the research process and phases of the study as well as the data 
collection and follow-up procedures. In the following chapter, the findings of this 




CHAPTER 6: RESULTS 
This Chapter provides the results of the studies undertaken in Phase 1 (i.e. 
preclinical/ remodelling) and Phase 2 (i.e. exploratory trial) to refine and evaluate a 
mHealth intervention to improve medication adherence in Cardiac Rehabilitation 
(CR) outpatients in Iran. Firstly, the survey results are reported that identified the 
pattern of ownership and utilisation of mobile phones in Iranian CHD patients and 
their preferences about a mHealth medication adherence intervention. Next, the 
results of the qualitative focus groups study that explored Iranian cardiac nurses’ 
perspectives about the potential effects, barriers and facilitators to implementation of 
a mHealth intervention among Iranian CHD patients are presented.  
The survey and focus group findings were used to inform the second phase of 
the research, the pilot Randomised Controlled Trial (RCT). The results of the pilot 
RCT, undertaken to evaluate the effect of the study intervention on CR patients’ 
medication adherence, are reported. The detailed aim and objectives of the study can 
be found in Section 4.2. 
6.1 Preclinical/ Modelling (Phase 1) Results 
The results of the first phase of the study as part of the preclinical/ modelling 
phase are presented in two sections including the results of the self-completed survey 
of CHD patients (Section 6.1.1) as well as the results of the cardiac nurses’ focus 
group (Section 6.1.2) that were used to inform the second phase of the study. 
6.1.1 Survey Study Results 
The survey results reported here were conducted as preliminary research prior 
to the initiation of a pilot RCT of the mHealth intervention to enhance adherence to 
cardiovascular medications among CHD patients in an Iranian CR setting. 
Specifically, the survey sought to identify:  
 The pattern of ownership and utilisation of mobile phones in Iranian CHD 
patients (Objective 1); 
 A preferable design for the study intervention based on Iranian CHD patients’ 








Overall, 132 Iranian CHD patients were approached from outpatient CR clinic 
of an educational research and medical centre for cardiovascular disease affiliated to 
Tehran University of Medical Sciences for participation in the survey. Of 9 patients 
who declined to complete the survey, 5 stated they were “not interested” and 4 said 
their reason for non-participation was due to “time limitation”. Of the 123 
respondents recruited from the CR clinic consenting to participate, 44.7% (55/ 123) 
were Acute Coronary Syndrome (ACS) patients, 34.1% (42/ 123) underwent a 
cardiac revascularisation (stenting or bypass surgery) and 21.1% (26/ 123) suffered 
from heart diseases other than Coronary Artery Disease (CAD) (i.e. heart valve 
disease, dysrhythmia, Left/ Right Bundle Brunch Blocks). The mean age was 57.24 
with a Standard Deviation (SD) of +11.2 years, 72.4% were male, around one-third 
had secondary school education and almost 83% were married. Around 44% (54/ 
123) of respondents were retired with self-reported ‘quite enough’ monthly income 
and the majority (90.2%) had health insurance. 88.6% (109/ 123) were living with 
their family. The mean length of hospital stay was 17.57 (SD+13.1) days and the 
mean for the number of medications consumed by patients were 5.35 (SD+2.7) per 
day. Detailed participant demographic characteristics compared to a national cross-
sectional and epidemiological study of cardiovascular patients registered in Iran 
Health and Medical Education Ministry (Department of Cardiovascular Disease 
Prevention) (Ahmadi et al., 2015) are presented in Table 6.1. 
Ownership and Utilisation of Mobile Phones (Objective 1) 
The majority of respondents (98.4% or 121/ 123) owned mobile phones and 
around 96% (118/ 123) kept the phone in their own possession. A total of 42.3% (52/ 
123) had a Smartphone. Participants had owned a mobile phone for a mean of 10.87 
(SD+5.8) years. OF 123 respondents, 68.3% used the Short Message Service (SMS) 
technology to send/ receive text messages to and from their mobile phones. 
Education was significantly associated with the usage of SMS, Odds Ratio (OR) 
=4.40 with 95% Confidence Interval (CI) of 1.86-10.4, P<0.001.  
Slightly over half of the participants knew how to connect their phones to the 




Similar to the usage of SMS, education was significantly associated with the 
utilisation of the Internet on mobile phones, OR=7.16 (95% CI: 2.3-22.26), P<0.001. 
In this study, 53.7% (66/123) of the patients used alarm function on their phone 
devices. Only 5.7% (7/123) set the alarm specifically as a medication reminder alone.  
Table 6.1. Characteristics of survey participants 
Characteristics Overall Population 
b
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No comparable data 
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Daily Medications, mean (+SD) 
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No comparable data 
a. Data are presented as frequency (percentage) unless otherwise specified. 
b. Data from a national cross-sectional and epidemiological study of cardiovascular patients registered 
in Iran Health and Medical Education Ministry (Department of Cardiovascular Disease Prevention). 
* In this study, Acute Coronary Syndrome (ACS) refers to Unstable Angina (UA), Non-ST-segment 
Elevation Myocardial Infarction (NSTEMI), and ST-segment Elevation Myocardial Infarction 
(STEMI). 
Ѱ CABG = Coronary Artery Bypass Grafting 
† PCI = Percutaneous Coronary Intervention 
‡ In this study, any cardiovascular problem other than ACS, CABG and PCI considered as “other 
diagnosis” including heart valve disease, dysrhythmia, Left/ Right Bundle Brunch Blocks. 
Patients’ Perceptions about mHealth Intervention (Objective 2) 
Almost 93% of participants perceived that receiving automatic reminders on 
their mobile phones would help them to remember to take their medications. 
Participants (48%) stated they would prefer to receive medication reminders via SMS 
on their mobile phones. Based on patients’ responses, the most preferred frequencies 
to receive medication reminders were “as often as the medications need to be taken” 
(50.4 %) and “on a daily basis” (28.5%), respectively.  
In terms of SMS timing, 44.7% stated they would like reminders to be sent just 
before the medication time, following 16.3% specified mornings (6 am–10 am) as 
the best time to receive SMS medication reminders. 
With regards to SMS reminder contents, patients were asked to write a short 
statement as an example of their preferred text message reminder. Of 123 





The most popular examples were as follow: 
“It is time to take your medications” (13%) 
“Don't forget to take your medications” (11.4%) 
Participants (74%) did not perceive mobile phone-based medication reminders 
as an intrusion in a person’s life and 72.3% reported an interest in receiving a text 
message intervention for their cardiac medications. Almost 45% of respondents 
stated they would prefer not to send a reply message to each reminder for the 
medications they would take (see Table 6.2). 
Table 6.2. Ownership and Utilisation of Mobile Phones in Survey Participants (n=123) 
No. Survey Questions Overall (%)
a
 
1 Do you have a mobile phone? 
Yes 
No (Have no use for it) 






2 Is this phone mostly kept in your possession? 
Yes 
No       
No Answer  





3 Since when have you used mobile phones?  


































7 For a cardiac patient, would it be helpful to have automatic 
reminders on the mobile phone to help remind the patient to 
take medicines?  
Yes 













No. Survey Questions Overall (%)
a
 









9 What do you use the alarm function for?  
No need to answer 
a. To wake up 
b. To remind me of errands 
c. As a reminder for medicines 
d. Both a & b 
e. Both a & c 
f. All Above 











10 What other use do you have for the mobile phones?  
a. Listen to radio 
b. Play games 
c. Camera 
d. a &c 
e. Other 
f. None  
No Answer 









11 If we were to provide automatic reminders to patients to 
take medications, what format would you like these 
reminders to be in? 
Telephone call  
SMS message  
Smartphone application 










12 How often would you like these medication reminders to be 
sent to the patient? 
As often as the medications need to be taken 
Daily 
Once a week 










13 What times would you like the reminders to be sent to you? 
Just before the drugs timings  
Morning:  6 am – 10 am 
Mid-day:  11 am – 2 pm 
Evening:  3 pm – 6 pm 


























No. Survey Questions Overall (%)
a
 









16 If we were going to develop an application using cell 
phones for cardiac patients – what other possibilities do you 
think would be useful? 
a. Communication with health provider  
b. Information on medicines 
c. Motivational Messages  
d. a & b 
e. a & c 













17 Do you prefer to send a reply message to each reminder 




No Answer  







18 Do you think the cell phone used in this way will be an 























a. Data are presented as frequency (percentage) unless otherwise specified. 
6.1.2 Qualitative Focus Groups Results 
Three Focus Groups Discussions (FGDs) were conducted among 23 Iranian 
cardiac nurses to inform the refinement of the study mHealth intervention to promote 
cardiac medication adherence among CHD patients at risk of non-adherence. FGDs 
specific objectives were to explore: 
 Nurses’ perspectives of the potential effect of a mHealth intervention among 
Iranian CHD patients (Objective 3); 
 Barriers and facilitators to implementation of the mHealth intervention 
through which such interventions may affect medication adherence in an 




The analysis of the focus group data identified three key themes:  
1. Positive impacts;  
2. Unpreparedness for mHealth implementation; and  
3. Considerations before implementation.  
Participant characteristics and identified themes are presented separately below. 
Participant Characteristics 
The mean age of nurse participants was 36.64 (SD+6.69) years, predominantly 
female (82.6%), married (60.9%), with an average of 12.06 (SD+6.51) years work 
experience. Table 6.3 and 6.4 presents the characteristics of FGDs’ participants. 
Table 6.3. Characteristics of focus groups participants (n=23) 
Characteristics Overall (%) 


























Cardiac Intensive Care 
Hospital Nursing Department 


















Working Experience, mean (+SD), years 
 
12.06 (+6.51) 












Have you ever participated in any mHealth Seminars? 
Yes  



















































































1 F 40 BSN S CICU 13 Yes 
2 F 54 BSN M Others 29 No 
3 M 27 MSc or Higher S CICU 6 No 
4 F 34 MSc or Higher M CICU 8 Yes 
5 F 24 BSN M CICU <1  No 
6 F 33 BSN S CICU 12 No 
7 M 34 MSc or Higher M HND 10 Yes 
8 F 37 BSN S Others 15 No 
9 F 46 BSN S HND 21 No 
10 F 37 BSN M CICU 5 No 
11 F 40 BSN M CICU 14 No 
12 M 37 MSc or Higher M HND 15 No 
13 F 35 BSN S CICU 10 No 
14 F 37 BSN S CICU 13 No 
15 F 30 BSN S Others 2.5 No 
16 F 24 BSN S Others 2 No 
17 M 42 BSN M CR 17 No 
18 F 40 BSN M CR 17.5 No 
19 F 35 BSN M CR 8 No 
20 F 36 BSN M CR 14 No 
21 F 39 BSN M CR 14 No 
22 F 42 BSN M CR 15 No 
23 F 40 BSN M CR 16 No 
a. F=Female, M=Male;  
b. BSN=Bachelor of Science in Nursing, MSc=Master of Science in Nursing; 
c. S=Single, M=Married; 
 
Positive Impacts 
Participants in all FGDs perceived mobile phone-based interventions as being 
beneficial to cardiac patients and their medication taking. Within the theme of 
‘Positive Impacts’, three sub-themes are presented; the nurses identified that 
mHealth-based interventions would act as a reminder, connect hospital to home and 





Acting as a reminder 
Cardiac nurses participating in FGDs felt that the intervention would be most 
helpful to those patients who tend to forget or who are so busy and preoccupied with 
other priorities that taking medications might be ignored. An illustrative quote 
included: 
 “I think these kinds of interventions are likely to be beneficial because it will 
remind that person to take their medications. From my own experience, patients 
simply forget to take their medications; it is common not only among cardiac 
patients but among the majority of patients in their busy lives’’ (Participant 1, FG 1). 
“It can really work especially for those patients who are forgetful. Some of 
them are so busy; but this intervention sends them reminders so that they’ll 
remember…now, it’s time for taking medications” (Participant 10, FG 2). 
“When you send reminders for their medications, they will never forget and it 
is a plus; some patients need to be reminded to take their pills. So the intervention 
you are trying to develop is what they really need!” (Participant 21, FG 3). 
Across all the focus group interviews, the nurses stated that the first months of 
hospital discharge are high risk for cardiac patients to forget the name, dose and 
instructions for their prescribed medications. One of the nurses expressed: 
“The most high risk time is when patients discharge from the hospital. I 
mean...when they are at home and they may forget when and how to take their 
drugs’’ (Participant 11, FG 2). 
“When patients are in hospital, nurses are responsible to administer their 
medications and so they do not have any concern about their medications; problem 
will occur when they are no longer at hospital. It is difficult for them to remember 
their newly prescribed medications and they may return to the hospital during the 
first months after discharge with many difficulties” (Participant 20, FG 3). 
Almost all of the staff nurses in the FGDs believed that the risk of non-
adherence may reduce as they received medication text message reminders. They 
discussed patients’ forgetfulness in early hospital post-discharge being due to the 
negative mental consequences of cardiovascular diseases and that sending text 
messages for reminding them about their medications could help address this 
problem. One of the nurses stated: 
“You know problems caused by cardiac diseases are not just related to heart 
and coronary arteries...I read an article that there is a link between heart disease 




mobile phones could make it easier for patients to remember complicated prescribed 
medication regimen following hospital discharge” (Participant 2, FG 1). 
“If some patients neglect to take their medications properly, it can be related 
to negative outcomes of myocardial infarction. I think it is because this event may 
lead to a temporary lack of oxygen to the brain. I noticed it first when one of the 
patients was discussing this problem with Dr. S and that's why I think they'll need 
text message medication reminders” (Participant 13, FG 2). 
It is evident from nurses’ discussions that cardiac patients may benefit from 
receiving the mHealth intervention for their medications since the intervention has 
the potential to act as a reminder. They highlighted that text-message reminders can 
help cardiac patients who are at risk of medication non-adherence mostly due to 
unintentional reasons (e.g. forgetfulness and carelessness) during the early phase of 
discharge from hospital. 
Connecting hospital to home  
The application of mHealth intervention needs to be facilitated by maintaining 
patient-provider communication after sending patients home. Post-discharge follow-
up and interaction between patients and healthcare providers play an important role 
in the statements expressed by all the FG groups; for example, one of the more 
experienced nurses identified that there is no interaction and follow-up with patients 
after hospital discharge:  
 “Unfortunately, most of our patients are missed after going home and are no 
longer in contact with us. That is because our hospitals are inefficient regarding 
patients’ post-discharge follow-up and I can say this kind of intervention is 
absolutely one of the essentials” (Participant 3, FG 1). 
This demonstrates some of the participants figured out that there is a lack of 
electronic health system to provide a connection between hospital and home. They 
also believed that there is a limitation in providing patients with post-discharge 
follow-up and reminding them of their healthcare needs and treatment regimen. The 
example below demonstrates patient-provider connection after inpatient stay can be 
established through electronic follow-up using mHealth interventions. 
 “There is no interconnected electronic health system or mHealth in our 
hospitals. How we can provide follow-up for our discharged patients? You 




needs and medications. We are not in contact with all of patients after hospital 
discharge” (Participant 9, FG 2). 
Nurses also appear to believe that sending medication reminders using mobile 
phones would make patients feel they can still be in contact with their healthcare 
providers and they are cared for even away from the hospital, at their home. This, in 
turn, would result to persuade patients to more adhere to their treatment. Viewing the 
intervention of text message reminders as a solution to medication non-adherence, 
demonstrates the nurses’ acceptance about the role of mHealth intervention to 
provide an ongoing connection with patients even when they are at home. This may 
also suggest that these participants appreciate the potential psychological impacts of 
post-discharge follow-up delivered by innovative interventions. Participant 18 in FG 
3 said: 
“Well...psychologically, patients really need this kind of intervention as a 
means of follow-up and support from their healthcare providers. You know, most of 
our cardiac patients are elderly people and live alone, they feel like yes! Someone 
cares about me, values me...so, it motivates him to follow his treatment”. 
Within the subtheme of “connecting hospital to home”, there was some 
evidence that highlighted participants were aware of the importance of post-
discharge patient-provider interaction to improve medication adherence and health 
outcomes. However, they criticised the inefficiency of healthcare organisations in 
Iran in providing an interconnected follow-up system. They also discussed the effect 
of the implementation of mHealth on preventing consequences of medication non-
adherence, this leads on to the next subtheme evident in the analysis. 
Preventing negative outcomes  
Participants in all focus groups discussed reduction in patients’ readmissions 
and healthcare expenditure as another advantage of applying mobile health 
interventions to improve medication adherence. They believed that patients who do 
not follow their medication regimen would experience negative consequences. 
Serious complications such as rehospitalisation, prolonged inpatient stay and even 
death were understood to be the results of non-adherence to medication regimen that 
can be prevented by implementation of mHealth intervention. There was some 




department visits and healthcare costs with improved medication taking as potential 
effect of the text message reminder intervention. Participant 4 in FG 1 explained this 
through a real example: 
“Sending medication reminders are 100% beneficial...Take patients taking 
Warfarin for example; I saw many patients readmitted due to major hemorrhagic 
events and/ or toxicity from an overdose of Warfarin. Many other cardiac conditions 
are quite similar...I had patients that developed serious heart failure and lower 
extremities oedema because they forgot or were careless to take their prescribed 
drugs properly...” 
Participant 12 in FG 2 added: 
“Do you know how much money is wasted on medicines?...applying this 
intervention may reduce readmissions, the length of hospital stay, and even death 
related to nonadherence to medications...”. 
It would appear that the nurses showed insight into the current challenges with 
poor medication adherence and the implications of this for the patient themselves and 
also for the cost to the health system. There was even a sense of positivity in the 
nurses towards the application of the mHealth intervention as they believed that the 
text message reminders may prevent medication non-adherence and consequently 
may reduce the negative outcomes associated with poor medication-taking. 
Unpreparedness for mHealth Implementation 
Under the previous category of “positive impacts”, the nurses highlighted the 
issue of healthcare system inefficiency in Iran in providing a uniform electronic 
health system. This issue clouds the participants' perceptions about the 
implementation of mHealth to improve medication adherence and that is of 
“unpreparedness to implement mHealth” in the Iranian setting. This notion of 
unpreparedness for mHealth implementation forms the second theme evident in the 
data. Three subthemes were identified from FGs describing the reasons for being 
unprepared to implement mHealth in Iran including lack of Information Technology 
(IT) knowledge among patients and healthcare providers, legal ambiguityand 






Lack of IT Knowledge  
The evidence presented here would suggest that in Iran there is limited 
education and training related to IT skills to general public and in medical education 
in universities and related informatics subjects. The importance of this issue is easily 
demonstrated by posing a question that whether everyone has adequate literacy to 
use text message reminders. A typical statement conveyed by participant 9 in FG 2:  
“I guess sending text-message reminders may benefit a limited number of 
patients; I mean patients' literacy level need to be considered as part of the 
intervention preparation...is everyone literate to read text messages?”  
This quotation shows the concern that the nurse participants expressed about cardiac 
patients without required literacy who may not benefit from the intervention. 
Participant 16 in FG 3 added: 
“If there is a possibility that some patients who receive the reminders may 
have problems in opening and reading text messages on their mobile phones and 
they may not feel comfortable asking for assistance from others, they may not benefit 
from the intervention”. 
The lack of nurse informatics speciality and basic IT knowledge among nurses 
and other healthcare professionals were identified as being problematic. The 
participants often cited cultural resistance and lack of  IT skills training and practice 
among clinicians in hospitals and healthcare organisations as barriers to set electronic 
health among the major priorities in Iran. From the data it was seen that such issues 
were identified as evidence of the healthcare system unpreparedness to use 
innovative mHealth interventions for patients. It is interesting, however, that the 
nurses were aware that receiving IT training as part of the undergraduate programme 
or in-service training and continuous education are among the basic necessities for 
applying mHealth in health care. In the words of participant 1 in FG 1: 
“Frankly speaking, we as healthcare professionals in a medical team do not 
have the knowledge of using assistive technology devices...I do not think that there is 
any related informatics course in our undergraduate programme. There is cultural 







Participant 12 in FG2 added: 
“I think if mobile health is going to happen, a proper continuous training 
should be performed and nurses who can work with this system should have the 
speciality”. 
Participant 23 in FG 3 stated: 
“As far as I am aware, at least in this hospital, there is no health informatics 
professional; I guess nursing informatics has not been introduced as a postgraduate 
speciality in nursing studies, yet. I myself  did not receive adequate IT training as 
part of the Bachelor's degree programme”.  
Similarly, Participant 6 in FG1 described: 
“You know what?...Healthcare professionals are resistance to any change in 
the system that requires them to receive training  for that. I think we really need a 
comprehensive in-service training to improve our IT knowledge and to be able to use 
mHealth in our country”. 
It would seem that the nurse participants in this study showed an awareness 
that lack of IT knowledge and skills among both patients and healthcare providers 
may be a challenge and this may result in an obtacle to the implementation of 
mHealth interventions in healthcare organisations in Iran. 
Legal ambiguity  
The application of mHealth interventions needs to be in accordance with 
established legal frameworks and good practice, and requires ethical considerations. 
Professional boundaries and liability are crucial considerations in the use of mHealth 
medication reminders described by all groups; for example, participant 10 in FG 2 
expressed his concerns about legal limitations of using mobile phone interventions 
and patients’ confidentiality that may increase the risk of unethical use and illegal 
practices: 
“I am thinking about legal limitations...sending medication reminders to 
patients’ mobile phones...have you thought about patients’ confidentiality?... some 
patients are not comfortable to talk with their family or friends about their heart 
disease...somebody may come and pick their mobile phone who does not know about 
their condition and he may see the text message accidentally... so this may be 
problematic for the patients and their families .... even for us as a healthcare staff 




There was some evidence that there is limited guidance in the National Code of 
Ethics for Nurses specifically about their responsibilities on medication 
administration as well as electronic health implementation in practice. This 
highlights the role of the national code of practice and legal framework to support 
nurses and address their ethical concerns. The statements from the participants in this 
study may suggest that ambiguous legal framework, confidentiality, data protection 
and security issues are evidence of unpreparedness to implement mHealth 
interventions in the Iranian settings that need prior considerations beforehand. The 
example below demonstrates the nurses’ concerns about the issues related to the 
patients’ data protection (i.e. patients’ mobile phone numbers may be sold to 
different businesses if they are not protected against third-party telemarkertes): 
“How will you send the reminders?... If you consider a company to send text 
messages, it will become an exposure. Most of them sell mobile phone numbers to a 
third party for advertising reasons”. (Participant 5,  FG 1) 
Moreover, the nurses appear to have developed their ideas wider than just 
discussing some potential issues to the use of mHealth to improve medication 
adherence; they showed an insight and real understanding of the bigger picture of 
mHealth implementation in health care. Percieving application of mHealth as a 
potential nursing duty, demonstrates an awareness about the role of the regulatory 
and legal framework that can support nurses in effective use of the technology in 
practice: 
“I believe one of the barriers to mobile health is the lack of a legal description 
and a documented framework. It has the potential to be included as a nursing duty 
and its implementation needs legal support.” (Participant 13, FG 2) 
It seems that having a legal framework with clear rules about the use of 
mHealth interventions may lead to a desire in nurses to apply it since they 
comprehend the potential positive impacts. 
Healthcare system-related barriers 
The preparedness to use mHealth interventions may be influenced by factors 
related to healthcare systems that were identified from the nurses’ discussions such 
as absence of a comprehensive interconnected system and electronic health 




system-related barriers, there was some evidence that showed the absence of a shared 
electronic health system as well as a system to order, dispense, or track medications 
were identified as important infrastructural problems related to implementation of 
mHealth medication adherence intervention. Participant 2 noted in FG 1: 
“ Excuse me, but you need to consider that unfortunately there is no shared 
patient information system accessible for all healthcare organisations. This may 
cause difficulties in monitor patients’ status, their medications, etc. Medications may 
be changed, dosage may be titrated particularly during the early phase of patients’ 
discharge. However, you won’t be aware of these changes and this may cause 
disaster...” 
Similarly, Participant 15 in FG 2 stated: 
“ Our healthcare system is fragmented ... you are not able to track our patients 
and update their medication changes over time. This issue may increase medical 
errors and unnecessary costly visits to health centres”. 
This limitation had an important impact in modification and remodelling of the 
study intervention regarding content and timing of medication reminders. Overall, 
there was a general consensus that it would be best if the messages did not contain 
the instruction and dosage of prescribed drugs and were not sent right before each 
medication. A detailed final refinement of the mHealth medication reminder 
intervention can be found in Table 6.5 in Section 6.1.3. 
Moreover, it was not just about poor electronic health infrastructure they 
identified as healthcare system-related barriers in Iran. In this case, they argued that 
another complication may arise when both healthcare providers and patients, 
especially elderly patients, prefer traditional modes of post-discharge follow-up such 
as traditional face-to-face visits. They appear to show an understanding that a 
resistance to the use of information and communications technology in health from 
healthcare professionals may limit the ability to develop appropriate interventions for 
mobile health. According to Partcipant 22 in FG 3: 
“The challenge is that most of the cardiac patients are in their 70s or 80s. They 
still prefer in-person physician visits and the direct contact with health professionals 
compared to remote contacts... Our doctors, nurses and other healthcare providers 
are not interested in using mobile health system to contact with their patients... 





Participant 15 in FG 3 stated: 
“It may be difiicult to convince clinicions to follow-up with their patients using 
mHealth interventions as they always encourage patients to come into the hospital’s 
outpatient clinic; that is because they belive that this is where the quality care can be 
offered and they are less flexible to accept infrastructural changes in health care”. 
The evidence from the participants in this study may suggest that to make the 
mHealth intervention appropriate to the Iranian setting, potential challenges need to 
be addressed prior to the intervention implementation. In addition to the 
aforementioned challenges, the nurse participants more specifically identified issues 
related to the mobile phone-based medication reminder intervention that seemed to 
play a big role in refinement and implementation of the intervention. This leads on to 
the next theme evident in the analysis. 
Considerations before Implementation  
Poor telecommunications coverage in some parts of the country and patients’ limited 
access to mobile phone devices were reported as some of the specific considerations 
for using mobile health interventions. Participant 5 in FG 1 said: 
“You need to think about some issues before implementation of the text-
message reminder intervention; Can you estimate, for example, if there are ten 
patients in a Cardiac Care Unit, how many of them own a mobile phone? I think only 
one or two !!...Moreover, there is no mobile signal in some remote areas”. 
The sustainability of the programme was noted by some nurses in FGs as 
another consideration in the intervention development. Their concern was that 
patients may get used to or feel bored by reminders over time indicating that text 
messages may be ignored. However, the nurses were not so explicitly seen to be 
concerned about the development of dependency on receiving text message 
reminders among patients. It was not clear for them if the programme can be used 
long term.The following is a selected quote of a participant:  
“I am not sure that how long patients need to receive those reminders?...they 
may get used to the messages...they may become tired of always repeating 
reminders”. (Particpant 14, FG 3) 
Participants in all FGs put forward a range of recommendations for the best 




appropriateness, piloting or small-scale implementation of the intervention and 
tailoring the intervention to fit the purpose. 
Intervention Acceptability 
There was a united consensus that assessing the appropriateness of the 
intervention for the Iranian context is needed prior to the initial evaluation of the 
intervention. Participants indicated that it would be better to conduct a preliminary 
study on cardiac patients. They stated that an initial assessment may help explore the 
pattern of ownership, use of mobile phones and acceptability of using mobile phones 
as an adherence aid, and explore patients’ perceptions and preferences about a 
potential mobile phone-based intervention to improve medication adherence. 
According to Participant 12 in FG 2: 
“I think it is better to ask our patients first…ask them in a survey, for example, 
…would you like to receive text-message reminders?...Is it useful for you? or what do 
you prefer to get from this intervention?...” 
Participant 6 in FG 1 said: 
“It is not clear that this kind of interventions using mobile phones really work 
here in this setting…can patients really use it?…are they interested?... we need to 
know whether all patients have their own mobile phone…have they ever used the text 
message on their mobile phones?” 
Some participants also elaborated a concern that patients may share their 
phones with family. They suggested sharing of mobile phones may present a 
drawback in its use in health care: 
“ I quite often see some patients share their mobile phone with their elder 
son… Sending reminders is just for the patient… I think it may be bothering for the 
person who is using the phone at the same time…”(Participant 14, FG 3) 
Taking everything into account, there was a general agreement that an initial 
patients’ survey would be helpful to best design of the intervention prior to its 
implementation. To identify technical issues related to the intervention, it was 
suggested to make a weekly or biweekly phone calls and ask patients whether they 






Pilot/ Small Scale Implementation  
Most of the participants explained that there is a lack of pilot projects or small 
implementations of mHealth-based interventions in healthcare centres in Iran. They 
stated that a feasibility study is an important step that is helpful in understanding 
potential programmatic problems and the initial effect of the applied intervention 
before any large-scale evaluation. Following quotes indicated participants’ 
suggestions regarding pilot implementation of the intervention: 
“Since there is not enough evidence that shows what can mHealth do for 
patients …you need to test this intervention in a small number of patients or a pilot 
group…Then you will find what’s the effect, problems,  and the patients’ 
reactions…how it works for different patients…”(Participant 1, FG1). 
“You can’t just bring a new intervention and say ok! let’s see what’s the 
effect…Full trials are usually very expensive…it is better at first to examine the 
feasibility of the programme in this particular setting…to see if any adjustments or 
adaptations to the programme are needed. Some unpredicted problems may happen 
during implementation such as issues with the setting, logistics and even evaluation 
of the outcomes; patients or even staff training may be necessary” (Participant 7, 
FG2) . 
The participants described that the pilot implementation of the programme 
provides initial information about positive effects the intervention may have on 
cardiac patients that can be shared with stakeholders, funders and policymakers. 
They also appear to have a positive insight into piloting the intervention among 
Iranian patients since they perceived it as a good opportunity to begin building an 
awareness and strengthening key partnerships, which will be important and helpful 
for a successful further implementation. According to Participant 16 in FG 3: 
“Early findings from your pilot study may indicate whether the patients enjoy 
the mHealth medication reminders? Or is there any improvement in the medication 
adherence of the participants as an outcome of interest? Then you can disseminate 
or share this information about your programme that is for example well-received 
with your patients…there will be lessons to learn for your larger study, as well”. 
Above-mentioned quotes also indicated that a pilot test can highlight any 
adjustments to the evaluation plan that might be necessary to ensure the desired 
outcomes are evaluated in the best way possible. This may suggest that the 
participants appreciate the importance of piloting the mHealth intervention.They 




proposed intervention on a small sample of the target population in the Iranian 
setting before full implementation and troubleshoot any logistical issues that might 
arise with the collection of the data. 
Intervention refinement 
In addition to the above-mentioned suggestions regarding the assessment of the 
intervention acceptability and its small-scale testing prior to the full implementation, 
the participants also provided useful recommendations about the intervention 
refinement. They believed that it is better to refine the inetervention to make it 
appropriate for patients who have been prescribed new medications in order to assist 
them in developing a routine. Participant 10 in FG 2 described why patients who 
have newly started cardiac medications may benefit more from the automated 
reminders: 
“In my opinion, sending reminders for newly prescribed medications would be 
useful; you see, for example, some patients are taking their blood pressure 
medications for more than ten years. It becomes a habit to take those pills.. but if a 
new medication starts for them, they take them like one week but after that, they are 
more likely to forget them”. 
A few number of participants also suggested using other mediums such as 
voice message, phone calls and emails with mobile phone reminders: 
“Most patients may ignore text messages or turn off their phones when they’re 
driving or working so I think it would be better if you call them or send an email in 
addition to sending text reminders.” (Participant 4, FG 1) 
 
In response to this suggestion, it was agreed to brief patients in the first visit 
about the importance of medication reminders and keeping their phones on during 
the course of the study. Participant 5 in the same FG said: 
“There is not enough staff to phone all patients…it will be really time-
consuming…I prefer mobile reminders that are automated. You need to brief your 
patients at the start point and stress on the importance of  reminders so that patients 
know that they should not ignore text messages.” 
With regards to the frequency of the messages, some participants felt that it is 
not necessary to send these messages right before or at the time patients are likely to 




repeated messages over time. Moreover, sending reminders before each medication 
may cause dependency to the programme: 
“You don’t want your patients to be dependent on these reminders, right? So, 
you don’t need to send them before each medication. They may get bored over time 
and even I can say they do not open the messages anymore”. (Participant 10, FG 2)   
The evidence from the participants in this study show that although the nurses 
perceived the mHealth intervention positively, they were aware of potential obtacles 
to its implementation in the Iranian settings that need to be tackled in different ways. 
Considering the recommendations of the nurse participants regarding the refinement 
of the medication reminder intervention to make it appropriate to the local context, 
modifications were applied to the intervention prior to the exploratory trial phase 
(see Table 6.5). 
6.1.3 Summary of the Phase 1 Results 
The results of the CHD patients’ perception survey presents the acceptability of 
using mHealth text message reminder interventions to improve medication adherence 
for this group of patients in an Iranian setting. Mobile phone ownership and the use 
of text messages were relatively high among the respondents of the survey indicating 
that using an automated daily medication reminder in this format, might be the most 
acceptable intervention in this context. 
In addition to the patients’ perception survey, the intervention was informed by 
qualitative focus groups findings that explored Iranian cardiac nurses’ perception 
about the potential effect, barriers and facilitators to implementation of the mHealth 
intervention in the Iranian settings. The emerging data from the focus groups 
identified three key themes of relevance as identified by the nurse participants 
including “positive impacts”, “unpreparedness for mHealth implementation” and 
“considerations before implementation”. The nurses perceived the intervention as 
being beneficial to CHD patients and their medication taking. The major benefits 
outlined in discussions were that the intervention would provide patients with 
reminders, connect hospital to home and prevent negative outcomes. Subthemes 
related to the unpreparedness to implement mHealth interventions included lack of 
IT knowledge among patients and healthcare providers, legal ambiguity and 




recommendations about the refinement of the mHealth reminder intervention. The 
majority of participants suggested surveying patients and conducting a pilot study to 
have a better understanding of feasibility and acceptability of the intervention. They 
also provided suggestions about following-up with patients using other mediums 
along with text messages as well as pragmatic considerations in developing text 
message reminders (e.g. less frequent text messages to prevent patients’ dependency 
and fatigue over time). Table 6.5 presents the number of refinements that were 
identified from the results of the first phase to make the intervention appropriate to 
the Iranian context. 
Table 6.5. Description of the modified SMS intervention used in the present study based on the 
Modelling Phase recommendations 
Modelling Phase 
Recommendations 
Description of the modified 
SMS intervention used in the 
present study 
Comparison with the original 
intervention in the previous 
study ( Master’s research) 
1. Patients’ Perceptions (Survey 
Findings): 
 No patients’ perception survey 
was conducted in the previous 
study. 
1.1 Preferred method of 
delivery: mobile phone text 
message 
Method of delivery: mobile 
phone text message 
Method of delivery: mobile 
phone text message 
1.2 Preferred frequencies to 
receive text message reminders: 
“as often as the medications 
need to be taken” (50.4 %) and 
“once a day” (28.5%) 
Frequency: once a day  
Note: see item 2.1 that clarifies 
the reason for choosing this 
option instead of the majority of 
the patients’preference) 
Frequency: before every cardio-
protective medication 
1.3 Preferred timing to receive 
text message reminders: just 
before the medication time 
(44.7%) and every morning (6 
am – 10 am) (16.3%) 
Timing: every morning (8am) 
Note: see item 2.1 that clarifies 
the reason for choosing this 
option instead of the majority of 
the patients’preference) 
Timing: according to the timing 
of medications 
1.4 Preferred reminder contents: 
short and simple with general 
(not personalised) content  
Content: short and simple with 
general (not personalised): 
“Please, don’t forget to take 
your medications”. 
Content: personalised to the 
patients’ names and 
medications 
1.5 Preferred 1-way reminders 
(not interested in sending a 
reply message to each 
reminder) 
 
It was not mandatory for 
participants to send reply 
message to each reminder. 
It was not mandatory for 
participants to send reply 







Description of the modified 
SMS intervention used in the 
present study 
Comparison with the original 
intervention in the previous 
study ( Master’s research) 
2. Nurses’ Perceptions (Focus 
Groups Findings): 
 No Focus groups was 
conducted in the previous study. 
2.1 Due to the lack of shared 
electronic health system in Iran, 
there was a general consensus 
that it would be best if the 
messages did not contain the 
instruction and dosage of 
prescribed drugs and were not 
sent right before each 
medication. 
See items1.2 and 1.4 The messages contained the 
instruction and dosage of 
prescribed drugs and sent right 
before each medication. 
2.2 Ethical considerations (e.g. 
to protect patients’mobile phone 
numbers against third-party 
telemarkertes) 
Steps undertaken to address 
ethical concerns are presented 
in Section 5.4; it was agreed 
with the TM service provider 
that patients’ phone numbers 
would not be sold/ passed on to 
a third party without explicit 
consent (Appendix 16). 
Similar to the present study. 
2.3 To conduct a preliminary 
survey study among cardiac 
patients to explore the pattern of 
ownership, use of mobile 
phones and acceptability of 
using mobile phones as an 
adherence aid 
A self-completion survey 
conducted among male and 
female CHD patients, aged 18 
and over in one hospital 
affiliated to Tehran University 
of Medical Sciences (Section 
5.2.1). 
No patients’ perception survey 
was conducted in the previous 
study. 
2.4 To conduct a feasibility 
pilot study to identify the 
intervention programmatic 
problems and its initial effect 
before any large-scale 
evaluation 
 
A 12-week pilot RCT, two-arm, 
pretest-posttest, with an 
equivalent comparison group 
was conducted among male and 
female Iranian CR patients of 
one Cardiovascular, Medical 
and Research Centre affiliated 
to Tehran University of Medical 
Sciences as a part of 
exploratory phase of the study 
(Section 5.3). 
An 8-week pilot RCT, two-arm, 
pretest-posttest, with an 
equivalent comparison group 
was conducted among male and 
female Malaysian ACS patients 
of a tertiary hospital in Kuala 
Lumpur. 
2.5 To consider poor 
telecommunications coverage in 
remote areas and other technical 
issues that may prevent delivery 
of text messages 
 
 
The researcher followed up 
with the participants in the 
intervention group via 
telephone calls once per two 
weeks during the study to 
reassure the delivery of 
reminders. 







Description of the modified 
SMS intervention used in the 
present study 
Comparison with the original 
intervention in the previous 
study ( Master’s research) 




Newly diagnosed CHD patients 
participating in CR were 
recruited to receive/ not receive 
reminders for their cardio-
protective medications. 
Newly diagnosed CHD patients 
were recruited immediately 
after hospital discharge to 
receive/ not receive reminders 
for their cardio-protective 
medications. 
2.7 To use other mediums such 
as voice message, phone calls 
and emails with mobile phone 
reminders 
See item 2.5 Similar to the present study. 
2.8 To consider patients may 
feel bored, turn off the device or 
ignore repeated messages over 
time 
 
All participants were fully 
informed about this research, 
such as its purpose and process 
both verbally and written by 
providing participants’ 
information sheets. During the 
first visit and over the biweekly 
phone calls, the importance of 
medication reminders and 
keeping the mobile phones on 
to receive text messages were 
emphasised. 
Similar to the present study. 
2.9 To send less frequent text 
message reminders (e.g. once a 
day) 
See item 1.2 More frequent reminders were 
sent (i.e.before every cardio-
protective medication) 
compared to the present study. 
6.2 Exploratory Trial (Phase 2) Results 
After remodelling the proposed mHealth intervention based on the survey and 
qualitative FGDs findings, the modified SMS intervention was piloted to investigate 
its effect on cardioprotective medication adherence during the second phase of the 
study through a RCT. The RCT sought to explore: 
 The effect of a 12-week mHealth intervention on medication adherence of 
Iranian male and female CHD patients participating in CR (Objective 5); 
 The effect of a 12-week mHealth intervention on the secondary outcomes: 
Medication Adherence Self-Efficacy (MASE); Cardiac Ejection Fraction 
(EF); Cardiac Functional Capacity (FC); CHD-related Readmission/Mortality 
Rate and Health-related Quality of Life (HR-QOL) of Iranian male and 




 The association between socio-demographic factors of the subjects and 
medication adherence in both intervention and control groups (Objective 7); 
 The perception of participants in the intervention group towards the received 
mHealth intervention at the end of the study (Objective 8). 
 The recruitment and retention rate and inform the sample sizes required for a 
further larger trial (Objective 9). 
6.2.1 Participants Flow and Follow-up 
During the recruitment period (February 2016), a total of 98 CR patients were 
newly admitted to the outpatient CR clinic. Among them, 3 patients refused to 
participate in the study, and 17 of them were excluded. Reasons for exclusion 
included being severely ill (n=2) and having travel commitments (n=15). Hence, 78 
(76.4%) eligible patients consented to participate in the study and were randomly 
assigned to control (n=39) and intervention groups (n=39). There were 3 dropouts 
after 12-week follow-up, 1 in the control and 2 in the intervention groups due to the 
patients’ hospitalisation for a surgery. In total, 75 (~96%) patients completed their 
participation; they were followed up and data were analysed for these patients in this 
study. Figure 6.1 presents the flow diagram of the study based on the Consolidated 








Figure 6.1. CONSORT Flow diagram of the study 
Assessed for eligibility 
(n=98) 
Excluded (n= 20) 
Reasons: 
Traveled out of the study area 
(n=15)  
Severely ill (n=2) 
Declined to participate (n=3) 
Analysed 
(n=37) 
Data were analysed based on the 




Lost to follow-up  
(n=2) 
 
Reason: Hospitalised for surgery 
Allocated to mHealth Medication 
Reminders plus usual care 
(n=39) 
 
Lost to follow-up  
(n= 1) 
 
Reason: Hospitalised for surgery 
 





Data were analysed based on the 












A total of 3510 SMS reminders were sent to all 39 patients in the intervention 
group (90 SMS reminders/ patient over the 12-week intervention period). From the 
total number, 2943 (83.84%) successful delivery reports were received. The delivery 
status of 543 (15.47%) messages was not recorded in the system. Although 
participants were not required to do so, some texted in during the first month of the 
study, notifying that they had taken their medications for the prior days (e.g. “took 
medication today, thank you”) (Mean 2.28 text messages, SD+3.02, Range: 0–10, 
over the first 4 weeks of the study period). The last follow-up visit occurred on June 
6, 2016. Of 78 patients, 75 (96.15%) were visited approximately 12 weeks after the 
study start-point while the other 3 patients had been hospitalised for a surgery in a 
hospital other than the study setting. 
6.2.2 Characteristics of Participants 
Characteristics of all 78 participants are shown in Table 6.6. All variables were 
similar between study groups with no statistically significant differences. 













Age, mean (+SD), years 
 
61.87 (+1.02) 60.44 (+1.57) 63.31 (+1.29) 0.16 
Sex  
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2-5 years ago 






























Hospital Stay, mean (+SD), days 
 
13.29 (+0.74) 12.38 (+6.78) 14.21 (+6.37) 0.18 












































Ejection Fraction, mean (+SD) 
 
48.05 (+0.97) 48.55 (+6.35) 47.56 (+10.31) 0.67 
MA Self Efficacy, mean (+SD) 
 
2.53 (+0.34) 2.45 (+0.34) 2.6 (+0.33) 0.05 
PCS
c 
, mean (+SD) 
 
42.15 (+0.82) 43.43 (+1.07) 40.87 (+1.21) 0.12 
MCS
d 
, mean (+SD) 
 
47.41 (+1.3) 46.72 (+1.76) 48.1 (+1.9) 0.6 
SD: Standard Deviation; ACS: Acute Coronary Syndrome; MA: Medication Adherence; PCS: 
Physical Component Summary; MCS: Mental Component Summary  
a. Data are presented as frequency (percentage) unless otherwise specified. 
b. Usual care group vs. intervention group. 
6.2.3 Medication Adherence (Objective 5) 
A self-report of medication adherence (MMAS-8-item) was used to measure 
medication adherence level at baseline and follow-up. The objective was to test if 




and intervention groups. It was found that 56.8% of participants in the intervention 
group who received SMS-reminders to take their medications had a high level of 
adherence compared to 5.3% of those in the usual care group. The majority of the 
patients in the control group had a medium adherence level to their cardiac 
medications (Table 6.7). The data are presented graphically in Figure 6.2. 
There was a highly significant difference in medication adherence levels 
between the control and intervention groups, χ
2
 (2) = 23.447; P<0.001. The Relative 
Risk was indicated that it is 2.19 times more likely for the control group to be less 
adherent to their medications than the intervention group (Relative Risk = 2.19; 95% 
CI 1.5 - 3.19). 
There was also a significant positive change in the patients’ medication 
adherence in the intervention group prior to and following the study (Z=-2.84; 
P<0.001) while the control group did not show a significant improvement over time 
of the study (Z =-0.08; P=0.93). 
Table 6.7. Medication adherence at baseline and post-test data collection 
Study Groups Study Time 
Medication Adherence (%) 
Low Medium High 
Intervention (n=37) Baseline 27 73 0 
Post-test 8.1 35.1 56.8 
Control (n=38) Baseline 13.2 86.8 0 
Post-test 21.1 73.7 5.3 
 
 




6.2.4 Medication Adherence Self-Efficacy (Objective 6) 
Another study objective was to test if there was a significant difference in 
patients’ Medication Adherence Self-Efficacy (MASE) between the control and 
intervention groups. The mean, Standard Deviation (SD), and median values for each 
of the groups studied in the experiment at recruitment and post-test data collection 
are presented in Table 6.8. A graph of the mean differences is also presented in 
Figure 6.3. 
Table 6.8. Medication Adherence Self-Efficacy at baseline and post-test data collection 
Study Group Study Time Mean Std. Deviation Median 
Intervention (n=37) Baseline 2.45 0.34 2.57 
Post-test 2.68 0.31 2.76 
Control (n=38) Baseline 2.6 0.33 2.63 
Post-test 2.29 0.65 2.46 
 
 
Figure 6.3. Mean MASE scores before and after the study within each study group 
In the analysis of the differences in changes of MASE, a Mann-Whitney U test 
indicated that MASE scores were statistically significantly greater for the 
intervention group that was receiving medication reminders than for those in the 
usual care group who were not receiving medication reminders (U=505; P=0.035). 
In line with these significant difference between the study groups, the MASE 




following the study, (Z=-3.18; P<0.001). Conversely, patients in the control group 
experienced significant fall in their self-efficacy in taking cardiac medications over 
time of the study, (Z =-1.98; P=0.04). 
6.2.5 Cardiac Ejection Fraction (Objective 6) 
In the study of the differences in patients’ cardiac Ejection Fraction (EF), the 
mean, SD, and median values for each of the groups studied in the experiment at 
recruitment and post-test data collection are presented in Table 6.9.  
Table 6.9. Ejection Fraction at baseline and post-test data collection 
Study Group Study Time Mean Std. Deviation Median 
Intervention (n=37) Baseline 47.43 6.62 50 
Post-test 49.35 6.27 50 
Control (n=38) Baseline 47.11 9.77 50 
Post-test 46.34 10.52 50 
 
A Mann-Whitney U test was applied to investigate the differences in EF 
between the intervention and control groups that indicated no significant differences 
(U=639.5, P=0.48). Therefore, there is insufficient evidence of a difference in 
Cardiac EF of participants in the intervention group receiving medication reminders 
compared to the usual care group who were not receiving medication reminders.  
There was a significant increase in EF of patients in the intervention group who 
received medication reminders between the pre-test and post-test data collection (Z= 
-3.31; P<0.001).  Patients in the usual care group who were not receiving medication 
reminders demonstrated a reduction in EF prior and following the study that was not 
statistically significant (Z =-1.22; P=0.22). 
6.2.6 Cardiac Functional Capacity (Objective 6) 
One of the objectives of this study was to test if there is a significant difference 
in patients’ cardiac Functional Capacity (FC) between the control and intervention 
groups. As can be seen from Figure 6.4, around 97% of participants in the 
intervention group had no symptoms and no limitations in ordinary physical activity 





Figure 6.4. Cardiac FC changes before and after the study within each study group 
The Chi-square test determined that there is a highly significant difference in 
cardiac FC between the control and intervention groups, χ
2
 (1) =9.722, P=0.002. In 
order to determine any significant changes in FC classification in each group over the 
study period, the McNemar test was performed. It did not elicit statistically 
significant changes in FC among intervention group (P=0.25). Indeed, more than half 
of the patients who received reminders were categorised in high and good FC 
classifications both pre- and post-intervention. However, there were significant 
negative changes in FC among the control group (P=0.006). Around one-third of the 
patients in the control group who were assigned in good FC class at recruitment 
categorised in fair and poor classes at the endpoint of the study. 
6.2.7 Hospital readmission and death rates (Objective 6) 
CHD-related readmissions were defined as any readmission due to a chest pain 
or recurrent cardiac events based on the patients’ hospital records as well as 
participants’ confirmation. Although there are more readmissions in the control 
group (n=3) compared to the intervention group (n=1), the p-value of the difference 
in the number of readmissions between the study groups for the Fisher’s Exact was 
0.61, which is not statistically significant. It indicates that there is no significant 
difference in the number of readmissions between the study groups. No death 




6.2.8 Health-related Quality of Life (Objective 6) 
In order to evaluate the Health-related Quality of Life (HR-QOL), two 
questionnaires, one pre-test, one post-test, were completed by all participants. Two 
scores including Physical and Mental Component Summary, PCS and MCS, were 
calculated (Range: 0-100) according to the instructions provided in the 
questionnaire’s user manual; a high score corresponded to a better state of health. 
The mean, SD, and median values of PCS and MCS for each of the groups studied in 
the experiment at recruitment and post-test data collection are presented in Table 
6.10 and 6.11, respectively. Linear graphs of these values are presented in Figure 6.5 
and 6.6. 
Table 6.10. Physical Component Summary at baseline and post-test data collection 
Study Group Study Time Mean Std. Deviation Median 
Intervention (n=37) Baseline 43.19 6.75 42.45 
Post-test 47.46 6.97 48.08 
Control (n=38) Baseline 41.13 7.52 41.45 
Post-test 44.41 8.81 42.62 
 
 







Table 6.11. Mental Component Summary at baseline and post-test data collection 
Study Group Study Time Mean Std. Deviation Median 
Intervention (n=37) Baseline 46.78 11.24 45.71 
Post-test 49.34 11.23 48.63 
Control (n=38) Baseline 47.51 11.42 46.5 
Post-test 47.99 8.27 48.66 
 
 
Figure 6.6. Mental Component Summary changes before and after the study within each study group 
The normality of the distribution of scores for PCS and MCS scores was 
confirmed with the Kolmogorov-Smirnov test. Then, the independent samples t-test 
was used to estimate the between-group difference in each subscale of HR-QOL. The 
PCS mean difference between groups was -3.04, 95% CI: -6.71- 0.61. Although the 
mean PCS of the intervention group (47.46, SD+6.97) was greater than the control 
group (44.41, SD+8.81), the two-tailed P-value of the test was 0.1. Thus, there was 
no statistically significant difference in the mean PCS between the two study groups. 
The MCS showed no significant effect of the intervention, as well (P=0.55).  
At recruitment time, participants in both groups reported an impaired physical 
functioning and an average mental wellbeing based on their PCS and MCS scores. At 
3 months, an improved HR-QOL was found in both study groups in comparison with 




questionnaire, with a difference of -3.28 points (95% CI -6.4 to -0.08) in the control 
group and -4.26 (95% CI -7.14 to -1.39) in the intervention group. There was no 
statistically significant improvement in the MCS scores within each study group over 
time. 
6.2.9 Participants’ Demographic Characteristics and Medication 
Adherence (Objective 7) 
One of the study objectives was to identify the association between 
participants’ demographic characteristics and medication adherence in both 
intervention and control group. The Multiple Logistic Regression was applied to test 
the hypothesis that a particular factor/variable predicts the outcome of medication 
adherence. The study of the association between participants’ characteristics and 
medication adherence indicated that socio-demographic data had no significant 
relationship with medication adherence (see Table 6.12). 
Table 6.12. Participants’ characteristics and medication adherence level 
Variable Chi-square value P value Exp (B) 95% CI for Exp (B) 
Lower Bound Upper Bound 
Age 0.093* 0.58 0.42 0.055 3.182 
Sex  0.923 0.337 1.749 0.555 5.510 
Education <0.001 0.989 0.993 0.354 2.783 
Marital status 0.656* 0.306 1.479 1.259 1.738 
Employment 0.307 0.579 1.425 0.406 5.006 
Living arrangement <0.001* 1 0.689 0.591 0.803 
Monthly Income 0.029 0.865 0.903 0.276 2.948 
Family Size <0.001* 1 0.895 0.161 4.993 
Diagnosis  0.913 0.339 1.979 0.479 8.176 
Diagnosis Time 1.137 0.286 1.731 0.628 4.767 
Co-morbid 0.206 0.65 0.753 0.222 2.562 
Hospital Stay 2.81 0.094 0.423 0.153 1.17 
Daily Medications 0.948 0.33 1.676 0.59 4.765 




6.2.10 Patients’ Perceptions about the Intervention (Objective 8) 
The majority of participants who received the intervention (28/39 or 71.8%) 
said the SMS reminders for taking medications were useful. Just over one-fifth of 
participants felt that it had helped them as a reminder to take their medications. They 
also reported SMS messages was not just a reminder; the intervention helped them in 
a variety of aspects including feeling support, maintaining interaction with healthcare 
system, promoting independence and self-efficacy in taking medications.  
Over 60% of participants strongly agreed / agreed SMS medication reminders 
should be continued in the future. Participants in the intervention group (~60%) also 
strongly agreed/ agreed to suggest SMS medication reminders to other patients. 
Almost 75% of patients perceived the intervention did not cause any intrusion into 
their life.  
Patients were asked for their recommendations to improve the intervention. 
Almost half of them reported their satisfaction with the same intervention 
component. Table 6.13 presents the details of the patients’ perceptions about the 
applied mHealth intervention. 














In which aspect this service help 
As reminder (prevent forgetfulness) 
Feeling support 
Keeping interaction with healthcare system 
Maintaining independence/ self-efficacy in taking medications 







































































What are your recommendations to improve this service in future? 
As perfect as it is (no changes needed) 
To be tailored to patients’ needs/ just for one specific medication 
To offer free of charge 
To be sent before every medication  
To be sent more than once a day 











6.2.11 Findings to Inform Future Definitive Large-scale RCT 
(Objective 9) 
One of the objectives of this pilot study was to determine recruitment, retention 
rate and the effect size obtained by this pilot to inform the sample size calculation for 
a future definitive RCT.  
Estimating Recruitment and Retention 
The initial strategy to identify participants was to approach CHD patients who 
were admitted for the first time to the outpatient CR clinic in a university-affiliated 
hospital in Teharn. To this end the researcher spoke with the CR clinic manager, the 
head nurse and the clinic administrator in several meetings. This proved a very 




and enabled the researcher to collect information on approaches to optimise 
recruitment and retention. A separate room in the CR clinic was allocated as 
recruitment area for baseline and follow-up visits, and patients were visited at the 
same day of their outpatient cardiology clinic appointment in the same building to 
prevent additional travelling between home and hospitals. It was estimated that the 
baseline and follow-up face-to-face visits to assess primary and secondary outcomes 
took no more than 10 minutes. This approach seemed to work well and indicated 
feasibility of recruitment. No financial incentives were offered to the patients. The 
attrition rate was 3.8% with the reason for loss to follow-up readmission for surgery.  
Determining Sample Size 
The intervention showed significant effect on improving cardiovascular 
medication adherence (i.e. the study primary outcome) among CHD patients in the 
CR setting in Iran. A relatively large effect (Relative Risk = 2.19; 95% CI 1.5 - 3.19) 
was found on medication adherence. The results of the pilot informed the sample size 
needed for a future definitive RCT. A sample size of 130 patients per group (260 in 
total) is required to have 90% power to detect a realistic difference of 20% or greater 
for the between-group percentage of patients with high adherence to their medication 
in a future study, assuming a (two-sided) 5% significance level. 
 




CHAPTER 7: DISCUSSION AND CONCLUSION 
The results that were presented in Chapter 6 will be discussed and interpreted 
in relation to the objectives of the study and existing literature. This Chapter will 
provide a comparison of the study findings with previous similar research studies, the 
strength and limitations of the study and the implications of the findings at micro-
level (patients and providers), meso-level (healthcare organisation) and macro-level 
(health policy). At the end of this Chapter, the conclusion of this research study will 
be presented, as well. 
The overall aim and specific objectives of the study were developed and the 
method of investigation selected following a review of the literature related to the 
development and evaluation of the mHealth interventions to promote medication 
adherence and the theories relevant to behavioural change interventions. The study 
aimed to develop and evaluate a nurse-led mHealth intervention to promote 
medication adherence in Iranian CHD patients who presented in Cardiac 
Rehabilitation (CR) clinic. The study phases (i.e. the Preclinical, Modelling Phase 
and the Exploratory Trial Phase) were developed based on the Medical Research 
Council’s (MRC) Framework on the development and evaluation of complex 
interventions. In order to ensure that the intervention would be fit for purpose (i.e. to 
capture fidelity of the intervention) and inform a future definitive RCT, it was 
necessary to apply the MRC framework to develop and refine the intervention. The 
first step (the Preclinical and Modelling Phase) was establishing the theory and 
evidence for developing a nurse-led mHealth intervention to promote cardiovascular 
medication adherence. The World Health Organisation (WHO) Adherence Model 
and Self-efficacy Theory were applied as guides in the refinement of the study 
intervention (i.e. the automated SMS medication reminder). Based on the MRC 
framework, a feasibility and piloting phase is recommended after the development of 
a new intervention (Arain et al., 2010, Craig et al., 2011). Therefore, in order to 
understand the feasibility of the intended intervention and make it appropriate to the 
local context, a formative patients’ perception survey and cardiac nurses’ focus 
groups were conducted. In the Exploratory Trial Phase, the effect of the automated 




cardiovascular medication adherence in the particular setting of Iranian CR. The 
findings of this evaluation will also be discussed. 
7.1 Interpretation of Results and Relationship to Previous Studies 
The interpretation of results and comparison with previous studies will be 
presented according to each of the study objectives. The first findings to be discussed 
will be the ownership and utilisation of mobile phones in Iranian CHD patients 
followed by patients’ perceptions about mHealth intervention as well as cardiac 
nurses’ perception regarding the potential benefits and associated challenges of 
mHealth intervention in the Iranian context. Finally, the findings of the pilot RCT of 
the automated SMS medication reminder will be discussed.  
7.1.1 Patients’ Perceptions Survey Findings (Objective 1 and 2) 
The results of patients’ perception survey indicated that there is a high 
ownership of mobile phones among Iranian CHD patients (98.4%). In this patient 
group, a high use of the Short Message Service (SMS) function was found (68.3%). 
Interestingly, it was found that education was significantly associated with using 
SMS function and using mobile phones to connect to the internet, suggesting these 
functions may not commonly be used by patients with lower level of education 
attainment. This was consistent with a similar study that aimed to design a mobile 
phone intervention to improve Anti-Retroviral Therapy (ART) adherence in India 
(Shet et al., 2010). They reported education level as the only socio-demographic 
variable that had a significant association with using SMS, based on a self-completed 
survey of 322 Indians with Human Immunodeficiency Virus (HIV).  
Owning a Smartphone (41.5%), using mobile phones to connect to the Internet 
(33.3%) and using the phone alarm function as a medication reminder (5.7%) were 
less common among the study participants. According to these findings, using a 
Smartphone application or a web-based intervention to improve medication 
adherence would be difficult to implement in an Iranian setting given the relatively 
low rates of Smartphone ownership and utilising of applications and the Internet. 
However, in contrast, participants reported higher levels of utilising SMS function; 




According to the International Telecommunication Union (2015), there were 
74.22 million mobile phone subscribers (93.4 subscribers per 100 people) in Iran in 
the year 2015. Major operators in Iran including Mobile Telecommunication 
Company of Iran (MCI/Hamrahe Aval), Irancell, Taliya and RighTel serve more than 
51 million mobile Subscriber Identity Module (SIM) cards associating with mobile 
phone penetration rate of 94.46% (International Telecommunication Union, 2015). In 
terms of accessibility to telecommunication services in rural areas, Iran has been 
given the United Nations Educational, Scientific and Cultural Organisation 
(UNESCO) special award (Tasnim News Agency, 2014). Costs of acquisition and 
using mobile phones in Iran are amongst the cheapest in the world (price of a basic 
mobile phone is around £19). Iranian main operators communicated more than 40 
million text messages each day in early 2010 (Goodarzi et al., 2012). This arising 
telecommunication feature has the potential to implement new grounds of utilisations 
in health care for different reasons (Fjeldsoe et al., 2009, Cole-Lewis and Kershaw, 
2010); the price is low, its use is extensive, and it is the simplest function accessible 
in even a basic model of mobile phone (Cole-Lewis and Kershaw, 2010, Dale et al., 
2015). Therefore, a SMS-based medication reminder intervention may have the 
potential to be a feasible mHealth intervention in the particular context of Iranian 
CHD patients.  
The survey study results showed that Iranian CHD patients perceived the 
mHealth intervention helpful to remind their prescribed medications. This finding is 
consistent with previous studies exploring the perception of patients with different 
chronic conditions about medication reminders. For example, Quilici et al. (2013) 
found that Acute Coronary Syndrome (ACS) patients who received unidirectional 
daily SMS reminders for aspirin intake perceived the intervention useful and 
acceptable (see Section 3.6). Another survey study on SMS reminders for ART 
treatment showed that the reminders were perceived by 139 Indian adult HIV 
patients to be useful in remembering medications (Sidney et al., 2012).  
Issues related to intrusion of privacy were less reported to be a significant 
barrier to using mobile phones as an adherence support among Iranian cardiac 
patients whereas in contrast confidentiality issues were found to be very important in 




mobile phone reminders (Crankshaw et al., 2010, Curioso et al., 2009). This finding 
highlighted the significance of context and culture-related issues in the development 
of a feasible and acceptable mHealth intervention and the nature of the condition 
begin treated. 
The results also showed the importance of obtaining patients’ preferences 
(shared decision making) about the timing, frequency and content of text message 
intervention before they were implemented. This is consistent with the findings from 
systematic reviews that found mHealth interventions must be flexible and be 
culturally and socially appropriate to the indication and to the needs of the patient 
(Gandapur et al., 2016, Kaplan, 2006). The majority of respondents preferred to 
receive a one-way SMS reminder either before each medication time or once a day in 
the morning with general content that simply remind them to take their medications. 
This informed the decision to formulate patient-preferred SMS content and develop 
an automated system to send each SMS reminder to patients’ mobile phones every 
morning over the time of the study. Participants in this study also expressed their 
high interests in receiving the intervention for their cardiovascular medications.  
7.1.2 Nurses’ Perception about mHealth Interventions (Objective 3 
and 4) 
Although the intended mHealth intervention and its evaluations drew on 
existing theories (i.e. the WHO adherence model and the Bandura’s self-efficacy 
theory), the intervention’s refinement was driven by other factors, such as patients’ 
(intervention recipients’) preferences and relevant healthcare providers’ (intervention 
deliverers’) experiences. Hence, in addition to the patients’ perception survey, focus 
groups were conducted with participation of Iranian cardiac nurses to explore their 
perspectives towards mHealth and to obtain suggestions for the best implementation 
of the automated SMS medication reminder intervention. 
In this study, Iranian nurses perceived mHealth interventions as useful and can 
act as reminders to prevent patients’ forgetfulness (as an important factor related to 
medication adherence in the WHO Adherence Model). In fact, nurses believed that 
the use of this intervention would be necessary as it has the potential to improve 




post-discharge adverse outcomes and health care expenses related to medication 
nonadherence. The results are in line with the findings of previous studies, in which 
healthcare professionals have emphasised the necessity of applying eHealth (i.e. an 
overarching term that includes mHealth and teleHealth (Kay, 2011) in practice. For 
example, the study by Ayatollahi, et al. (2015) who explored Iranian clinicians’ 
knowledge and perceptions of eHealth showed that the majority of respondents 
agreed with the essentiality of using eHealth to promote and facilitate the patients’ 
accessibility to health care services. In another study, Sharifi, Ayat et al. (2013) 
conducted a literature review and qualitative interviews with 15 professional experts 
to identify eHealth implementation challenges in Iran. They found that the 
implementation of eHealth has the potential to improve patient access to health care, 
decrease total health expenses, and quality of care delivery. Another study by El-
Mahalli et al. (2012) exploring the perceptions of health professionals in Saudi 
Arabia about teleHealth showed that the major perceived benefit of teleHealth 
adoption related to patients’ follow-up after face-to-face contact. Therefore, the 
current findings are supported by the results of the previous studies that have 
emphasised the positive aspects of eHealth.  
To develop a successful mHealth intervention, understanding the nature of 
challenges and barriers is needed. Using this knowledge and following thoughtful 
consideration, it is possible to predict potential challenges and barriers, develop a 
context-appropriate approach to address challenges, make proper modifications and 
ultimately implement the new intervention (Chaplin, 2008). In spite of the discussed 
potential advantages of mHealth, the findings from the focus groups also shed light 
on associated challenges to the implementation of the mobile health interventions in 
the context of Iran. Patients’ and healthcare professionals’ limited knowledge, legal 
challenges, security and privacy concerns, lack of a shared and interconnected 
electronic health records within hospitals and other healthcare settings in Iran were 
frequently expressed by the nurses. Some of these barriers to mHealth 
implementation resonate with another similar study. Ayatollahi, et al. (2015) reported 
that Iranian health care providers’ knowledge of teleHealth was at a low or very low 
level which was an important obstacle for initiating a teleHealth programme. 




concerned about the teleHealth security compared to physicians and specialists. 
When the nurses in the focus groups for this study were discussing their legal and 
security uncertainties in utilising mHealth in practice, they highlighted the need for a 
national guidance specifically for mHealth implementation to support nurses and 
address their ethical concerns. The National Code of Ethics for Nurses in Iran that 
has been compiled under the Ministry of Health and Medical Education (MOHME) 
supervision, outlines the nurses’ ethical responsibilities in five parts in relation to 
people, nursing profession, practice,  co-workers, education and research (Zahedi et 
al., 2013); however, there is limited  guidance specifically about nurses’ 
responsibilities on medication administration  as well as eHealth implementation in 
practice. According to Sharifi Ayat et al. (2013), in Iran some pilot and small-scale 
eHealth projects have been initiated in the 2000s including gathering and recording 
health-related information of Iranian citizens which is still in the initial stages. They 
also extracted numerous factors related to the utilisation of eHealth from interview 
sessions with Iranian professionals including a lack of a comprehensive hospital 
information system, security and privacy issues for the protection of data, limited 
training and knowledge, legal concerns to protect both healthcare providers and 
patients (Sharifi et al., 2013). In another study conducted by Rezai-Rad et al. (2012), 
a framework was designed to assess eHealth implementation readiness in Iran; Based 
on the literature and opinions of 24 Iranian experts’, privacy concerns, clinicians’ 
and patients’ information literacy and technology skills were perceived to have the 
highest priority in the utilisation of eHealth. The same challenges were reported in a 
review of eHealth in the Eastern Mediterranean Region (including Iran) indicating 
multiplicity and diversity of constraints in eHealth implementation in the Region (Al-
Shorbaji, 2008). El-Mahalli et al. (2012), in their cross-sectional descriptive study 
showed that the major perceived barriers to the adoption of teleHealth from Arab 
health professionals’ point of view were the limited health workers’ knowledge and 
the lack of appropriate training about teleHealth.  
Considering the acknowledged mHealth limitations, the nurses were asked to 
put forward recommendations and suggestions for optimising the design and 
evaluation of the study intervention (i.e. the automated SMS-based medication 




information within Iranian hospitals and pharmacies and therefore it would be 
difficult to update SMS reminders in the case of prescription changes over the time 
of the study. To address this concern, the majority of the participants suggested to 
not include the instruction and dosage of medications in SMS reminders. This 
suggestion was also in line with similar findings from the patients’ perception survey 
indicating patients’ preference on receiving general SMS reminders to prevent any 
misunderstanding of medication regimen.  
In programmatic suggestions for making the intervention fit to the Iranian 
context, cardiac nurses advised investigating patients’ perceptions and preferences 
about the intervention prior to the pilot RCT. It was described to the nurses that at the 
same time, the patients’ perception survey has been conducting and the findings from 
both studies would be used to refine and make the study intervention appropriate to 
the context. Participants also suggested that SMS reminders would be most helpful if 
they were sent less frequently to prevent potential dependency on or tiredness of 
receiving messages with high frequency. This finding is consistent with similar 
previous studies, too. For example, Quilici et al. (2013) examined the effect of one-
month daily SMS reminders for aspirin intake (see Section 3.5.1); they reported 
significant improvement in medication adherence and high satisfaction among ACS 
patients who received the intervention. In another study, Pop-Eleches et al. (2011) 
examined the effect of high versus less frequent SMS reminders on adherence to 
ART among 431 patients in Kenya. After 48 weeks, they found that participants who 
received less frequent SMS reminders had significantly higher medication adherence 
compared to the control group (P=0.03). Habituation, or the reduction of a reaction to 
a frequent and repeated stimulus, need to be considered in sending medication 
reminders, particularly in long-term studies. High frequent messages might also be 
perceived intrusive. Considering the results from the patients’ survey and nurses’s 
focus groups, to prevent the potential fatigue or useless of receiving high frequent 
text messages, SMS reminders were sent once a day every morning (as patients 
preferred mornings and the majority of cardioprotective medications or the first dose 
of them are taken in the morning). 
In addition to the patients’ survey results, the intervention was informed by 




of the mHealth interventions, its associated challenges in the context of Iran and 
pragmatic suggestions to enhance the intervention design. This study revealed that 
Iranian cardiac nurses were open to the introduction of the mHealth intervention to 
improve cardiovascular medication adherence, but perceived different reasons why 
mHealth would be challenging to implement in the Iranian healthcare system. These 
involved issues of limited technology knowledge and training among patients and 
health care providers and lack of a shared electronic health records within Iranian 
health care system as well as privacy and legal issues. Nurses’ views can only 
contribute to obtaining part of the information required to refine the intervention. 
Nevertheless, it is unlikely that mHealth interventions will be implemented without 
the vigorous support of nurses.Therefore, exploring their views was an important 
step. In order to develop an effective and feasible mHealth intervention, a patients’ 
preferred design should be included (in this study, related information obtained from 
the patient perception survey), as it is more likely to obtain acceptability and success. 
The effectiveness of the automated SMS medication reminders required further 
piloting after making the necessary modifications (based on the findings of the study 
phase 1), that would inform a larger RCT.  
7.1.3 Main Findings of Pilot RCT (Objectives 5–9) 
Information obtained from the preclinical/ modelling phase was used to 
develop the context-appropriate mHealth intervention. The automated SMS 
medication reminder intervention was then piloted using an exploratory trial that is a 
critical phase of the MRC framework. It enabled the researcher to evaluate the 
components, acceptability and feasibility of the intervention in practice. It also 
provided the opportunity to determine sample size, the potential effect of the 
intervention (effect size), recruitment and attrition rate.  In the remainder of this 
chapter, the effect of the automated SMS reminders on medication adherence and a 
number of secondary outcomes of Iranian male and female CHD patients 
participating in CR over the 12 weeks of the study are presented. 
The Effect of the Intervention on Medication Adherence (Objective 5) 
Participants in the current study were not diverse (i.e. they were homogenous) 




automated SMS reminder intervention on adherence showed promising results 
among Iranian CR outpatients. A Complete Case Analysis indicated positive effect 
of the intervention on medication adherence in the experimental group who received 
SMS reminders compared to those who did not. The goals of medication therapy for 
chronic CHD are, primarily, to prevent recurrent MI and sudden cardiac death and, 
secondly, to alleviate symptoms and promote quality of life (Ambrosio et al., 2016, 
Iqbal et al., 2015, Manolis et al., 2016, Thadani, 2016). Guideline-Directed Medical 
Therapy (GDMT) that promote prognosis include antiplatelet, statins, and 
antihypertensive agents (Piepoli et al., 2016, Yancy et al., 2016). A recent systematic 
review of 10 completed trials suggested that mHealth  interventions can improve 
medication adherence in cardiovascular patients (Gandapur et al., 2016). Review 
studies recently showed the most successful intervention for medication adherence 
was text-message reminders (Santo et al., 2016, van Driel et al., 2016). These 
findings are consistent with the present study.  
Patients in this study had inadequate self-reported medication adherence before 
the intervention. After 12 weeks, the intervention group that received SMS 
medication reminders had an improved adherence compared to the control group. 
These results documented that the effectiveness of SMS reminder was not only 
between groups but also it was effective within groups. This may illustrate the 
importance of medication reminder on both promoting and maintenance of 
adherence. Considering the WHO adherence model, for each factor in the Morisky 
scale that predicts medication adherence, at the end point of the study, SMS 
reminders showed to be effective in preventing participants’ forgetfulness to take 
medication (patient-related dimension), reduce the frequency of nonadherence for 
reasons other than forgetfulness (condition-related dimension), and due to 
medications’ side effects (therapy-related dimension). The study findings are also 
supported by other researchers examining the effect of text-message reminders on 
medication adherence in a variety of medical conditions including asthma 
(Strandbygaard et al., 2010), cardiovascular (Akhu-Zaheya and Wa’ed, 2016, Dale et 
al., 2015, Fang and Li, 2016, Pandey, 2015, Park et al., 2014, Quilici et al., 2013, 




et al., 2015) and hypertensive patients (Bobrow et al., 2016). The details of 
mentioned studies can be found in Chapter 3. 
7.1.3.2 The Effect of the Intervention on Secondary Outcomes (Objective 6) 
One of the study objectives was to explore the effect of the automated SMS 
reminder intervention on the secondary outcomes including Medication Adherence 
Self-Efficacy (MASE); Cardiac Ejection Fraction (EF); Cardiac Functional Capacity 
(FC); CHD-related readmission/mortality rate and Health-related Quality of Life 
(HR-QOL) among Iranian male and female CHD patients participating in CR after 
12 weeks of the study. 
This study demonstrated substantial differences between the MASE of the 
patients who received the automated SMS reminders and those who did not. After 12 
weeks, patients in the intervention group had significantly higher self-efficacy to 
adhere to their medications compared to the usual care group as a result of the 
intervention. This finding can be understood within the theoretical context of 
Bandura’s Self-efficacy Theory that guided the study intervention. According to 
Bandura (1982), self-efficacy is one of the most important factors relating to health-
related behaviour change, such as medication adherence. Self-efficacy has been also 
considered as “cornerstone” of medication adherence (McCann et al., 2008). This 
concept was shown to be able to influence medication taking in patients with chronic 
conditions (Saffari et al., 2015). If patients have low self-efficacy in taking their 
medications, they are less likely to adhere to their medications (Park, 2011b). 
Therefore, changes in the patients’ MASE may indicate the intervention effect on 
medication taking and the self-efficacy of the patients to follow their medication 
regimen (Saffari et al., 2015). Patients in this study reported low self-efficacy in 
taking their medications at the baseline assessment. At the end point of the study, the 
intervention group that received SMS medication reminders showed a significant 
improvement in medication adherence self-efficacy than the control group. This 
finding is consistent with the results from a previous systematic review that showed 
SMS-based interventions have the potential to promote self-efficacy through 
providing patients with medication reminders, as a form of social support in patients 
with long-term diseases (De Jongh et al., 2012).  Another prospective RCT showed 




patients who received text-message reminders; however, in contrast to the present 
research findings, the difference in reported improvement was not significant 
between the study groups (Park et al., 2015). The reason for the nonsignifant results 
in the Park and her collegues’ study may be due to the short follow-up period that 
might not be adequate to identify self-efficacy changes, specifically in the sample 
suffering from a chronic condition such as CHD. According to a meta review of 
eleven systematic reviews looking at the effect of mobile phones and SMS on 
promoting self- management for long-term conditions, SMS significantly improves 
medication adherence (Jones et al., 2014). The present study findings show that the 
automated SMS reminder intervention would increase self-efficacy for adherence to 
cardiac medications. 
Adherence to cardio-protective medications and Beta Adrenergic Blockers 
have been shown to prevent mortality and arrhythmia, promote EF and symptoms of 
heart failure (Bristow, 2011). There are limited trials aimed at medication adherence 
that assessed CHD patients’ clinical outcomes. This study demonstrated differences 
in cardiac functional capacity and ejection fraction (as objective measures) based 
upon the most recent patients’ documents to capture the effect of the applied 
mHealth intervention on patients’ clinical outcomes and address the limitation of the 
self-reported assessment (i.e. subjective measures). The functional capacity of 
patients who received the automated SMS reminders significantly improved in 
comparison with the usual care group. Patients who received SMS reminders also 
showed a significant increase in their EF over 12 weeks of the study; however, this 
improvement was not significant between the two study groups (intervention vs. 
usual care). Increased EF could be the outcome of CR programme, revascularisation 
treatment or/ and adherence to cardio-protective medications. The study short-term 
follow-up might be insufficient to capture clinical impact of such intervention. It may 
reflect the complexity of EF changes, as well. Similar findings were reported in a 
cohort study undertaken by Sueta et al. (2015) aimed at assessing post-discharge 
medication adherence of 402 Heart Failure (HF) patients in the United States (US). 
The investigators found no significant association between medication adherence and 
EF <50% or ≤40% after 12 weeks indicating the complexity of medication adherence 




serve as an effective mHealth intervention for the improvement of cardiovascular 
medication adherence that may consequently improve CHD patients’ clinical 
outcomes such as functional capacity. 
There were more CHD-related readmission events among the usual care group 
in comparison with the intervention group; however, the difference was not 
statistically significant between the groups. This result might be related to the short 
period of study and small sample size. A previous review study focused on the effect 
of technology-based adherence interventions on improving hospital readmission and 
other cardiac outcomes showed mixed results (Bosworth et al., 2011). However, a 
similar finding to the present study was reported in a 12-months RCT looking at the 
effect of mobile phone text messaging on medication adherence of hypertensive 
patients in South Africa (Bobrow et al., 2016). The authors found no significant 
differences in hospital readmissions between the study groups. The result is also 
consistent with another similar study, undertaken by the same researcher to the 
present study in Malaysia, to improve medication adherence of acute coronary 
syndrome patients. No difference was found in the rehospitalisation rate between the 
intervention and control groups after 8 weeks of the study (Khonsari et al., 2015). In 
the study by Choudhry et al (2013) investigating the effect of enhanced 
cardiovascular prescription coverage on medication adherence and rate of vascular 
events, the overtime differences in clinical outcomes started to deviate after 12 
months. It indicates the importance of longer term follow-up to understand whether 
the improved adherence in the intervention group led to the improved clinical 
outcome.  
Adherence to chronic disease management is also crucial to obtaining 
enhanced health outcomes and quality of life (Viswanathan et al., 2012, Kamran et 
al., 2014). The majority of participants had an impaired or average physical 
functioning and mental wellbeing prior to the study. Although there were 
improvements in perceived HR-QOL components in both groups at the end point of 
the study, the difference was not significant between the intervention and control 
groups. Many valid and reliable instruments are available to measure QOL. Among 
them, the 12-item Short Form (SF-12v2) Health Survey, a short version of the SF-36, 




patients (De Smedt et al., 2013). There are limited trials to provide a clear view of 
the effect of mHealth interventions on CHD patients’ quality of life over time. 
According to the result of a 6-month RCT evaluated SMS–based intervention (TExT-
MED) on low-income diabetic patients in the US, the TExT-MED improved 
patients’ clinical outcomes and quality of life; but the improvement was not 
statistically significant that is in line with the present study findings (Arora et al., 
2014). It implicates no clear benefit on HR-QOL for the recipients of mHealth 
interventions. Among different components of CHD patients’ quality of life, 
dimension of physical functioning had the lowest mean scores. This result is in 
agreement with a previous systematic review of 18 articles evaluated the quality of 
life in Iranian cardiovascular patients (Yaghoubi et al., 2012). The authors reasoned 
that this finding may be possibly related to poor quality of provided social and 
economical support for cardiovascular patients and expensive welfare services in 
Iran. Impaired QOL among CHD patients might be related to pain, anxiety, 
limitations in functional and social activities (Dyer et al., 2010, Xie et al., 2008). 
Since quality of life is multi-dimensional (i.e. physical, mental and social), it might 
be impossible to investigate the effect of the intervention in a short-term study with a 
small sample size. Therefore, a longer-term follow-up with a larger sample size are 
needed for a future RCT. 
Participants’ Characteristics and Medication Adherence (Objective 7) 
Identifying factors associated with medication adherence would be useful for 
nurses and other health care professionals to promote their strategies (Lee et al., 
2013). Five dimensions have been determined by The WHO (2003) in the Adherence 
Model including patient-related factors (e.g. patients’ knowledge, expectations and 
self-efficacy) therapy-related factors (e.g. medical regimen complexity, treatment 
duration, side-effect), socioeconomic factors (e.g. poverty, high cost of medications, 
low levels of literacy, unemployment, family dysfunction), condition-related factors 
(e.g. severity of symptoms and disease, level of disability, co-morbidities) and health 
care team- and system-related factors (e.g. inadequate patient-provider relationship, 
lack of health insurance and poor community support). According to a systematic 
review of 11 studies investigating factors related to cardiovascular medication 




for this could be that different studies applied diverse measurs to assess adherence, 
which may have provided various results. Another reason could be the inclusion of 
patients with different characteristics in different studies (e.g. patients with different 
age ranges, diverse geographical regions, and different levels of disease severity). 
Some studies showed an association between age, sex, educational level as well as 
number of comorbid diseases and medication adherence (Doggrell, 2010, Fleg et al., 
2011, Krueger et al., 2015, Oosterom-Calo et al., 2013). The present study, however, 
found no significant relationship between the patients’ characteristics and 
medications adherence. A possible explanation might be the small sample size that 
caused some issues; for example, there were only a small number of elderly above 75 
years old. Additionally, the majority of the particpants were male (71.8%) and 
suffered from different comorbid conditions (82.1%). These might have an impact on 
identifing factors predicting medication adherence. 
7.1.3.4 Patients’ Perceptions of the Applied Intervention (Objective 8) 
In this study, the results showed the majority of the participants in the 
intervention group who received SMS reminders to take their cardiovascular 
medications percieved the mHealth intervention positively. According to the 
patients’ responses, reminders prevented forgetfulness in medication taking and 
contributed to maintain patients’ interaction with healthcare system after hospital 
discharge, feel support, promote their independence and self-efficacy in following 
prescribed medication regimen. The results are in line with the principles of the 
Bandura’s self-efficacy theory and the WHO adherence model; SMS reminders 
showed promise in promoting medication adherence mainly through addressing 
patient-related factors (i.e. forgetfulness and poor self-efficacy) and health care 
system-related factors (i.e. inadequate patient-provider interaction). The survey 
findings are also supported by studies used mobile phone SMS reminders for patients 
with various chronic diseases that perceived receiving medication reminders useful 
(Arora et al., 2014, Kamal et al., 2015, Park et al., 2014, Strandbygaard et al., 2010).  
7.1.3.5 Findings to Inform Future Definitive Large-scale RCT (Objective 9) 
This study showed that the MRC framework (2011) for the development and 
evaluation of RCTs is a helpful guideline that explains and provides support and 




guidance on how to develop, evaluate, and reshape a mHealth-delivered medication 
adherence intervention. Although there are few examples of the MRC framework 
application in developing mHealth-delivered interventions, the framework was 
successfully used in the previous studies to design technology-mediated interventions 
to improve medication adherence behaviour in chronic conditions (O'Carroll et al., 
2010, Linn et al., 2013). According to a systematic review of 14 studies identifying 
the most comprehensive model to develop nursing interventions, the MRC 
framework were the most widely used guideline (Corry et al., 2013). In another 
extensive review of 21 studies conducted by Banning (2009) to examine the simple 
to complex adherence interventions, the MRC framework appears to be useful in the 
refinement and evaluation of medication adherence interventions. Application of this 
framework in designing interventions to improve medication intake behaviour has 
been also recommended by the NHS National Coordinating Centre for Service 
Delivery and Organisation (NCCSDO) (Horne et al., 2005). By using the MRC 
framework to develop and refine the intervention, resources waste is eliminated and 
the benefit (i.e. the proportion of adherent patients) is maximised. In addition, for 
interventions that are shown to be ineffective, it helps review the circular process. 
Then, insufficiency in the refinement or evaluation phase can be identified, rather 
than leaving the intervention and the process altogether (Craig et al., 2011).  
Following the implementation of the patients’ perception survey and 
qualitative focus groups (i.e. Modeling Phase), the findings had led to the refinement 
of the developed mHealth intervention that was fit-for-purpose to be delivered to 
Iranian CHD patients presented in the CR clinic. For example, focus groups 
indicated that mHealth-delivered medication reminders would be helpful, but it 
should be simple, short, easy to understand and delivered less frequently. The 
Modeling Phase also contributed to identifying perceptions and key preferences of 
Iranian CHD patients regarding the potential mHealth intervention (e.g. the timing, 
frequency and content of SMS reminders) and allowed the researcher to make the 
intervention appropriate to the Iranian context. The application of the MRC 
framework to develop and refine the mHealth intervention was necessary to make it 
fit-for-purpose and inform a larger trial (Craig et al., 2011). The automated SMS 




Exploratory Phase), in terms of recruitment, retention, acceptability and 
effectiveness. The results of this study illustrated positive feedback for the feasibility 
of recruiting participants to a mHealth study in a university-affiliated hospital in the 
capital city of Iran, as showed by the positive rate of the patients’ recruitment. There 
was an approximately low attrition rate, as well. Although there was a large range in 
participants’ age (38–84 years), the mean age of 61.8 years (Standard Deviation 
+1.02) showed the feasibility of using mHealth for older patients. A limited number 
of participants reported technical difficulties. There was no harm or unexpected 
effects on participants as a result of the study intervention. 
Overall a promising evidence for the effectiveness of the automated SMS 
reminder intervention on cardiovascular medication adherence was provided in the 
two phases of the study. The main effect was observed on improved medication 
adherence, specifically what the intervention aimed to change. A relatively large 
effect (Relative Risk=2.19; 95% CI: 1.5-3.19) was found on the main outcome 
measure (i.e. medication adherence). High patients’ satisfaction scores demonstrated 
the feasibility and acceptability of the SMS medication reminder intervention in an 
Iranian setting. Therefore, the next step is to validate the intervention effect in an 
adequately powered RCT. However, the present study findings added to the existing 
evidence supporting mHealth as an innovative approach for promoting 
cardiovascular medication adherence that showed to be effective, feasible and 
acceptable in Iran.  
7.2 Strengths and Limitations 
One of the study’s strengths is that the MRC framework criteria (2011) were 
used to develop a theory- and evidence-based mHealth intervention to improve 
cardiovascular medication adherence that provides a comprehensive and circular 
process for the intervention refinement and evaluation. Moreover, Bandura’s self-
efficacy theory and the WHO adherence model were successfully used in the 
refinement of the automated SMS medication reminder intervention to overcome 
patient-related (i.e. forgetting and low self-efficacy) and health care system-related 




To the best of the researcher’s knowledge, this study is one of the first studies 
that has used a nurse-led mHealth intervention to improve medication adherence 
among Iranian CHD patients. Furthermore, the intervention was refined based on the 
Iranian cardiac nurses’ opinions and customised to CHD patients’ preferences prior 
to its implementation. Using the tailored intervention to the local setting has made 
the intervention more likely to be feasible and acceptable in this particular context.  
The intervention was a web-based software that was not dependent on a 
specific hardware. Therefore, it offered maximum portability and ease of use. It also 
comprised of different parts that were designed to gather and manage the patients’ 
information and their medications, store data, schedule, send SMS and record SMS 
delivery status. All mentioned tasks were operated automatically. It also offered 
further features including query, advanced search and report generation that could be 
exported to a variety of standard formats. 
There are some limitations to the present study that should also be noted to rule 
out alternative explanations. First, making fortnightly phone calls with patients in the 
intervention group to ensure they received the text-message reminders, may have 
added unintentional attention to their medication taking for this study group. The 
Hawthorne effect of the phone calls should be considered, although no conversation 
were made regarding patients’ medication taking. Second, the sample for the 
qualitative focus groups may have underrepresented Iranian cardiac nurses as they 
were selected and invited through the gatekeepers to participate in the study leading 
to unintentional sample selection bias. However, literature suggests that the common 
method for selecting participants for focus groups is purposive or convenience 
sampling (i.e. without any random selection) who may provide the best information 
to answer research questions (Ritchie et al., 2013).  
Third, because the sample size was small and only included CHD patients 
presented at an outpatient CR clinic of a university-affiliated hospital in the city of 
Tehran, they might not represent all Iranian CHD population. In addition, the 
intervention was refined and tailored to the Iranian settings. All these may limit the 
generalisability of the study findings. However, linking the components of the 




address the generalisability issue of the study findings and prevent duplicating 
attempts for further studies. 
The forth limitation of the study is the patients’ self-completion bias, although 
the self-report questionnaire is simple, cost-efficient and the most common method 
of data collection (Berben et al., 2011, Osterberg and Blaschke, 2005, Rolley et al., 
2008). It may be affected by recall bias and socially desirable responding (Berben et 
al., 2011, Rolley et al., 2008); however, a comparison of other studies demonstrated 
that there was an association between a patient’s self-report of medication intake and 
blood drug levels (Glintborg et al., 2007, Ho et al., 2009, Rolley et al., 2008). There 
is no “gold standard” to measure the medication adherence behaviour (Ho et al., 
2009, Jose and Jimmy, 2011) and all measurement approaches have their strengths 
and limitations (Jose and Jimmy, 2011, Rolley et al., 2008). For example, application 
of direct methods such as detection of a metabolite or marker in a blood sample as 
well as electronic monitoring device or Medication Event Monitoring System 
(MEMS) may overcome the limitation of self-report methods; however, they are 
expensive and less practical particularly in a developing country such as Iran (Jose 
and Jimmy, 2011, Park et al., 2014). Considering the anxiety that CHD patients may 
experience following the cardiac event and hospital discharge, using MEMS may 
cause additional levels of stress in these patients (Park et al., 2014). Moreover, to the 
researcher's knowledge, electronic monitoring devices for medication taking were 
not available in Iran during the study time. There was also no electronic pharmacy 
claim data in this country to monitor the prescription refill or measuring adherence 
using Medication Possession Ratio (MPR) and Proportion of Days Covered (PDC). 
Pill count method may not be a fully reliable method because the patients in order to 
appear adherent can change medications between bottles or throw them out before 
the follow-up visit (Jose and Jimmy, 2011). Therefore, a combination of different 
measures was used in this study to maximise the accuracy of adherence assessment. 
In this study, the NYHA classification (with an adequate validity and reliability in 
measuring functional status) was used to measure cardiac function capacity of the 
participants that the subjectivity issue is a common critique of this measure. To 
increase the objectivity of the NYHA classifications, objective assessment were 




baseline and endpoint of the study. The objective assessment were made based on the 
results of  electrocardiograms, stress tests, x-rays and echocardiograms (see Section 
5.3). 
Fifth, the follow up period of 12 weeks was relatively short and did not provide 
long-term sustainability of the intervention effect on adherence or clinical outcomes, 
considering the setting of a chronic disease such as CHD, in particular. However, the 
study evaluated the effect of the mHealth intervention on improving cardiovascular 
medication adherence during the early phase of hospital discharge when the majority 
of CHD patients are most susceptible of discontinuation of their medications (Airoldi 
et al., 2007, Balaguer-Malfagón et al., 2006, Park et al., 2014). In this study, the 
number of patients who dropped out from the CR programme was not measured as 
this was beyond the scope of the present study. However, there might be a potential 
association between the CR drop outs and medication adherence that needs to be 
explored in further studies. 
7.3 Implications of the Study 
The MRC framework was applied to determine the feasibility and refinement 
of the nurse-led mHealth intervention to improve cardiovascular medication 
adherence based on the principles of the self-efficacy theory and the WHO 
medication adherence model. According to the study findings, the effectiveness of 
the intervention was found to be statistically significant at least in the short term in 
achieving an improvement in reported levels of adherence to cardioprotective 
medications.  
This two-phase study has established feasibility and acceptability with a nurse-
led mHealth intervention among CHD patients in Iran. It will also inform a future 
definitive RCT in order to confirm the present study findings and validate the 
mHealth intervention as a potential solution to the medication nonadherence 
challenges. The following sections will discuss the potential implications of the 
present research at different levels of healthcare, micro- (patients and providers), 




7.3.1 Implications at Micro-level (Patients and Providers) 
According to the WHO adherence model, patient-level factors refer to patients’ 
characteristics such as knowledge, beliefs and self-efficacy that only comprise the 
small proportion of the variability in nonadherence . The quality of communication 
between the health care providers and patients has been found to have an important 
impact on adherence to the recommended treatment and consequently on patients’ 
clinical outcomes (Berben et al., 2012, Najafi et al., 2016, Zolfaghari et al., 2012). 
Healthcare professionals providing care for patients with cardiovascular disease are 
strongly encouraged to employ adherence supporting interventions in their every day 
practice (Berben et al., 2011). As the most influential person in improving the 
patients’ adherence to theraputic regimen, nurses and health care providers should be 
aware of the potential effects of innovative contemporary approaches at multiple 
levels, the micro-, meso-, and macro-level (Berben et al., 2011, McLeroy et al., 
1988). They can significantly contribute to provide the patients with support and help 
them improve self-efficacy in medication adherence that can lead to a better patients’ 
adaptation with their treatment regimen in the post-discharge period (Najafi et al., 
2016). In this way, nurses’ optimal selection of the myriad of interventions available 
is of great importance; it can lead to patients’ adherence to prescribed medications 
and prevent progression of the negative outcomes, and the disease-related 
complications (Gandhi et al., 2016, Stolic et al., 2010).  
As a part of electronic health, telenursing is an encouraging approach that can 
expand the involvement of nurses in patient care (Souza-Junior et al., 2016). It also 
provided the possibility of delivering nursing care through information and 
communication technology including the Internet, and mobile phones among which 
mobile phone is widely available and used by most of the people (Kumar, 2011). 
Without the active support of nurses, the implementation of mobile health 
interventions to achieve the optimal level of care is less possible (Zolfaghari et al., 
2012). Application of mHealth and specifically text-messaging have been found to 
be efficient and promising to deliver nurse-led interventions that manage various 
chronic diseases (Jones et al., 2014). Furthermore, it can provide patients with 
medication reminder and post-discharge follow-up, that potentially strengthens the 




According to the WHO, innovative care for chronic patients has been recommended 
(Duplaga and Winnem, 2006) and it indicates that quality care should be delivered to 
patients whenever is required through different approaches, not limited to traditional 
face-to-face visits. Hence, the health care providers are responsible for providing 
patients’ access to care using mobile phones or other means of communication in 
addition to clinical visits (Gentles et al., 2010). 
During hospitalisation, nurses are responsible for administering patients’ 
medications regularly based on the hospital’s policy; however, non-adherence occurs 
as a major problem among CHD patients during the early phase of hospital discharge 
(Akhu-Zaheya and Wa’ed, 2016). In Iran, after patients’ discharge from the hospital, 
a follow-up home visit is barely available and patients’ drop-out from a hospital-
based CR is quite high (Heydarpour et al., 2015, Moradi et al., 2011). Thus, mobile 
phone text messaging could be an accessible means of support to promote patients’ 
post-discharge follow-up (Gandapur et al., 2016, Sarabi et al., 2016, Thakkar et al., 
2015).This study evaluated one of the telenursing approaches (i.e. mobile phone text-
messaging) and showed the significant effect of using automated SMS reminders on 
promoting adherence to the prescribed regimen of medication among adult patients 
with CHD. Considering the shortage of nurses in developing countries such as Iran, it 
was found in the present study that automated text-messaging as a type of mHealth 
interventions has the potential to be used as an alternative to in-person appointments 
in order to improve post-discharge medication adherence. 
7.3.2 Implications at Meso-level (Healthcare Organisation) 
The delivery and the quality of the services offered are coordinated and 
evaluated by the health care organisation (Berben et al., 2012, McLeroy et al., 1988). 
Interventions used in regular clinical practice to optimise patients’ medication 
adherence can illustrate the characteristics or practice patterns of hospitals, which 
play their roles under meso-level factors (Berben et al., 2012). Although health 
promotion and prevention programmes should be essential components of health care 
organisations, this is far from daily clinical practice (Rogers et al., 2015, World 
Health Organisation, 2002). It is necessary for healthcare organisations to expose 




management along with training on acute care and provide them with innovative 
evidence-based tools and techniques that promote therapeutic management by 
assisting patients with adherence and other self-management approaches 
(Dwarswaard et al., 2016).  
Application of electronic health is essential for organised, integrated, and 
evidence-informed patient care (Sharifi et al., 2013). Moreover, it is useful to review 
health trends and clinical care process (Souza-Junior et al., 2016). In terms of chronic 
care management including cardiovascular diseases, technology-mediated 
interventions such as text-messaging can provide patients with a reminder with 
different components, and it can help encourage patient’s self-efficacy and modify 
health behaviours such as adherence to medication regimens or other important 
health changes when they are away from hospital (Gandapur et al., 2016, Sarabi et 
al., 2016, Thakkar et al., 2015). 
It was shown in different review studies that mHealth-delivered interventions 
such as mobile phone text-messaging as a means of communication has a potential 
for use in healthcare system to improve clinical outcomes and behavior modifications 
(Gandhi et al., 2016, Sarabi et al., 2016, Thakkar et al., 2015, Albertini et al., 2011). 
In the present study, the mHealth intervention of automated SMS medication 
reminders showed a significant improvement in patients’ adherence. Unlike 
complicated interventions and time-consuming face-to-face approaches, SMS 
reminders are transmitted automatically to patients beyond a specific location at a 
predefined time with limited efforts from health care professionals. It was also 
designed to provide a database for patient information management in an efficient 
and organised way that enable users to query, advance search, generate reports and 
export to different formats. 
7.3.3 Implications at Macro-level (Health Policy) 
Based on the study findings and from what has been discussed previously, 
mHealth has excellent potential to be widely used in the future as it could be helpful 
in improving efficiency and effectiveness of healthcare delivery and patients’ follow-
up in medical sectors. Despite the advantages of mHealth applications such as 




eliminated total health care expenses, mHealth interventions have been less 
developed in comparison with other approaches (Sharifi et al., 2013) due to a variety 
of challenges highlighted by cardiac nurses in this study. Lack of IT knowledge and 
training, legal ambiguities, privacy and security concerns and educational issues have 
been identified as challenges of implementation of mHealth in Iran that deserve and 
require policymakers’ attention.  
The effectiveness of mHealth interventions has important implications for 
future health policy and the development of strategies related to medication 
adherence and secondary prevention of cardiovascular disease. This is particularly of 
importance when considering the adherence rate was reported to be 38.8-60.0% for 
cardiovascular medications (Sarayani et al., 2013). In Iran, nonadherence to 
medications was found to be the leading cause of ischemic heart disease 
rehospitalisation followed by a high level of stress and physical inactivity (Heydari et 
al., 2015). The importance of preventative policies and innovative interventions (e.g. 
mHealth) which focus on improving adherence to therapeutic regimen among cardiac 
patients has been highlighted in different studies (Dabaghian et al., 2016, Heydari et 
al., 2015, Sarayani et al., 2013). The findings of the present study would suggest that 
development of theory-based mHealth interventions that tailored to the local context 
and exploring their effectiveness on medication adherence are areas pertinent for 
future policy and secondary prevention improvement in Iran. The study also 
demonstrated that the significant improvement in medication adherence may be 
achievable through the implementation of the mHealth intervention for CHD 
patients. 
7.4 Conclusion 
Qualitative and quantitative data collected during refinement and piloting of 
the automated SMS medication reminders suggested that the nurse-led mHealth 
intervention in the Iranian CHD patients participated in CR programme had the 
desired effect (improved cardiovascular medication adherence) and confirmed that 
the recruitment and data collection strategies used were feasible for implementation 
in a future definitive RCT. According to the MRC framework (2013), the next step 




results by conducting a larger trial in order to confirm the feasibility and 
transferability of the intervention from research into practice.The large-scale RCT is 
the Evaluation Phase of the MRC framework (Senn et al., 2013).  
7.4.1 What was already known? 
 Poor medication adherence is one of the most significant barriers to 
successful treatment among CHD patients after discharge from the hospital 
that could be related to unintentional reasons such as forgetfulness and 
inadequate self-efficacy in medication taking. 
 Mobile phone text messaging was evaluated in different chronic conditions, 
and shown to be effective in optimising adherence and health outcomes; 
however, few studies developed, refined and evaluated a theory-based 
mHealth intervention based on the MRC framework to promote medication 
adherence among CHD patients in an Iranian CR setting. 
 In Iran, there are limited follow-up home visits available after discharge from 
a cardiac event and regular attendance in an outpatient cardiac rehabilitation 
programme is suboptimal. Therefore, telenursing using SMS could be the 
most accessible way to potentially promote patients’ adherence to prescribed 
medication regimen and self-efficacy. 
7.4.2 What this study has added to the body of knowledge? 
Conducting a multi-stage mixed methods research study using the MRC 
framework contributed to collect and analyse rich research data. The original 
literature highlighted the lack of research which developed and evaluated a theory-
based, patient-centered, nurse-led mHealth intervention to improve cardiovascular 
medication adherence in the Iranian CR setting. In addition, the most recent 
litereature identified the need to explore perspectives of both CHD patients and 
experienced cardiac nurses about potential effects and challenges of mHealth 
implementation in Iran. The aims of the study addressed these issues. The MRC 
framework was used as a guide to develop and evaluate the study mHealth 
intervention. The findings supported the application of behavioural theory to 
practice, in this case self-efficacy construct. The automated SMS medication 




WHO and Bandura’ Self-efficacy Theory. The intervention was refined according to 
the findings from Phase 1 and then piloted in an Iranian CR setting. A self-
completed survey of CHD patients and cardiac nurses’ focus groups were conducted 
as part of the preclinical/ modelling phase which informed the second phase of the 
study (exploratory trial). The survey results indicated that mobile phone ownership 
and the use of text messages were relatively high among Iranian CHD patients and 
using mHealth intervention to improve medication adherence for this group of 
patients would be acceptable. Focus groups findings revealed that Iranian cardiac 
nurses were open to the introduction of the mHealth intervention to improve 
medication adherence, but perceived different reasons why mHealth would be 
challenging to implement in the Iranian healthcare system. The nurses also discussed 
their views and recommendations about the refinement of the mHealth intervention. 
In the second phase of the study, the refined mHealth intervention was piloted 
among 78 Iranian CR patients for 12 weeks.The findings showed that a nurse-led 
mHealth intervention was well accepted and feasible with significantly higher 
reporting of medication adherence in Iranian CHD patients at 3 months. In order to 
identify the long-term impact of the mHealth intervention on medication adherence, 
a larger study with longer follow-up is needed. 
In summary: 
 This study provides a full description of the refinement and evaluation of a 
nurse-led mHealth intervention to promote cardiovascular medication 
adherence in Iran, using the WHO adherence model and the self-efficacy 
theory principles, based upon the MRC framework to inform a future 
definitive RCT.  
 The processes followed to develop the automated SMS medication reminder 
intervention can be replicated in other studies. The evaluation of qualitative 
and quantitative data improved and tailored the intervention to the local 
context and ensured it could be applied to the Iranian CHD patients. 
 Automated SMS-based intervention as reminders showed promise in 
encouraging CHD patients to adhere to the prescribed medication regimen 
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Appendix 3: Patients’ Socio-demographic Questionnaire 
Subject ID:         
1. Discharge Date: 2. Diagnosis:  
3. Gender: Male = 1     Female = 2 
4. Age: ….years 
5. Marital status 
1 Married  3 Divorced  
2  Single  4 Other  
6. Education level 
1 None 4 University 
2 Primary    
3 Secondary    
7. Are you currently employed?   
1 Yes 0 No  
8. Financial Resource 
1 Government Servant 4 Pensioner 
2 Self Sponsored 5 Other  
3 Welfare Assistance   
9. Insurance 
1 Yes 0 No  
10. Average Income (Monthly): 
11. Living Arrangement 
1 With family members 4 Alone 
2 With relatives 5 Others   
3 With friends   
12. Length of stay in hospital (days): 
13. Any other diseases: 
14. Number of daily medications:  





Appendix 4: Patients’ Perception Survey Questionnaire 
Q No. Question 
 
Responses Instructions 





If ‘Yes’ go to Q3 
If ‘No’ go to Q2 
Q2 Why do you not use a cell 
phone? (tick all that applies) 
1. Lack of money 
2. No network 
3. Have no use for it 
4. Inability to use 
5. Other 
 
Skip to Q10 
Q3 Do you have a cell phone? 1. Yes 
2. No 
 
If ‘No’ skip to Q10 
Q4 Is this phone mostly kept in 
your possession? 
1. Yes 
2. No, shared by .. 
 
 
Q5 Since when have you used cell 
phones? 
 
_____yrs Fill in years  
Q6  Do you use cell phones to talk? 1. Yes 
2.    No 
 
If ‘Yes’ go to Q6a 
If no, skip to Q7 
Q6a. How often do you  
a. call others 
b. receive calls 
 
___/day or wk 
___/day or wk 
 
Mark whether day or 
week.  
Q7  Do you use the SMS function 




If ‘Yes’ go to Q7a  
If no, skip to Q8 
Q7a How often do you  
a. send SMS 
b. receive SMS 
 
___/day or wk 
___/day or wk 
Mark whether day or 
week.  
 





If ‘Yes’ go to Q8a 
If no, skip to Q9 
Q8a What do you use the alarm 
function for? (tick all that 
applies)   
1. To wake up 
2. To remind me of 
errands 





Q9 What other use do you have for 
the cell phones?  (tick all that 
applies) 
 
1. Listen to radio 
2. Play games 
3. Camera 
4. Other 




Q10 For a cardiac patient, would it 
be helpful to have automatic 
reminders on the cell phone to 






If ‘Yes’ go to Q11 




Q No. Question 
 
Responses Instructions 
Q11 If we were to provide automatic 
reminders to patients to take 
medications, what format would 
you like these reminders to be 
in? 
 
1. Telephone call (Voice 
format) 
2. SMS message  
3. Smartphone application 
4. No preference 
Choose only 1.  
 
Q12 Do you have a Smartphone? 1. Yes 
2. No 
 
If ‘Yes’ go to Q13 
If No, skip to Q14. 






Q14 If we were to provide automatic 
reminders for medication, how 
often would you like these 




1. As often as the 
medications need to be 
taken 
2. Daily 
3. Once a week 
4. Twice a week 
Choose only 1 
answer 
 
Q15 If we provide automatic 
reminders, what times would 




1. Just before the drugs 
timings  
2. Morning:  6am – 10 am 
3. Mid day:  11 am – 2 pm 
4. Evening:  3 pm – 6 pm 
5. Late evening/night: 7 pm 











Q16 Why is this time convenient for 
you?  
 
 Skip to Q18 
Q17 Why do you think that these 
reminders for medication are 
not useful? 
 
 Write reasons.  
Q18 If we were going to develop an 
application using cell phones for 
cardiac patients – what other 
possibilities do you think would 
be useful? (tick all that applies) 
 
1. Communication with 
health provider  
2. Information on 
medicines 
3. Motivational Messages  
4. Other (Please specify) 
 
 
Q19 Do you think the cell phone 
used in this way will be an 
intrusion in a person’s life? 
1. Yes 
2. No   
3. Don’t know 
 
 
Q20 Do you prefer to send a reply 
message to each reminder when 




2. No   
3. Don’t know 
 
 
Q21. Can you please write your 







Appendix 5: SCVI/Ave for the Survey Questionnaire 
Items Expert 1  Expert 2 Number in 
agreement 
Item CVI 
1 - √ 1 0.5 
2 √ √ 2 1 
3 √ - 1 0.5 
4 √ √ 2 1 
5 √ √ 2 1 
6 - - 2 1 
7 √ √ 2 1 
8 √ √ 2 1 
9 √ √ 2 1 
10 √ √ 2 1 
11 √ √ 2 1 
12 √ √ 2 1 
13 √ √ 2 1 
14 √ √ 2 1 
15 √ √ 2 1 
16 √ √ 2 1 
17 √ √ 2 1 
18 √ √ 2 1 
19 √ √ 2 1 
20 √ √ 2 1 
21 √ √ 2 1 
Proportion 
Relevant 
0.90 0.90  Mean I-CVI = 
0.95 
S-CVI/UA = 0.85 











Appendix 6: Morisky Adherence Scale and Coding Instructions 
 
 
8. How often do you have difficulty remembering to take all your medications? 
 (Please circle your response below) 
Never/Rarely……………………………………....4 
Once in a while……………………………………3 
Sometimes………………………………………....2 
Usually…………………………………………….1 
All the time………………………………………..0 
©Morisky Medication Adherence Scale (MMAS-8-Item). This is a generic 
adherence scale and the name of the health concern can be substituted in each 
question item. You indicated that you are taking medication for your (identify 
health concern).  Individuals have identified several issues regarding their 
medication-taking behaviour and we are interested in your experiences.  There is 
no right or wrong answer.  Please answer each question based on your personal 
experience with your [health concern] medication.   
                                                                        (Please check your response below) 
  No=1 Yes=0 
1. Do you sometimes forget to take your [health concern] pills?   
2. People sometimes miss taking their medications for reasons 
other than forgetting. Thinking over the past two weeks, were 








3. Have you ever cut back or stopped taking your medication 






4. When you travel or leave home, do you sometimes forget to 





5. Did you take your [health concern] medicine yesterday?   
6. When you feel like your [health concern] is under control, do 





7. Taking medication every day is a real inconvenience for 
some people. Do you ever feel hassled about sticking to your 










Coding Instruction:  
You will need to reverse the code response in a positive direction for item number 5 
and standardize the code for item 8 (0-4), resulting in a scale from low adherence to 
high adherence.  Item 8 is divided by 4 when calculating a summated score. This 
procedure standardizes the 5-point Likert scale.  The total scale has a range of 0 to 
8.0.  The eight-item compliance scale had an alpha reliability of 0.83 (n= 1367) 
among patients diagnosed with essential hypertension attending an outpatient clinic 
of a large teaching hospital.  We have used a 75% completion criterion for 
establishing eligibility.  The median value of all non-missing items would be 
substituted for the missing item for individuals meeting the eligibility criterion.”  I.e. 
if 1 or 2 items are missing, the median values of the other 7 or 8 items would be 
substituted for the missing item. 
 Re-codes: 
If Item5 = 0 Item5r = 1 (high adherence) 
If Item8=4 Item8r = 1 (highest adherence) 
If Item8=3 Item8r = 0.75 (high adherence) 
If Item8=2 Item8r = 0.50 (moderate adherence) 
If Item8=1 Item8r = 0.25 (low adherence) 
If Item8=0 Item8r = 0 (lowest adherence) 
Adherence Level Percent 
 Low Adherence (< 6)                                                    32.1 
Medium Adherence (6 to <8)                                        52.0 





Appendix 7: MMAS- 8 License Contract and Copyright Agreement 
Required citation and footnote for the 8-item MMAS are as follows: 
MMAS-8 
Morisky DE, Ang A, Krousel-Wood M, Ward H. Predictive Validity of a Medication 
Adherence Measure for Hypertension Control. Journal of Clinical Hypertension 2008; 
10(5):348-354 
Krousel-Wood MA, Islam T, Webber LS, Re RS, Morisky DE, Muntner P. New 
Medication Adherence Scale Versus Pharmacy Fill Rates in Seniors With 
Hypertension. Am J Manag Care 2009;15(1):59-66. 
Morisky DE, DiMatteo MR. Improving the measurement of self-reported medication 
nonadherence: Final response. J Clin Epidemio 2011; 64:258-263. PMID:21144706 
This footnote is required on all tables or figures which present the ©MMAS-8. 
Use of the ©MMAS is protected by US copyright laws. Permission for use is 
required. A license agreement is available from: Donald E. Morisky, ScD, ScM, 
MSPH, Professor, Department of Community Health Sciences, UCLA School of 
Public Health, 650 Charles E. Young Drive South, Los Angeles, CA 90095-1772, 
dmorisky@ucla.edu. 
License Agreement for use of the Morisky Medication Adherence Intellectual 
Property 
In consideration for the right to use certain Morisky proprietary psychometric tools 
and intellectual property, the undersigned researcher (hereunder "Licensee" or "you") 
agrees to the following: 
A.  Ownership and Fees: All psychometric products as well as their translations, 
adaptations, computer programs, and scoring algorithms, trade secrets, and any other 
related documents and information (including those in electronic form) which 
embody or are related to the MMAS tools (including without limitation the Morisky 
Medication Adherence Scale 4- and 8-item versions, 4-item Morisky Adherence 
Questionnaire, and any documentation thereof) are intellectual property of Donald E. 
Morisky, ScD, ScM, MSPH. ("Owner") Professor of Community Health Sciences, 
UCLA Fielding School of Public Health, Los Angeles, CA 90095-1772 (the address 
for all payments and communications related to this agreement).  
B.  Translations: Permission will only be granted to translate the MMAS tools 
subject to the following requirements: all new translations must be made by 
contracting with the MAPI Institute and final translations must be approved by the 
Owner.  The MAPI Institute employs the most rigorous standards in the translation 
process using two native linguistic experts to independently conduct forward and 
backwards translation; the Owner is actively involved in validating each item in the 
scale and grants use of the translated scale through a separate license agreement that 
is linked to the License Agreement Contract/Copyright Agreement.  Languages that 
have already been translated and validated by the MAPI Institute can be requested 
through the Owner/Developer, Dr. Donald E. Morisky. 
C. Use:  Licensee understands and agrees that 
 1) Changes to the wording or phrasing of any Morisky scale, tool or 
document require written permission. If any changes made to the wording or 
phrasing of any MMAS item or other Morisky document without permission, the 




to other MMAS data may violate Owner's rights. 
 2) Coding and scoring criteria of the MMAS-8 are trade secrets of the Owner 
and as such cannot be divulged in any publication or report without the Owner's prior 
written permission; 
 3) Permission to use the trademarks "Morisky," "MORISKY SCALE" or 
"MMAS" is not and will not be granted for any unauthorized use or translations of 
the MMAS or other MORISKY intellectual property, in whole or in part. No 
analyses, research results or publications based on unauthorized changes or translated 
versions, or results thereof, will use MORISKY, MMAS or confusingly similar 
attributions. 
 4) The MORISKY SCALE intellectual property legend on the documents 
provided to you must be included on the first page of a MORISKY SCALE 
questionnaire in study documents, and in any reproductions for manuscript or other 
publication purposes. The footnote must be noted at the end of the first Table or 
Figure that displays the MMAS-8 items. 
 5) In case of scientific, administrative or intellectual property misconduct in 
using the MORISKY SCALE system of questionnaires or the Morisky name or 
MMAS names, Owner reserves the right to withdraw permission for use and to 
pursue all legal remedies.  Licensee agrees to the jurisdiction in and venue of the 
State and Federal Courts in Los Angeles County. 
 6) Rights granted under this Agreement to use the Morisky scales terminate 
one-year from the date below or on termination of Licensee's study, whichever is 
shorter. Licensee acknowledges understanding and agreeing to abide by the above 
requirements regarding use of any Morisky Medication Adherence Scale or other 
Morisky intellectual property. 
 7) Further specific requirements, e.g., citations required in publications, may 
be obtained from the Owner via <dmorisky@ucla.edu>. Additional terms and 
agreements via hardcopy or email will become a part of and subject to the provisions 
of this Agreement.           
The license agreement is in effect for a one-year period or the duration of the study, 
whichever is shorter.  If your study is longer than one year, a renewal of license is 
available based upon a brief status report prior to expiration of the waiver of license 
fee and copyright agreement. 
If I am eligible for a waiver of license fee contractual agreement, I agree to provide 
Dr Morisky with a detailed report that includes the specific number of MMAS-8 tests 
given and the findings upon completion of this study, cite the required references as 
noted on this waiver of license fee agreement and will comply with the copyright 
specification outlined above regarding the use of the Morisky Medication Adherence 
Scale, 8-Items, MMAS-8 and will abide with its requirements. If I fail to file the 
report within 30 days following the end of the study or after the one year period, I 
agree to pay Dr. Morisky a fee of $500. 
Please print, sign, and scan and email this agreement to dmorisky@ucla.edu  
Please sign and return this contractual agreement in a PDF format, to Professor 




re-coding criteria and signature authorizing full use of this copyrighted scale.  I agree 
to use only the English version of the MMAS-8 unless I purchase a validated 
translation of the MMAS-8 through Professor Morisky. I understand that it is a 
violation of international copyright laws to either use your own translation and call it 
the “MMAS-8” or use an existing MMAS-8 scale that has been translated and used 
for another study.  The validated translation is non-transferrable and is linked to a 
specific license agreement and cannot be reproduced, copied, distributed, placed on 
the internet, published, or used by another individual. If the licensee violates any 
copyright laws contained in this licensing agreement they will be solely responsible 
for a $5000.00 penalty and any associated legal costs. 
Name and Contact Information of Licensee: Dr Aisha Holloway 
CNO Clinical Academic Re-engagement Research Fellow 
Florence Nightingale Scholar 
Chair Scottish Alcohol Research Network (SARN) 
Nursing Studies 
Room 2M6 
School of Health in Social Sciences, 
The University of Edinburgh, 





For doctoral student Sahar Khonsari 
Title of Study:   Development of a Mobile Health Intervention for Outpatients 
Cardiac Rehabilitation: A Feasibility Study to Evaluate Impact on Medication 
Adherence  
Total number of administrations:   
Signature of developer/owner of the MMAS-8:  
Donald E. Morisky, ScD, Developer/Owner of the MMAS-8/ 
Date Signed: 6/10/15 
 Signature of Licensee: Dr Aisha Holloway /  














The confirmation of payment for the validated Persian translation of the English 







Appendix 8: The SF-12v2® Health Survey 
 
Your Health and Well-Being 
 
 
This survey asks for your views about your health. This information will help keep 
track of how you feel and how well you are able to do your usual activities. Thank 
you for completing this survey! 
 
For each of the following questions, please tick the one box that best describes your 
answer. 
 
1. In general, would you say your health is: 
2. The following questions are about activities you might do during a typical day.  










    
 a Moderate activities, such as moving a table,  
pushing a vacuum cleaner, bowling, or playing golf ..  1 .............  2 ..........  3 
 b Climbing several flights of stairs ......................  1 .............  2 ..........  3 
Excellent Very good Good Fair Poor 
     




3. During the past 4 weeks, how much of the time have you had any of the 
following problems with your work or other regular daily activities as a result 
of your physical health? 
4. During the past 4 weeks, how much of the time have you had any of the 
following problems with your work or other regular daily activities as a result 
of any emotional problems (such as feeling depressed or anxious)? 
5. During the past 4 weeks, how much did pain interfere with your normal work 
(including both work outside the home and housework)?  
Not at all A little bit Moderately Quite a bit Extremely 
     
   1    2    3    4    5 










      
 a Accomplished less than you  
  would like ..............................  1 ........  2........  3 ..........  4 ........  5 
 b Were limited in the kind of  
  work or other activities ..........  1 ........  2........  3 ..........  4 ........  5 










      
 a Accomplished less than you  
  would like ............................  1 ........  2 ..........  3 ........  4 ..........  5 
 b Did work or other activities 




6. These questions are about how you feel and how things have been with you 
during the past 4 weeks.  For each question, please give the one answer that 
comes closest to the way you have been feeling.  How much of the time during 
the past 4 weeks… 
7. During the past 4 weeks, how much of the time has your physical health or 
emotional problems interfered with your social activities (like visiting with 








Thank you for completing these questions! 
  










      
 a   Have you felt calm and   
peaceful? ................................  1 ........  2........  3 ..........  4 .........  5 
 b   Did you have a lot of energy?  1 ........  2........  3 ..........  4 .........  5 
 c   Have you felt downhearted   











     











Appendix 10: Nurses’ Socio-demographic Questionnaire 






















1. Cardiac Rehabilitation 
2. Cardiac Intensive Care 
3. Hospital Nursing 
Department 




1. Staff Nurse 
2. Head Nurse  
3. Supervisor 
4. Ward Administrator 
 
Working Experience ……years 
 
Have you ever participated in any mHealth 
Seminars? 
     
1. Yes  







Appendix 11: Focus Group Discussion Topic Guide 
 Welcoming and Introduction (short biography of researcher and participants) 
 Describing the research study (aim, objectives and method) 
 Description the study intervention (mHealth-based intervention) 
 Asking questions: 
1. Have you ever heard of Mobile Health (mHealth)? If YES can you give 
examples of this. If NO then refer them back to the definition from the 
provided printed copy of the definition of mHealth. 
2. Do you have any experience of using mHealth in your current or previous 
clinical practice?  
3. What do you feel are the potential effects of using the proposed mHealth 
intervention (automated reminder system) on medication adherence of 
cardiac patients after discharge? 
4. What are the possible challenges/ barriers of using mHealth interventions to 
promote carediac medication adherence? 
5. How can we address these challenges? 
6. In your opinion, what is the best strategy to implement the proposed mHealth 
























Appendix 13: New York Heart Association's Functional and Therapeutic 




I Cardiac disease, but no symptoms and no limitation in ordinary physical 
activity, e.g. shortness of breath when walking, climbing stairs etc. 
II Mild symptoms (mild shortness of breath and/or angina) and slight 
limitation during ordinary activity. 
III Marked limitation in activity due to symptoms, even during less-than-
ordinary activity, e.g. walking short distances (20–100 m). 
Comfortable only at rest. 







Appendix 14: Post-test Patient’s Perceptions about the Applied 
Intervention 
Perceptions items Responses 




2. No difference 
3. Not useful 
 




3. Interaction with healthcare providers 
4. Maintaining independence/ self-efficacy 
in taking medications 
 
Want the SMS reminder to be 
continued in future?  
 




5. Strongly disagreed 
 
Suggest this SMS reminder system to 
other patients? 
 




5. Strongly disagreed 
 
SMS reminders may cause intrusion in 
a person’s life? 
 




5. Strongly disagreed 
 
Would you pay for receiving SMS 
reminders? 
 




5. Strongly disagreed 
 
Recommendations to improve this 








Appendix 15: Letter of permission to use the Medication Adherence 







Appendix 16: Agreement with the Text Message Service Provider about 
























Appendix 19: Participants’ Information Sheets 
Document Title: Patients’ Information Sheet 
Version: 1.1  
Date:  
Study Title: Development of a Mobile Health Intervention for Outpatients 
Cardiac Rehabilitation: A Feasibility Study to Evaluate Impact on Medication 
Adherence  
You are invited to take part in a research study. Before you decide whether or not to 
take part, it is important you understand why the research is being done and what it 
will involve. Please read the following information carefully. If there is anything that 
is not clear please do not hesitate to contact me. 
Introduction 
The immediate discharge period is a time of high risk for non-adherence to 
prescribed medications. Nearly 1 in 4 patients is partially or completely nonadherent 
in filling prescriptions after discharge. Cardiovascular patients may face significant 
health problem related to the premature discontinuation of therapies after discharge. 
Evidence-based interventions that assist adherence to prescribed medications have 
the potential to delay disease progression and the development of complications, 
contributing to reduced health care costs for health systems and the people who use 
them. Therefore the researcher aims to develop mobile phone reminders and evaluate 
the effect of the intervention on medication adherence among outpatients Cardiac 
Rehabilitation. 
What is the purpose of this study? 
This study wishes to achieve a solution to medication non-adherence problem 
involved in supporting patients’ adherence by focusing on the most common factors 
(forgetfulness and carelessness) which affect each individual to prevent 
complications, and improve patient health outcomes. 
What are the procedures to be followed? 
The mobile health reminder system will be introduced to patients in the first session 
of phase III cardiac rehabilitation, and then patients will be recruited into the study 
with their agreement. The participants’ medications will be recorded in accordance 
with their physicians’ advice. Each day following recruitment, medication reminders 
will be sent to patients’ mobile phones automatically at predefined times in an 8-
week programme.  
Who should not enter the study? 
 Those who are unwilling to participate in this study, 
 Those who do not have cell phone to receive related text messages, 
 Patients who are illiterate for reading text messages, 
 Unavailability for the 2 months period of the study (including being 
unavailable by phone and/or travelling out of the country), 
 Patients with a level of cognitive impairment 





What will be benefits of the study? 
(a) to you as the subject? 
This study will employ automated reminders for medications follow-up care as a 
popular way which assist patient’s medication adherence with rapid, effective 
guidance and pharmaceutical care after discharge. Hence the use of this free of 
charge medication reminders may improve pharmaceutical care, nurse–patient 
interaction, and the effect and safety of medication. It finally may lead to delay 
disease progression and the development of complications, and also may contribute 
to reduced healthcare costs for health systems and the people who use them. 
(b) to the investigator? 
This study will help investigator to complete the research project required for 
achieving postgraduate degree and to explore the effectiveness of a research-tested 
strategy as a complementary service to cardiac rehabilitation focused on medication 
adherence. The success of this study will indicate that mobile health intervention 
may improve the effect and safety of medication taking, clinical outcomes, and 
nurse–patient interaction after discharge.  
What are the possible drawbacks? 
There are no draw backs for the participants of this study. 
Can I refuse to take part in the study? 
Yes. 
Who should I contact if I have additional questions during the course of the 
study? 
Researcher’s Name: Sahar Khonsari       
Tel: Telephone number was added 
Local Supervisor’s Name: Professor Alireza Nikbakht Nasrabadi       











Document Title: Staff Information Sheet 
Version: 1.1  
Date:  
Study Title: Development of a Mobile Health Intervention for Outpatients 
Cardiac Rehabilitation: A Feasibility Study to Evaluate Impact on Medication 
Adherence 
You are invited to take part in a research study. Before you decide whether or not to 
take part, it is important you understand why the research is being done and what it 
will involve. Please read the following information carefully. If there is anything that 
is not clear please do not hesitate to contact me. 
Introduction 
The immediate discharge period is a time of high risk for non-adherence to 
prescribed medications. Nearly 1 in 4 patients is partially or completely non-adherent 
in filling prescriptions after discharge. Cardiovascular patients may face significant 
health problems related to the premature discontinuation of therapies after discharge. 
Evidence-based interventions that assist adherence to prescribed medications have 
the potential to delay disease progression and the development of complications, 
contributing to reduced healthcare costs for healthcare systems and the people who 
use them. Therefore the researcher aims to develop and evaluate the effect of mobile 
phone reminders on medication adherence in outpatients Cardiac Rehabilitation. 
During the first phase of the study, focus group interviews will be carried out to 
identify cardiac nurses’ views and experiences towards mobile phone interventions 
improve medication adherence. 
What is the purpose of this study? 
As part of my PhD, I am conducting a study; developing mobile phone reminders to 
improve medication adherence of cardiac rehabilitation patients. I wish to gain an 
insight into the experiences of the cardiac nurses from their perspectives and identify 
potential barriers or challenges related to using mobile phone medication reminders 
based on their clinical observations and thoughts that then guide the development of 
an appropriate, patient-centred intervention. 
What it will involve for you? 
If you decide to take part in this research study, I will conduct a digitally recorded 
group discussion. This will take place at an appropriate time and place that will be 
arranged with you prior to the session. You must have a work experience in cardiac 
rehabilitation and/ or cardiology wards to participate in the study. The interviews will 
last for approximately 1 hour. 
Do I have to take part? 
Taking part is completely voluntary; you are not obliged to take part. 
What will happen if I want to take part? 
If you decide to take part in this research study, you will be asked to sign a consent 
form. The interview will be digitally recorded and then transcribed (written up). All 




ensure you remain anonymous. The interview data and quotes from your interview 
will be used in my PhD thesis and/or in articles published in journals - once again all 
the data will be anonymously coded. Both the digital data and written data gathered 
will be stored securely on password protected computers in a locked room and may 
be kept until data analysis is deemed complete. You are free to withdraw from the 
study at any time, without giving any reason.  
What are the possible drawbacks? 
There are no draw backs for the participants of this study. 
Can I refuse to take part in the study? 
Yes. 
Who should I contact if I have additional questions during the course of the 
study? 
Researcher’s Name: Sahar Khonsari       
Tel: Telephone number was added 
Local Supervisor’s Name: Professor Alireza Nikbakht Nasrabadi       





Appendix 20: Participants’ Consent Forms 
Document Title: Patients’ Consent Form 
Centre Number:  
Study Number: 
Participant Identification Number for this study: 
CONSENT FORM 
Title of Project: Development of a Mobile Health Intervention for Outpatients 
Cardiac Rehabilitation: A Feasibility Study to Evaluate Impact on Medication 
Adherence 
Name of Researcher: Sahar Khonsari 
Please initial box  
1. I confirm that I have read the information sheet dated.................... 
(version............) for the above study. I have had the opportunity to consider 
the information, ask questions and have had these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason, without my medical care or 
legal rights being affected. 
 
3. I understand that relevant sections of my medical notes and data collected 
during the study may be looked at by individuals from the University of 
Edinburgh and Tehran University of Medical Sciences, where it is relevant to 
my taking part in this research. I give permission for these individuals to have 
access to my records.  
 
4. I understand that the information collected about me will be used to support 
other research in the future, and may be shared anonymously with other 
researchers. 
 
5. I understand that my phone number will be shared with a text messaging 
service provider anonymously and my mobile phone number would not be 
sold or passed on to a third party in any case without my explicit consent. 
 




Name of Participant Date  Signature 
Name of Person taking consent         Date Signature 
            
      
 




Document Title: Staffs’ Consent Form 
Centre Number:  
Study Number: 
Participant Identification Number for this study: 
CONSENT FORM 
Title of Project: Development of a Mobile Health Intervention for Outpatients 
Cardiac Rehabilitation: A Feasibility Study to Evaluate Impact on Medication 
Adherence 
Name of Researcher: Sahar Khonsari 
1. I confirm that I have read the information sheet dated.................... 
(version............) for the above study. I have had the opportunity to 
consider the information, ask questions and have had these answered 
satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time 
without giving any reason, without my medical care or legal rights 
being affected. 
 
3. I understand that relevant sections of my medical notes and data 
collected during the study may be looked at by individuals from the 
University of Edinburgh and Tehran University of Medical Sciences, 
where it is relevant to my taking part in this research. I give 
permission for these individuals to have access to my records. 
 
4. I understand that the information collected about me will be used to 
support other research in the future, and may be shared anonymously 
with other researchers. 
 
5. I give permission for the audio-recording of my interview and 
possible use of (anonymised) quotes using my exact words. 
 





Name of Participant Date  Signature 
Name of Person taking consent         Date Signature 




Appendix 21: Permission Letter for Access to the Study Settings in 










In the name of God, the Beneficent, the Merciful 
 











for Research  
 
Dear Vice Chancellor for Research in Iran University of Medical Sciences 
Dear Vice President of Tehran Heart Centre 
Dear Vice President of Dr. Shariati Hospital 
Title of Project: Development of a Mobile Health Intervention for Outpatients 
Cardiac Rehabilitation: A Feasibility Study to Evaluate Impact on Medication 
Adherence. Ethics Approval Code: 92-04-28-28802-145738 Approval Date: 
2015/4/21 
Principal investigator: Alireza Nikbakht Nasrabadi  
PhD student: Sahar Khonsari 
are introduced to you. Please cooperate with them in conducting the above research 
project.  
Research findings will be reported to you at the completion of the study in future. 
 
Dr. Mojgan Karbakhsh Davari 
Director of Research and Technology 












Translated – version: 




Dear Mrs. Sahar Khonsari 
Greetings 
That is to inform you that your research proposal numbered 768 entitled: 
“Development of a Mobile Health Intervention for Outpatients Cardiac 
Rehabilitation: A Feasibility Study to Evaluate Impact on Medication Adherence” 
has been reviewed and approved in the 126
th
 Research Ethics Committee Meeting on 
September 28, 2015. 
 
Dr Saeed Sadeghian 
Vice Chancellor of Research 
Tehran Heart Centre 
Signed 
 
 
 
